UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

iQSTEL INC.

(Exact name of registrant as specified in its charter)

Nevada

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM S-1/PRE-EFFECTIVE AMENDMENT NO. 5

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


B-MAVEN, INC.

(Exact name of registrant as specified in its charter)

4813

NEVADA

45-2808620

(State or other jurisdiction of

incorporation or organization)

5122

(Primary Standard Industrial

Classification Code Number)

45-2808620

(I.R.S. Employer

Identification Number)

3272 Reynard Way, San Diego, CA 92103

619-846-4614

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

The Corporate Place, Inc., 601 E. Charleston Street, Suite 100, Las Vegas, NV, 89104

801-885-0113

(Name, address, including zip code, and telephone number, including area code, of agent of service)


Copies of communications to:

Quick Law Group P.C.

1035 Pearl Street, Suite 403

Boulder, Colorado 80302

720-259-2292

Attn: Jeffrey M. Quick


From time to time after the effective date of this Registration Statement

(Approximate date of commencement of proposed sale to the public)


300 Aragon Avenue, Suite 375

Coral Gables, FL33134

Phone: (954) 951-8191

(Address and telephone number of principal executive offices and principal place of business)

The Corporate Place, Inc.

601 E. Charleston Blvd. Ste. 100

Las Vegas, NV 89104

Phone: (877) 786-8500

(Name, address and telephone number of agent for service)

With copy to:

Scott Doney, Esq.

The Doney Law Firm

4955 S. Durango Dr. Ste. 165

Las Vegas, NV 89113

Phone: (702) 982-5686

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

If any of the securities being registered on this Formform are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box:   X.box.


If this Formform is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. .


If this Formform is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. .


If this Formform is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer," "accelerated” “accelerated filer,” “smaller reporting company” and "smaller reporting company"“emerging growth company” in Rule 12b-2 of the Exchange Act (Check One):Act:


Large accelerated filer

.

Accelerated filer

.

Non-accelerated filer

.(Do not check if a smaller reporting company)

Smaller reporting company

 X.

Emerging growth company




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.



CALCULATION OF REGISTRATION FEE



Title of Each Class Of Securities To Be Registered

 



Amount To Be

Registered

 

Proposed

Maximum

Offering Price

Per Share1

 


Proposed Maximum

Aggregate Offering

Price1

 


Amount of

Registration

Fee

 

 

 

 

 

 

 

 

 

Common stock, $ .001

par value per share

 

2,500,000 shares

 

$ .01

 

$ 25,000

 

$ 2.91



The registrantRegistrant hereby amends this registration statementRegistration Statement on such date or dates as may be necessary to delay its effective date until the registrantRegistrant shall file a further amendment which specifically states that this registration statementRegistration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statementRegistration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.


__________________________

1

Estimated solely for purposed of calculating the registration fee under Rule 457(a) and (o) of the Securities Act.





The information contained in this preliminary prospectus is not complete and may be changed. TheseNeither we nor the selling shareholders may sell these securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.


Subject to completion May 11, 2012

2,500,000 SHARES

COMMON STOCK

B-MAVEN, INC.


B-Maven, Inc. (“BMI” or the “Company”) is offering for sale a maximum of 2,500,000 shares of its common stock at a fixed price of $.01 per share. There is no minimum number of shares that must be sold by us for the offering to close, and we will retain all the proceeds from the sale of any of the offered shares that are sold. The offering is being conducted on a self-underwritten, direct primary basis, which means our president and chief executive officer, Ms. Anna C. Jones, will attempt to sell the shares herself. This prospectus will permit our president and chief executive officer to sell the shares directly to the public, with no commission or other remuneration payable to her for any shares she may sell. Ms. Jones will sell the shares and intends to offer them to friends, family members and business acquaintances. In offering the securities on our behalf, she will rely on the safe harbor from broker-dealer registration set out in Rule 3a4-1 under the Securities and Exchange Act of 1934. The intended methods of communication include, without limitations, telephone and personal contact. For more information, see the section of this prospectus entitled "Plan of Distribution."


The proceeds from the sale of the shares in this offering will be payable to Quick Law Group, P.C. - COLTAF Account. All subscription funds will be held in a noninterest-bearing account pending the completion of the offering. The offering will be completed 180 days from the effective date of this prospectus, unless extended by our board of directors for an additional 180 days. There is no minimum number of shares that must be sold. All subscription agreements and checks for payment of shares are irrevocable (except as to any states that require a statutory cooling-off period or provide for rescission rights). For more information, see the section of this prospectus entitled "Plan of Distribution."


There is currently no public or established market for our shares. Consequently, our shareholders will not be able to sell their shares in an organized market place and may be limited to selling their shares privately. Accordingly, an investment in our Company is considered an illiquid investment.


We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. See “ Risk Factors ” beginning on page 6.


THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE "RISK FACTORS" BEGINNING ON PAGE6 

Number of Shares

Offering Price

Underwriting Discounts & Commissions

Proceeds to the Company

 

 

 

 

 

Per Share

1

$0.01

$0.00

$0.01

Total

2,500,000

$25,000

$0.00

$25,000


This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is prohibited.

Subject to completion, dated February 13, 2024

PRELIMINARY PROSPECTUS

32,222,222 Shares of Common Stock

This prospectus covers the resale by the selling shareholders of iQSTEL Inc. (“iQSTEL,” “we,” “us”, “our” or the “Company”) identified in the “Selling Shareholders” section of this prospectus of up to an aggregate of 32,222,222 shares of our common stock, including 2,020,202 shares of common stock, 20,202,020 shares of common stock issuable upon conversion of a secured convertible promissory note (the “Note”) and 10,000,000 shares of common stock issuable upon exercise of a common stock purchase option (the “Option”). We will not permitted.receive any of the proceeds from the sale of shares of our common stock or conversion of the Note by the selling shareholders. We will receive cash from the sale of the Option, if exercised, which we intend to use as working capital.


The selling shareholders or their permitted transferees, pledgees, assignees, distributees, donees or successors or others who later hold any of the selling shareholders’ interests in the shares of common stock described this prospectus may offer and sell the shares of common stock described in this prospectus in a number of different ways and at varying prices. We provide more information about how the selling shareholders may sell their shares of common stock in the section titled “Plan of Distribution” appearing elsewhere in this prospectus. If necessary, the specific manner in which the shares may be offered and sold will be described in a supplement to this prospectus. We will pay the expenses incurred in registering the securities covered by the prospectus, including legal and accounting fees.

Our common stock is quoted on OTCQX Market under the symbol “IQST.” The last reported sale price of our common stock on February 9, 2024, was $0.261 per share.

You should read this prospectus, together with additional information described under the headings “Information Incorporated by Reference” and “Where You Can Find More Information,” carefully before you invest in any of our securities.

Investing in our securities involves risks. See the section titled “Risk Factors” beginning on page 6 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacydetermined if this prospectus is truthful or accuracy of the prospectus.complete. Any representation to the contrary is a criminal offense.


The date of this prospectus is ___, 2012.February 13, 2024



3



PROSPECTUS SUMMARY

About B-Maven, Inc.TABLE OF CONTENTS


B-Maven, Inc. was

INFORMATION CONTAINED IN THIS PROSPECTUS1
WHERE YOU CAN FIND MORE INFORMATION1
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE2
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS3
SUMMARY OF THE OFFERING4
RISK FACTORS6
MANAGEMENT17
EXECUTIVE COMPENSATION23
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS25
PRINCIPAL STOCKHOLDERS25
DESCRIPTION OF CAPITAL STOCK27
PRIVATE PLACEMENT OF NOTE AND OPTION30
USE OF PROCEEDS30
SELLING SHAREHOLDER31
PLAN OF DISTRIBUTION32
LEGAL MATTERS34
EXPERTS34
MATERIAL CHANGES34
DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES34

i

INFORMATION CONTAINED IN THIS PROSPECTUS

We incorporate by reference important information into this prospectus. You may obtain the information incorporated by reference without charge by following the instructions under the laws of the State of Nevada on June 24, 2011, at which time it acquired certain formulas for skin care products from Ms. Anna C. Jones. At May 11, 2012, we had one employee, our founder and president, Anna C. Jones. During the period June 24, 2011 (date of inception) through March 31, 2012, Ms. Jones has devoted a minimum of five (5) hours per week to in excess of thirty (30) hours per week as necessary for the business and its development. For calendar year 2012, Ms. Jones will commit to providing at least fifteen (15) hours a week to us but may increase that number as necessary to continue to develop the business. As of“Where You Can Find More Information.” You should carefully read this date and throughout calendar year 2012 Ms. Jones will continue to provide these services at no cost to the Company. Ms. Jones currently provides her services to another unrelated business upon which she is compensated through a paycheck.


The Company issued 5,000,000 shares of its common stock to Ms. Jones at inception in exchange for organizational costs/services incurred upon incorporation. These services were valued at $5,000. Following our formation, we issued an additional 2,500,000 shares of our common stock to Ms. Jones, in exchange for various formulas that she had developed over the preceding 12 months which consists of a combination of essential oils and other all natural products, and numerous samples of productprospectus as well as older formula product samples whichadditional information described under “Incorporation of Certain Information by Reference,” before deciding to invest in our securities.

Unless the context otherwise may be used as testersrequires, “iQSTEL,” “Company,” “we,” “us” and “our” refer to iQSTEL Inc., and M2B Funding Corp and ADI Funding LLC refer to the selling shareholders identified in focus groups, additional raw materials, customer lists, before and after photographs, testimonials that can be used in marketing materials along with edited user information. The cost of formula development and other materials incurred by Ms. Jones was approximately $2,500 which is the value placed upon the shares issued to Ms. Jones. The Company as“Selling Shareholders” section of this date believesprospectus and its respective permitted transferees, pledgees, assignees, distributees, donees or successors or others who later hold any of the selling shareholder’s interests in any of the securities. References to “securities” include any security that these formulas can be used to develop at least eight distinct products.


B-Maven, Inc. is an early stage company (“development stage”) and has no financial resources. We have not established or attempted to establish a source of equity or debt financing. Our auditors included an explanatory paragraph in their report on our financial statements that states that “the Company’s losses from operations raise substantial doubt about its ability to continue as a going concern.”


The Company has no plans or intention to be acquired or merge with an operating business entity nor does the Companyselling shareholders might offer under this prospectus or any of its shareholders have any plans to enter into any change of control or similar types of transactions.


At the time of this filing, we are a “shell company” as such term is defined by Rule 405 of the Securities Act and Rule 12b-2 of the Exchange Act.


BMI is in the business of developing, manufacturing, marketing and selling the E-Scentual Skin Care Collection, a skin care line combining science with nature to form what we believe to be an advanced beauty treatment using all natural ingredients. Specifically, BMI believes it has developed what it calls its basic “E-Scentual” product line, a proprietary anti-aging formula that will make up the main ingredient in our E-Scentual Skin Care Collection. BMI owns the intellectually property relating to E-Scentual, including the unique formulation of natural ingredients.


Based on the E-Scentual product formulations, BMI is developing a full spectrum of skin care products designed to naturally improve skin wellness and provide anti-aging properties through its E-Scentual Skin Care Collection. The E-Scentual system will combine science with nature to form an advanced beauty treatment, using a variety of essential oils and other naturally produced and available ingredients. Utilizing aromatherapy and a variety of specific actives and botanically-based formulas that include our proprietary process, E-Scentual products are intended to deliver a dramatic improvement in the general health, well-being and increased vitality for the user in great looking skin. The Company is currently developing and testing its own products through the skills of its president, engaging in discussions with potential suppliers, vendors, and distributors that could eventually help establish and sell our products into the marketplace. To date no saleable product or sales have been generated from these development efforts. We believe that BMI’s products, when available, will stimulate cell renewal, prevent and reduce the appearance of wrinkle and fine lines, dark circles, spider veins, rosacea, varicose veins and reduce under eye puffiness. Our initial internal observations based on limited product development procedures and product testing primarily in the San Diego area has shown these effects. However, we cannot guarantee that our products, once developed will have these qualities or generate such positive results on a widespread basis or otherwise.prospectus supplement.

 

We believe that E-Scentual, our intellectual property, is a unique formula blend made of essential oils, natural botanicals and other native ingredients that provide nourishmenthave filed or incorporated by reference exhibits to the skin. These formula blends rapidly penetrateregistration statement of which this prospectus forms a part. You should read the skin delivering essential nutrients beneathexhibits carefully for provisions that may be important to you.

We have not authorized any dealer, salesperson or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus. This prospectus does not constitute an offer to sell or the top layersolicitation of skinan offer to buy any securities other than the registered securities to which it relates, nor does this prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the body uses in its natural process of collagen regeneration. Numerous anecdotal stories have described a dramatic decrease in the appearance of fine lines and wrinkles after regular use of the E-Scentual formula derived sample products.


Our executive offices are located at 3272 Reynard Way, San Diego California, 92103, and our telephone number is 619-846-4614. We may refer to ourselvesinformation contained in this prospectus as “BMI,”is accurate on any date subsequent to the “Company,” "we,"date set forth on its front cover or "us.”




The Offering


BMIthat any information we have incorporated by reference is offering for sale a maximum of 2,500,000 shares of common stock at a fixed price of $0.01 per share. There is no minimum number of shares that must be sold by us forcorrect on any date subsequent to the offering to close, and we will retain the proceeds from the sale of anydate of the offered shares thatdocument incorporated by reference, even though this prospectus is delivered or securities are sold. The offering is being conductedsold on a self-underwritten, direct primary basis, which means our president and chief executive officer, Ms. Jones, will attempt to sell the shares. This prospectus will permit our president and chief executive officer to sell the shares directly to the public, with no commission or other remuneration payable to her for any shares she may sell. Ms. Jones will sell the shares and intends to offer them to friends, family members and business acquaintances. In offering the securities on our behalf, she will rely on the safe harbor from broker-dealer registration set out in Rule 3a4-1 under the Securities and Exchange Act of 1934 (the "Exchange Act"). The intended methods of communication include, without limitations, telephone and personal contact.


The proceeds from the sale of the shares in this offering will be made payable to Quick Law Group P.C. – COLTAF Account, BMI’s fund retention agent. Quick Law Group P.C., acts as legal counsel for BMI and, therefore, may not be considered an independent third party. All subscription agreements and checks are irrevocable and should be delivered to the Quick Law Group P.C. at the address provided on the Subscription Agreement (see Exhibit 99.1a).


All subscription funds will be held in a noninterest-bearing account pending the completion of the offering. The offering will be completed 180 days from the effective date of this prospectus, unless extended by our board of directors for an additional 180 days. There is no minimum number of shares that must be sold. All subscription agreements and checks for payment of shares are irrevocable (except as to any states that require a statutory cooling-off period or provide for rescission rights).


The Company will deliver stock certificates attributable to the shares of common stock purchased directly by the purchasers within 30 days of the close of the offering or as soon thereafter as practicable.


The offering price of the common stock has been determined arbitrarily and bears no relationship to any objective criterion of value. The price does not bear any relationship to our assets, book value, historical earnings (if any), or net worth.


Shares of common stock offered by us

A maximum of 2,500,000 shares. There is no minimum number of shares that must be sold by us for the offering to close.

Use of proceeds

BMI will use the proceeds from the offering to pay for professional fees and other general expenses. The total estimated costs of the offering ($65,000) exceeds the maximum amount of offering proceeds ($25,000).

Termination of the offering

The offering will conclude when all 2,500,000 shares of common stock have been sold, or 180 days after this registration statement becomes effective with the Securities and Exchange Commission. BMI may at its discretion extend the offering for an additional 180 days.

Risk factors

The purchase of our common stock involves a high degree of risk. The common stock offered in this Prospectus is for investment purposes only and currently no market for our common stock exists. Please refer to the sections entitled "Risk Factors" and "Dilution" before making an investment in our common stock.

Trading market


None. While a market maker has agreed to file a Rule 211 application with the Financial Industry Regulatory Authority (“FINRA”) in order to apply for the inclusion of our common stock in the Over-the-Counter Bulletin Board (“OTCBB”), such efforts may not be successful and our shares may never be quoted and therefore owners of our common stock may not have a market in which to sell their shares. Also, no estimate may be given as to the time that this application process will require.


Even if BMI's common stock is quoted or granted listing, a market for the common shares may never develop.




5



SUMMARY FINANCIAL DATA


The following summary financial data should be read in conjunction with the financial statements and the notes thereto included elsewhere in this prospectus.


Balance Sheet Data:

 

 

 

 

 

 

As of

March 31, 2012

 

As of

June 30, 2011

 

 

(unaudited)

 

 

 

 

 

 

 

Current assets

$

2,605

$

-

 

 

 

 

 

Other Assets

$

28,286

$

2,500

 

 

 

 

 

Current liabilities

$

44,784

$

665

 

 

 

 

 

Stockholders’ equity (deficit)

$

(13,893)

$

1,835


Operating:

 

For the

Nine Month

Period Ended

March 31, 2012

 

For the Period

June 24, 2011

(inception) to

June 30, 2011

 

 

(unaudited)

 

 

Net revenues

$

-

$

-

Operating expenses

$

15,728

$

5,665

Net (loss)

$

(15,728)

$

(5,665)

Net (loss) per common share basic and diluted

$

(0.00)

$

(0.00)

Weighted average number of shares outstanding – basic and diluted

 

7,500,000

 

,285,714


RISK FACTORS


You should be aware that there are various risks to an investment in our common stock. You should carefully consider these risk factors, together with all of the other information included in this prospectus, before you decide to invest in shares of our common stock.


If any of the following risks develop into actual events, then ourlater date. Our business, financial condition, results of operations and/and prospects may have changed since those dates.

WHERE YOU CAN FIND MORE INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act for the securities being offered by this prospectus. This prospectus, which is part of the registration statement, does not contain all of the information included in the registration statement and the exhibits. For further information about us and the securities offered by this prospectus, you should refer to the registration statement and its exhibits. References in this prospectus to any of our contracts or prospects couldother documents are not necessarily complete, and you should refer to the exhibits attached to the registration statement for copies of the actual contract or document. SEC filings are also available to the public at the SEC’s website at www.sec.gov.

We are subject to the reporting and information requirements of the Exchange Act and, as a result, we file periodic and current reports, proxy statements and other information with the SEC. We make our periodic reports and other information filed with or furnished to the SEC, available, free of charge, through our website as soon as reasonably practicable after those reports and other information are filed with or furnished to the SEC. Additionally, these periodic reports, proxy statements and other information are available for inspection and copying at the public reference room and website of the SEC referred to above.

1
Table of Contents

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

The SEC allows us to “incorporate by reference” information from other documents that we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents listed below that we have filed with the SEC (other than any filing or portion thereof that is furnished, rather than filed, under applicable SEC rules):

our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on April 14, 2023;
our Quarterly Reports on Form 10-Q for the periods ended March 31, 2023,  June 30, 2023, and September 30, 2023, filed with the SEC on May 15, 2023, August 14, 2023, and November 14, 2023, respectively;
our Current Reports on Form 8-K (or Form 8-K/A) filed with the SEC on February 13, 2024, February 8, 2024, February 5, 2024, January 25, 2024, January 2, 2024, June 13, 2023, March 21, 2023, February 6, 2023, December 14, 2022, November 18, 2022, November 2, 2022, October 6, 2022, October 5, 2022, May 10, 2022, and April 26, 2022,
the description of our common stock contained in our Registration Statement on Form 8-A (File No. 000-55984), filed with the SEC pursuant to Section 12(g) of the Exchange Act on September 5, 2018, as may be amended, including any further amendment or report filed hereafter for the purpose of updating such description.

Additionally, all documents filed by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after (i) the date of the initial registration statement and prior to effectiveness of the registration statement, and (ii) the date of this prospectus and before the termination or completion of any offering hereunder, shall be deemed to be incorporated by reference into this prospectus from the respective dates of filing of such documents, except that we do not incorporate any document or portion of a document that is “furnished” to the SEC, but not deemed “filed.”

Upon written or oral request made to us at the address or telephone number below, we will, at no cost to the requester, provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in this prospectus (other than an exhibit to a filing, unless that exhibit is specifically incorporated by reference into that filing), but not delivered with this prospectus. You may also access this information on our website at www.iqstel.com and the URL where incorporated reports and other reports may be accessed is http://iqstel.com/investors.

Alvaro Quintana Cardona

Chief Financial Officer

iQSTEL Inc.

300 Aragon Avenue, Suite 375

Coral Gables, FL 33134

Phone: (954) 951-8191

Except as expressly provided above, no other information, including none of the information on our website, is incorporated by reference into this prospectus or any supplement to this prospectus. You should not consider any information on, or that can be accessed through, our website as part of this prospectus or any supplement to this prospectus (other than those filings with the SEC that we specifically incorporate by reference into this prospectus or any supplement to this prospectus).

Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement.

2
Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus contains forward-looking statements. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, prospective products, product approvals, timing and likelihood of success, plans and objectives of management for future operations, and future results of current and anticipated products are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially adversely affected. Ifdifferent from any future results, performance or achievements expressed or implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this prospectus are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that happens,we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this prospectus and are subject to a number of risks, uncertainties and assumptions. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

This prospectus also contains estimates and other statistical data made by independent parties and by us relating to market pricesize and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions and estimates of our common stock, if any, could decline,future performance and investors may losethe future performance of the markets in which we operate are necessarily subject to a high degree of uncertainty and risk. 

3
Table of Contents

SUMMARY OF THE OFFERING

This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information that you should consider before deciding to invest in our securities. You should read this entire prospectus carefully, including the “Risk Factors” section in this prospectus and under similar captions in the documents incorporated by reference into this prospectus.

Business Overview

iQSTEL Inc. (www.iqstel.com) is a technology company with a presence in 19 countries and 70 employees that is offering leading-edge services through its business divisions.

Our Telecom Division, which represents the majority of current operations and which also represents the source for all of our revenues for the financial periods presented, offers VoIP, SMS, proprietary Internet of Things (IoT) solutions (www.iotsmartgas.com and www.iotsmarttank.com), and international fiber-optic connectivity through its subsidiaries: Etelix (www.etelix.com), SwissLink Carrier (www.swisslink-carrier.com), Smartbiz Telecom (www.smartbiztel.com), Whisl Telecom (www.whisl.com), IoT Labs (www.iotlabs.mx), and QGlobal SMS (www.qglobalsms.com).

Our developing Fintech Business Line (www.globalmoneyone.com) (www.maxmo.vip) offers a complete Fintech ecosystem MasterCard Debit Card, US Bank Account (No SSN Needed), Mobile App/Wallet (Remittances, Mobile Top Up). Our Fintech subsidiary, Global Money One, is to provide immigrants access to reliable financial services that makes it easier to manage their money and stay connected with their families back home.

Our developing BlockChain Platform Business Line (www.itsbchain.com) offers our proprietary Mobile Number Portability Application (MNPA) to serve the in-country portability needs through its subsidiary, itsBchain.

Our developing Electric Vehicle (EV) Business Line (www.evoss.net) offers electric motorcycles for work and recreational use in the USA, Spain, Portugal, Panama, Colombia, and Venezuela. EVOSS is also working on the development of an EV Mid Speed Car to serve the niche of the 2nd car in the family.

Our Artificial Intelligence (AI)-Enhanced Metaverse Division (information and content) is currently developing a groundbreaking white-label solution designed specifically for corporations, businesses, and the telecommunications industry. Delivering a full suite of immersive content services, creating a comprehensive virtual experience that can be accessed through the Web or our proprietary mobile apps. The features include up to four simultaneous video screens for versatile content presentation, various virtual halls such as the main hall, home hall, auditorium, exhibition space, shopping center, and meeting rooms. Stands for mobile application downloads, clickable gates for immediate purchasing, and direct communication tools are seamlessly integrated to foster collaboration, engagement, and interactivity. It goes beyond traditional virtual spaces by utilizing cutting-edge AI technology. This ensures video conferencing and real-time communication with other users within the Metaverse, offering our customers a collective and fully immersive experience that caters to diverse needs such as content acquisition, entertainment, and shared virtual experiences. It is a future-ready platform that encourages creativity, connectivity, and collaboration like never before.

The information contained on our websites is not incorporated by reference into this prospectus and should not be considered part of their investment.this or any other report filed with the SEC.

4
Table of Contents


Going Concern Considerations

Risks RelatedOur consolidated financial statements incorporated into this prospectus have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. We have suffered recurring losses from operations with an accumulated deficit of $25,960,018 as of September 30, 2023, and do not have an established source of revenues sufficient to the Business


1.

BMI has virtually no financial resources. Our independent registered auditors’ report includes an explanatory paragraph stating that there iscover our operating costs. These conditions raise substantial doubt about our ability to continue as a going concern.


BMI is an early stage company and has virtually no financial resources. We have negative working capital of $42,179 and stockholders’ deficit of $13,893 at March 31, 2012. Our independent registered auditors included an explanatory paragraph in their opinion on ourconcern. The consolidated financial statements asdo not include any adjustments that might result from the outcome of and for the period ended June 30, 2011 that Company losses from operations raise substantial doubt about itsthis uncertainty.

Our ability to continue as a going concern. No assurancesconcern is dependent upon raising capital from financing transactions, increasing revenue, and keeping operating expenses below our revenue levels in order to achieve positive cash flows, none of which can be given that weassured.

During the next year, our foreseeable cash requirements will generate sufficient revenue or obtain necessary financingrelate to continue as a going concern.


2.

BMI is and will continue to be completely dependent oncontinual development of the servicesoperations of our founderbusiness, maintaining our good standing in the industry and president, Anna C. Jones, the loss of whose servicescontinuing our marketing efforts. We may cause our business operationsexperience a cash shortfall and be required to cease.raise additional capital.


BMI’s operations and business strategy are completely dependent upon the knowledge and business connections of Ms. Jones. She is under no contractual obligation to remain employed by us. If she should choose to leave us for any reason or if she becomes ill and is unable to work for an extended period of time beforeHistorically, we have hiredrelied upon funds from our stockholders in the sale of our securities and from third-party loans. Management may raise additional personnel,capital through future public or private offerings of our operations will likely fail. Even if we are able to find additional personnel, it is uncertain whether we could find someone who could develop our business along the lines described in this prospectus. We will most likely fail without the services of Ms. Jonesstock or an appropriate replacement(s).




We intend to acquire key-man life insurance on the life of Ms. Jones naming us as the beneficiary when and if we obtain the resources to do so and if she is insurable. We have not yet procured such insurance, andthrough loans from investors, although there iscan be no guaranteeassurance that we will be able to obtain such insurancefinancing. Our failure to do so could have a material and adverse effect upon our operations and our stockholders.

The Offering

Common stock offered by the selling shareholderUp to up to an aggregate of 32,222,222 shares of our common stock, including 2,020,202 shares of common stock, 20,202,020 shares of common stock issuable upon conversion of the Note, and 10,000,000 shares of common stock issuable upon exercise of the Option.
Use of ProceedsWe will not receive any of the proceeds from the sale of the shares of common stock or conversion of Note by the selling shareholders pursuant to this prospectus. We will receive cash from the sale of the Option, if exercised, which we intend to use as working capital.
Offering PriceThe selling shareholders may sell all or a portion of their shares through public or private transactions at prevailing market prices or privately negotiated prices.
Risk FactorsAn investment in our securities involves a high degree of risk. See the section entitled “Risk Factors” of this prospectus and the similarly titled sections in the documents incorporated by reference into this prospectus.
OTCQX symbolIQST

5
Table of Contents

RISK FACTORS

Investing in our common stock involves a high degree of risk. You should carefully consider the future.


following risk factors and all other information contained in this prospectus before purchasing our common stock. If any of the following risks actually occur, we may be unable to conduct our business as currently planned and our financial condition and results of operations could be seriously harmed. In addition, the trading price of our common stock could decline due to the occurrence of any of these risks, and you may lose all or part of your investment. The risks and uncertainties discussed below are not the only ones we face. Our business, results of operations, financial condition or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. In assessing the risks and uncertainties described below, you should also consider carefully the other information contained in this prospectus before making a decision to invest in our common stock.

3.

Risk Factors Related to the Financial Condition of the Company

BMI will needBecause our auditor has issued a going concern opinion regarding our company, there is an increased risk associated with an investment in our company.

We have continually operated at a loss with an accumulated deficit of $25,960,018 as of September 30, 2023. We have not attained profitable operations and are dependent upon obtaining financing or generating revenue from operations to engage and retain qualified employees and consultants. No assurance can be givencontinue operations for the next twelve months. Our future is dependent upon our ability to obtain financing or upon future profitable operations. We reserve the right to seek additional funds through private placements of our common stock and/or through debt financing. Our ability to raise additional financing is unknown. We do not have any formal commitments or arrangements for the advancement or loan of funds. For these reasons, our auditors stated in their report that they have substantial doubt we will be able to attract these employees or consultants when needed.continue as a going concern. As a result, there is an increased risk that you could lose the entire amount of your investment in our company.

Because we have a limited operating history, you may not be able to accurately evaluate our operations.


The interruption of services of Anna C. Jones willWe have had limited operations to date. Therefore, we have a material adverse effectlimited operating history upon which to evaluate the merits of investing in our company. Potential investors should be aware of the difficulties normally encountered by new companies and the high rate of failure of such enterprises. The likelihood of success must be considered in light of the problems, expenses, difficulties, complications and delays encountered in connection with the operations that we plan to undertake. These potential problems include, but are not limited to, unanticipated problems relating to the ability to generate sufficient cash flow to operate our business and additional costs and expenses that may exceed current estimates. We expect to continue to incur significant losses into the foreseeable future. We recognize that if the effectiveness of our business plan is not forthcoming, we will not be able to continue business operations. There is no history upon which to base any assumption as to the likelihood that we will prove successful, and it is doubtful that we will generate any operating revenues or ever achieve profitable operations. If we are unsuccessful in addressing these risks, our business will most likely fail.

We are dependent on outside financing for the continuation of our operations.

Because we have generated limited revenues and currently operate at a loss, we are completely dependent on the Company's future operations, potential profits and development, if suitable replacements are not promptly obtained, and there can be no assurance that such key personnel would accept compensation other than cash for their servicescontinued availability of financing in the future. In addition, the Company's success depends, in part, upon its abilityorder to attract and retain other talented personnel.continue our business operations. There can be no assurance that the Companyfinancing sufficient to enable us to continue our operations will be ableavailable to attract and retain such personnel necessary forus in the future.

We will need additional funds to complete further development of the Company’s business.


4.

Because we have only recently commenced business operations, we face a high risk of business failure.


We were formed in June 2011. All of our efforts to date have been related to developing our business plan creating and modifying formulas which will make up our E-Scentual product line, beginningto achieve a sustainable level where ongoing operations can be funded out of revenues. We anticipate that we must raise for the next 12 months: $1,750,000 for acquisitions to fully implement our business activitiesplan to its fullest potential and the pursuit of this public offering. Through March 31, 2012, we had no operating revenues and have distributed only samples ofachieve our planned products to potential customers or end-users. We face a high risk of business failure.


5.

Because we will operate in a highly competitive direct response market and retail environment, we face a high risk of business failure or at the very least a competitive disadvantage.


We are aware of many competitors to our skin care collection, many of which are more established and have significantly more financial resources than we do. Our success in this industry will be largely dependent on our ability to educate the consumer as to why our product will be better than our competition’s and establish the consumer’s need for our intended products. Our ability to compete effectively in this industry also depends on our ability to be competitive in pricing, servicing and performance.


6.

Because we will be dependent on advertising and marketing firms, we will be at a competitive disadvantage to companies having greater resources to pay larger fees.


We will require aggressive efforts in placing quality advertisements for our budgeted price that will reach the expected number of consumers. We do not know if we will be able to obtain optimal advertising placement within our projected budget or will even find advertising placement.


7.

We have had no product sales to date, and we can give no assurance that there will ever be any sales in the future.


All of our skincare products are still being developed and tested, and we have not generated any revenues from product sales.growth plans. There is no guarantee that we will ever develop commercially viable products. To become profitable, we will have to successfully develop, manufacture, market and sell a number of skincare products. There can be no assurance that our product development efforts will be successfully completed, that we will be able to manufacture our products at an acceptable cost and with acceptable quality, or that our products can be successfully marketed in the future. We currently do not expect to receive revenues from the sale of any products until sometime late in 2012, if ever.


8.

There is no guarantee that our products will be accepted by consumers.


We have not yet commercially released any of our proposed products. The market acceptance of skincare and cosmetic products varies significantly and cannot be predicted. Factors that may cause a skincare and cosmetic product to be accepted or rejected by consumers include price, quality of ingredients, effectiveness, packaging, availability, advertising, and numerous other intangible factors. Consumer demand for our proposed products also may be affected by word of mouth testimonials, fads, and general consumer trends. Since we have not consumer test marketed our products, we are not certain if any of our products will appeal to our target consumer market. While we have distributed samples of our products the targeted consumer market could be quite different from the end-users that have used our samples to date. There can be no assurance that any additional financing will be available or if available, on terms that will be acceptable to us.

Our failure to obtain future financing or to produce levels of revenue to meet our products will gain broad acceptance among consumers. Unless we can achieve a sufficient following of consumers who purchase our products, we will not operate profitably and may have to cease our operations. No assurance can be given that any of our products will achieve sufficient consumer acceptance.




9.

Fluctuationsfinancial needs could result in our financial results make quarterly comparisonsinability to continue as a going concern, and, financial forecasting difficult.as a result, our investors could lose their entire investment.


Any revenues and operating results are likely to vary significantly from quarter to quarter because our industry experiences seasonal fluctuations, which reflect seasonal trends for health and beauty products.


We expect that our results will vary significantly in the future because of a number of reasons, including:


·

Our ability to establish acceptance and usage of our products,

·

Our ability to contract with competent manufactures and appropriate wholesalers and retailers,

·

Costs related to future growth and capital investment,

·

Results of strategic agreements with companies that may supply and produce our products,

·

Our ability to attract, retain and motivate qualified personnel.


We have not started revenue producing activities so we have no direct experience with seasonality. However, we understand that other entities in our industry have experienced seasonal impacts. Many skin products sell better during the summer months because of the impact on skin from the exposure to sun and others during the winter months because of the dryness associated with winter weather.


Because of these fluctuations and uncertainties, our operating results may fail to meet the expectations of investors. If this happens, any trading price of our common stock would almost certainly be materially adversely affected.


10.

We will be dependent on independent operators and other operators of retail outlets for the ultimate sale of our products.


The success of our planned marketing and distribution program is totally dependent on signing license agreements with owner/operators or distribution agreements with other operators, including those who operate carts in malls. We do not know the likelihood of entering into agreements with retailers or the timing that it will take to do so. There will also be uncertainty about the sales success of retailers, if any, that do agree to sell our products.


11.

Regulatory and legal uncertainties could harm our business.


We believe that our business is not subject to material regulation under the laws of the United States or any of the states in which we plan to sell our products. Laws and regulations often differ materially between states and within individual states such laws and regulations are subject to amendment and reinterpretation by the agencies charged with their enforcement. If we become subject to any licensing or regulatory requirements, the failure to comply with any such requirements could lead to a revocation, suspension or loss of licensing status, termination of contracts and legal and administrative enforcement actions. We cannot be sure that a review of our current and proposed operations will not result in a determination that could materially and adversely affect our business, results of operations and financial condition. Moreover, regulatory requirements are subject to change from time to time and may in the future become more restrictive, thereby making compliance more difficult or expensive or otherwise affecting or restricting our ability to conduct our business as now conducted or proposed to be conducted.


12.

We will be dependent on programs designed by independent advertising and marketing firms.


BMI will require aggressive efforts in placing quality advertisements that will reach our target audience of potential consumers. We do not know if we will be able to obtain optimal advertising placement given the likelihood of an extremely limited budget.


The ability to obtain prime advertising slots in various forms of media (online, print, radio, television, etc.) will be reliant upon the expertise and capabilities of the advertising and marketing firms that we may work with, as well as what the available budget is to initiate a marketing campaign.


There are also no assurances that we will obtain sufficient financing or resources to enter into agreements with advertising or marketing firms.




13.

We will be subject to competition from numerous companies, including a number of multi-national companies that have significantly greater financial and other resources.


The skincare and cosmetic products business is highly competitive. We will be competing with hundreds of large and small cosmetics companies, including such companies as L’Oreal S.A., The Procter & Gamble Company, The Estée Lauder Companies Inc. and numerous other multi-national manufacturers. Most of our competitors market products that are well known and trusted by the consumer marketplace. Since virtually all of our competitors have significantly greater financial and other resources than we do, our competitors have the ability to spend more aggressively on advertising and marketing, spend more on product development and testing, and have more flexibility than we do to respond to changing business and economic conditions. Competition in the skincare business is based on pricing of products, the quality of the products, innovation, perceived value, promotional activities, advertising, new product introductions, name recognition, and other factors. It is difficult for us to predict how we will be able to effectively compete with our competitors’ actions in these areas.


14.

We will have to rely on third parties to manufacture our products who may not perform to our standards or timeline.


Our business plan assumes that we will have our products manufactured by one or more third-party manufacturing companies on a contract basis. No contractual arrangement is currently in place. We will seek to enter into agreements with third-party manufacturers to manufacture both the ingredients and the containers for our products. We will be dependent on the timeliness and effectiveness of their efforts.


Failure or lack of reliability in the manufacture of our products is likely to result in loss of business. Among other risks:

 

6
Table of Contents

·

Our products may fail to provide the expected results,

·

We may experience limited availability of quality ingredients for manufacturing,

·

We may experience poor quality manufacturing,

·

Our products may have new competition from other companies attempting to duplicate our formulas, and

·

Our customers could experience results different from our test results.


There are also no assurances that we will obtain sufficient financing or resources to enter into agreements with manufacturers.


15.

We have no patent protection and may not be able to protect our proprietary rights.


Our ability to compete successfully will depend, in part, on the quality and uniqueness of our products. Although we intend to have trademark protection for our “E-Scentual” brand, we have no product patent protection for any of our proposed products or any of the ingredients or compounds used in our products. We may claim proprietary rights in various unpatented technologies, know-how and trade secrets relating to our products and manufacturing processes, and we intend to protect our proprietary rights in our product formulas and operations through contractual obligations with consultants and vendors. However, because we do not currently have patent protection on any of our products or compounds, other companies can attempt to compete with us by imitating our products. We cannot guarantee the adequacy of the protections we intend to take to protect our proprietary rights, or that our competitors will not independently develop or produce products or processes that are substantially equivalent or superior to our products or processes.


While we will attempt to protect our proprietary information as trade secrets through agreements with each of our employees, licensing partners, consultants, agents and other organizations to which we disclose our proprietary information, we cannot give any assurance that these agreements will provide effective protection for our proprietary information in the event of unauthorized use or disclosure of such information.


16.

We may be subjectunable to product liability claims.achieve some, all or any of the benefits that we expect to achieve from our plan to expand our operations.


The development, manufactureIn the future we may require additional financing for capital requirements and sale of skincare and cosmetic products expose us to the risk of damages from product liability or other consumer claims. Although each of our proposed products will be subject to industry accepted product tests to reduce the likelihood of any successful product liability claim against us, no assurance is given thatgrowth initiatives. Accordingly, we will depend on our ability to generate cash flows from operations and to borrow funds and issue securities in the capital markets to maintain and expand our business. We may need to incur debt on terms and at interest rates that may not be subject to product liability claims in the future. We intend to obtain and maintain product liability insurance for liabilities arising from the use of our productsas favorable. If additional financing is not available when they enter the marketplace assuming that we have sufficient funds therefore. Additionally, we intend to use manufacturers of our products that maintain appropriate levels of liability insurance. If we are unable to locaterequired or engage manufacturers of our products that maintain or will agree to maintain appropriate levels of liability insurance,is not available on acceptable terms, we may be unable to operate our business as planned or at risk for product liability claims. A successful claim in excess ofall, fund our expansion, successfully promote our business, develop or enhance our products liability coverage, ifand services, take advantage of business opportunities or respond to competitive pressures, any of which could have a materiallymaterial adverse effect on our business, financial condition and results of operations.




17.As a growing company, we have yet to achieve a profit and may not achieve a profit in the near future, if at all.

We have revenues but we are not profitable and may not be in the near future, if at all. Further, many of our competitors have a significantly larger industry presence and revenue stream but have yet to achieve profitability. Our ability to continue as a going concern is dependent upon raising capital from financing transactions, increasing revenue and keeping operating expenses below our revenue levels in order to achieve positive cash flows, none of which can be assured.

Risk Factors Related to the Business of the Company

Our telecommunications line of business is highly sensitive to declining prices, which may adversely affect our revenues and margins.

The telecommunications industry is characterized by intense price competition, which has resulted in declines in both our average per-minute price realizations and our average per-minute termination costs.

A reduction of our prices to compete with any other offers in the market will not always guarantee and increase in the traffic, which may result in a reduction of revenue. If these trends in pricing continue or accelerate, it could have a material adverse effect on the revenues generated by our telecommunications businesses and/or our gross margins.

The continued growth of Over-The-Top calling and messaging services, such as WhatsApp, Skype and Viber has adversely affected the use of traditional phone communications. We expect this IP-based services which offer voice communications for free to continue to increase, which may result in increased substitution on our service offerings.

Our products face intense competitive challenges, including rapid technological changes, and pricing pressure from competitors, which could adversely affect our business.

There are significant potential conflicts of interest


All of our product lines are subject to significant competition from existing and future competitors, market conditions and technological change, or a combination of them, and our sales revenues and gross margins may suffer protracted and serious declines with the result that we would likely incur protracted losses. Further, the barriers to entry in several of our lines of business are not so significant that we may be facing competition from others who see significant opportunities to enter the market and undercut our prices with products that possess superior technological attributes at prices that offer our customers a better value. In this instance, we could incur protracted and significant losses and persons who acquire our common stock would suffer losses thereby.

From time to time, we may need to reduce our prices in response to competitive and customer pressures and to maintain our market share. Competition and customer pressures may also restrict our ability to increase prices in response to commodity and other input cost increases. Our results of operations will suffer if profit margins decrease, as a result of a reduction in prices, increased input costs or other factors, and if we are unable to increase sales volumes to offset those profit margin decreases. We may also need to increase spending on marketing, advertising and new product innovation to protect existing market share or increase market share. The success of our investments is subject to risks, including uncertainties about trade and consumer acceptance. As a result, our increased expenditures may not maintain or enhance market share and could result in lower profitability.

7
Table of Contents

Our operating results may fluctuate, which could have a negative impact on our ability to grow our client base, establish sustainable revenues and succeed overall.

Our key personnelresults of operations may fluctuate as a result of a number of factors, some of which are requiredbeyond our control including but not limited to:

general economic conditions in the geographies and industries where we sell our services and conduct operations; legislative policies where we sell our services and conduct operations;
the budgetary constraints of our customers; seasonality;
the success of our strategic growth initiatives;
costs associated with the launching or integration of new or acquired businesses;
timing of new product introductions by us, our suppliers and our competitors; product and service mix, availability, utilization and pricing;
the mix, by state and country, of our revenues, personnel and assets;
movements in interest rates or tax rates;
changes in, and application of, accounting rules;
changes in the regulations applicable to us;
Litigation matters.

As a result of these factors, we may not succeed in our business, and we could go out of business.

The termination of our carrier agreements or our inability to commit timeenter into new carrier agreements in the future could materially and adversely affect our ability to compete, which could reduce our revenues and profits.

We rely upon our carrier agreements in order to provide our telecommunications services to our affairscustomers. These carrier agreements are in most cases for finite terms and, according­ly,therefore, there can be no guarantee that these individual(s) (particularlyagreements will be renewed at all or on favorable terms to us. Our ability to compete would be adversely affected if our president) may have conflictscarrier agreements were terminated or we were unable to enter into carrier agreements in the future to provide our telecommunications services to our customers, which could result in a reduction of interestour revenues and profits.

Our customers, could experience financial difficulties, which could adversely affect our revenues and profitability if we experience difficulties in allocating management time among various business activities. Incollecting our receivables.

As a provider of international long-distance services, we depend upon sales of transmission and termination of traffic to other long distance providers and the coursecollection of other business activities, certain key personnel (particularlyreceivables from these customers. The wholesale telecommunications market continues to feature many smaller, less financially stable companies. If weakness in the telecommunications industry or the global economy reduces our president) may become aware of business opportu­nities whichability to collect our accounts receivable from our major customers our profitability may be appropriatesubstantially reduced. While our most significant customers, from a revenue perspective, vary from quarter to quarter, our eleven largest customers (3% of our total customer base) collectively accounted for presenta­tion87.8% of total consolidated revenues by the nine months ended September 30, 2023. This concentration of revenues increases our exposure to us, as well as the other entitiesnon-payment by our larger customers, and we may experience significant write-offs if any of our large customers fail to pay their outstanding balances, which could adversely affect our revenues and profitability.

8
Table of Contents

We may fail to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions.

We believe there are meaningful opportunities to grow through acquisitions and joint ventures across all product and service categories and we expect to continue a strategy of selectively identifying and acquiring businesses with which they are affiliated. As such, therecomplementary products and services. We may have con­flicts of interest in determiningbe unable to which entity a particular business opportunity shouldidentify, negotiate, and complete suitable acquisition opportunities on reasonable terms. There can be presented.


In an effort to resolve such potential conflicts of interest, we have entered into a written agreement with Ms. Jones specifyingno assurance that any business opportunities that she may become aware of independentlyacquired by us will be successfully integrated with our operations or directly through her association with us (as opposedprove to disclosure to her of such business opportunities by management or consultants associated with other entities) would be presented by her solelyprofitable to us. A copyWe may incur future liabilities related to acquisitions. Should any of this agreement is filedthe following problems, or others, occur as Exhibit 10.2 toa result of our Registration Statement, of which this prospectus is a part of.acquisition strategy, the impact could be material:


difficulties integrating personnel from acquired entities and other corporate cultures into our business;

We cannot provide assurances that our efforts to eliminate the potential impact of conflicts of interest will be effective.

difficulties integrating information systems;


the potential loss of key employees of acquired companies;

the assumption of liabilities and exposure to undisclosed or unknown liabilities of acquired companies; or

the diversion of management attention from existing operations.

18.

BecauseNatural disasters, terrorist acts, acts of war, cyber-attacks or other breaches of network or information technology security may cause equipment failures or disrupt our operations.

Our inability to operate our telecommunications networks because of such events, even for a limited period of time, may result in loss of revenue, significant expenses, which could have a material adverse effect on our results of operations and financial condition.

We could be harmed by network disruptions, security breaches, or other significant disruptions or failures of our IT infrastructure and related systems. To be successful, we need to continue to have nominal assetsavailable a high capacity, reliable and secure network for our and our customers’ use. As any other company, we face the risk of a security breach, whether through cyber-attacks, malware, computer viruses, sabotage, or other significant disruption of our IT infrastructure and related systems. There is a risk of a security breach or disruption of the systems we operate, including possible unauthorized access to our proprietary or classified information. We are also subject to breaches of our network resulting in unauthorized utilization of our services, which subject us to the costs of providing those services, which are likely not recoverable. The secure maintenance and transmission of our information is a critical element of our operations. Our information technology and other systems that maintain and transmit customer information may be compromised by a malicious third-party penetration of our network security, or impacted by advertent or inadvertent actions or inactions by our employees, or those of a third party service provider or business partner. As a result, our or our customers’ information may be lost, disclosed, accessed or taken without the customers’ consent, or our services may be used without payment.

Although we make significant efforts to maintain the security and integrity of these types of information and systems, there can be no assurance that our security efforts and measures will be effective or that attempted security breaches or disruptions would not be successful or damaging, especially in light of the growing sophistication of cyber-attacks and intrusions. We may be unable to anticipate all potential types of attacks or intrusions or to implement adequate security barriers or other preventative measures. Certain business units have been the subject of attempted and successful cyber-attacks in the past. We have researched the situation and do not believe any material internal, or customer information has been compromised.

9
Table of Contents

We operate a global business that exposes us to currency, economic and regulatory.

Our revenue comes primarily from sales outside the U.S. and our growth strategy is largely focused on emerging markets. Our success delivering solutions and competing in international markets is subject to our ability to manage various risks and difficulties, including, but not limited to:

our ability to effectively staff, provide technical support and manage operations in multiple countries;  

fluctuations in currency exchange rates;  

timely collecting of accounts receivable from customers located outside of the U.S;

trade restrictions, political instability, disruptions in financial markets, and deterioration of economic conditions;  

compliance with the U.S. Foreign Corrupt Practices Act, and other anti-bribery laws and regulations;  

variations and changes in laws applicable to our operations in different jurisdictions, including enforceability of intellectual property and contract rights; and  

compliance with export regulations, tariffs and other regulatory barriers.  

If we are consideredunable to successfully manage growth, our operations could be adversely affected.

Our progress is expected to require the full utilization of our management, financial and other resources, which to date has occurred with limited working capital. Our ability to manage growth effectively will depend on our ability to improve and expand operations, including our financial and management information systems, and to recruit, train and manage sales personnel. There can be no absolute assurance that management will be able to manage growth effectively.

If we do not properly manage the growth of our business, we may experience significant strains on our management and operations and disruptions in our business. Various risks arise when companies and industries grow quickly. If our business or industry grows too quickly, our ability to meet customer demand in a "shellcompany"timely and willefficient manner could be challenged. We may also experience development delays as we seek to meet increased demand for our products. Our failure to properly manage the growth that we or our industry might experience could negatively impact our ability to execute on our operating plan and, accordingly, could have an adverse impact on our business, our cash flow and results of operations, and our reputation with our current or potential customers.

Risks Related to Legal Uncertainty

We may be subject to more stringent reporting requirements.securities litigation, which is expensive and could divert management attention.


The Securities and Exchange Commission ("SEC") adopted Rule 405 ofIn the Securities Act and Exchange Act Rule 12b-2 which defines ashellcompany as a registrantpast companies that has no or nominal operations, and either (a) no or nominal assets; (b) assets consisting solely of cash and cash equivalents; or (c) assets consisting of any amount of cash and cash equivalents and nominal other assets. Our balance sheet reflects that we have no cash or any other tangible asset and, therefore, we are defined as ashellcompany. The new rules prohibit shell companies from using a Form S-8 to register securities pursuant to employee compensation plans. However, the new rules do not prevent us from registering securities pursuant to S-1 registration statements. Additionally, the new rule regarding Form 8-K requires shell companies to provide more detailed disclosure upon completion of a transaction that causes it to cease being ashellcompany. If an acquisition is undertaken (of which we have no current intention of doing), we must file a current report on Form 8-K containing the information required pursuant to Regulation S-K within four business days following completion of the transaction together with financial information of the acquired entity. In order to assist the SECexperienced volatility in the identificationmarket price of shell companies, we are also requiredtheir stock have been subject to check a box on Form 10-Q and Form 10-K indicating that we are ashellcompany. To the extent that we are required to comply with additional disclosure because we are ashellcompany, wesecurities class action litigation. We may be delayedthe target of this type of litigation in executing any mergers or acquiring other assets that would causethe future. Litigation of this type could result in substantial costs and diversion of management’s attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to cease being ashellcompany. The SEC adopted a new Rule 144 effective February 15, 2008, which makes resales of restricted securities by shareholders of ashellcompany more difficult.


significant liabilities.

19.

We intend to becomemay be subject to tax and regulatory audits which could subject us to liabilities.

We are subject to tax and regulatory audits which could result in the periodic reporting requirementsimposition of liabilities that may or may not have been reserved. We are subject to audits by taxing and regulatory authorities with respect to certain of our income and operations. These audits can cover periods for several years prior to the date the audit is undertaken and could result in the imposition of liabilities, interest and penalties if our positions are not accepted by the auditing entity.

10
Table of Contents

Our global operations subject us to many different and complex laws and rules, and we may face difficulty in compliance.

Due to our global operations, we are subject to many laws governing international relations (including but not limited to the Foreign Corrupt Practices Act, the U.S. Export Administration Act the EU General Data Protection Regulation, and the U.K. Modern Anti-Slavery Act); which prohibit improper payments to government officials and restrict where and how we can do business, what information or products we can supply to certain countries, what personal information we can transfer, and what information we can provide to a non-U.S. government. Although we have procedures and policies in place that should mitigate the risk of violations of these laws, there is no guarantee that they will be sufficiently effective. If, and when we acquire new businesses, we may not be able to ensure that the pre-existing controls and procedures meant to prevent violations of the Exchange Actrules and laws were effective, and we may not be able to implement effective controls and procedures to prevent violations quickly enough when integrating newly acquired businesses. Acquisitions of new businesses in new non-U.S. jurisdictions may also subject us to new regulations and laws, and we may face difficulties ensuring compliance with these new requirements.

Changes in regulations or user concerns regarding privacy and protection of user data, or any failure to comply with such laws, could adversely affect our business.

Federal, state, and international laws and regulations govern the collection, use, retention, disclosure, sharing and security of data that willwe receive from and about our users. The use of consumer data by online service providers is a topic of active interest among federal, state, and international regulatory bodies, and the regulatory environment is unsettled. Many states have passed laws requiring notification to users where there is a security breach for personal data, such as California’s Information Practices Act. We face similar risks in international markets where our products and services are offered. Any failure, or perceived failure, by us to comply with or make effective modifications to our policies, or to comply with any applicable federal, state, or international privacy, data-retention or data-protection-related laws, regulations, orders or industry self-regulatory principles could result in proceedings or actions against us by governmental entities or others, a loss of user confidence, damage to our business and brand, and a loss of users, which could potentially have an adverse effect on our business.

In addition, various federal, state and foreign legislative or regulatory bodies may enact new or additional laws and regulations concerning privacy, data retention, data transfer and data protection issues, including laws or regulations mandating disclosure to domestic or international law enforcement bodies, which could adversely impact our business, our brand or our reputation with users. For example, some countries are considering or have enacted laws mandating that user data regarding users in their country be maintained in their country. In addition, there currently is a data protection regulation applicable to member states of the European Union that includes operational and compliance requirements that are different than those currently in place and that also includes significant penalties for non-compliance.

The interpretation and application of privacy, data protection, data transfer and data retention laws and regulations are often uncertain and in flux in the United States and internationally. These laws may be interpreted and applied inconsistently from country to country and inconsistently with our current policies and practices, complicating long-range business planning decisions. If privacy, data protection, data transfer or data retention laws are interpreted and applied in a manner that is inconsistent with our current policies and practices, we may be fined or ordered to change our business practices in a manner that adversely impacts our operating results. Complying with these varying international requirements could cause us to incur substantial costs or require us to incur audit fees and legal feeschange our business practices in connection with the preparation of such reports. These additional costs could reduce or eliminate our abilitya manner adverse to earn a profit.


Following the effective date of our registration statement of which this prospectus is a part, we will be required to file periodic reports with the SEC pursuant to the Exchange Act and the rules and regulations promulgated thereunder. In order to comply with these requirements, our independent registered public accounting firm will have to review our financial statements on a quarterly basis and audit our financial statements on an annual basis. Moreover, our legal counsel will have to review and assist in the preparation of such reports. The costs charged by these professionals for such services cannot be accurately predicted at this time because factors such as the number and type of transactions that we engage in and the complexity of our reports cannot be determined at this time and will have a major affect on the amount of time to be spent by our auditors and attorneys. We currently estimate the annual maintenance and compliance costs of the periodic reporting requirements to be in the range of up to $50,000 per annum. The incurrence of such costs will obviously be an expense to our operations and thus will have a negative effect on our ability to meet our overhead requirements and earn a profit. We may be exposed to potential risks resulting from any new requirements under Section 404. If we cannot provide reliable financial reports or prevent the occurrence of fraud, our business and operating resultsresults.

We may be subject to legal liability associated with providing online services or content.

We host and provide a wide variety of services and technology products that enable and encourage individuals and businesses to exchange information; upload or otherwise generate photos, videos, text, and other content; advertise products and services; conduct business; and engage in various online activities both domestically and internationally. The law relating to the liability of providers of online services and products for activities of their users is currently unsettled both within the United States and internationally. We may be subject to domestic or international actions alleging that certain content we have generated or third-party content that we have made available within our services violates laws in domestic and international jurisdictions.

11
Table of Contents

It is also possible that if any information provided directly by us contains errors or is otherwise wrongfully provided to users, third parties could make claims against us. For example, we offer web-based e-mail services, which expose us to potential risks, such as liabilities or claims, by our users and third parties, resulting from unsolicited e-mail, lost or misdirected messages, illegal or fraudulent use of e-mail, alleged violations of policies, property interests, or privacy protections, including civil or criminal laws, or interruptions or delays in e-mail service. We may also face purported consumer class actions or state actions relating to our online services, including our fee-based services. In addition, our customers, third parties, or government entities may assert claims or actions against us if our online services or technologies are used to spread or facilitate malicious or harmful code or applications.

Investigating and defending these types of claims are expensive, even if the claims are without merit or do not ultimately result in liability, and could subject us to significant monetary liability or cause a change in business practices that could negatively impact our ability to compete.

Nevada law and certain anti-takeover provisions of our corporate documents could entrench our management or delay or prevent a third party fromacquiring us or a change in control even if it would benefit our shareholders.

Certain provisions of Nevada law may have an anti-takeover effect and may delay or prevent a tender offer or other acquisition transaction that a shareholder might consider to be in his or her best interest. The summary of the provisions of Nevada law set forth below does not purport to be complete and is qualified in its entirety by reference to Nevada law.

The issuance of shares of preferred stock, the issuance of rights to purchase such shares, and the imposition of certain other adverse effects on any party contemplating a takeover could be harmed, investorsused to discourage an unsolicited acquisition proposal. For instance, the issuance of a series of preferred stock might impede a business combination by including class voting rights that would enable a holder to block such a transaction. In addition, under certain circumstances, the issuance of preferred stock could lose confidence in our reported financial information, andadversely affect the trading pricevoting power of holders of our common stock.

Under Nevada law, a director, in determining what he reasonably believes to be in or not opposed to the best interests of the corporation, does not need to consider only the interests of the corporation’s shareholders in any takeover matter but may also, in his discretion, may consider any of the following:

(i)The interests of the corporation’s employees, suppliers, creditors and customers;  
(ii)The economy of the state and nation;  
(iii)The impact of any action upon the communities in or near which the corporation’s facilities or operations are located;  
(iv)The long-term interests of the corporation and its shareholders, including the possibility that those interests may be best served by the continued independence of the corporation; and  
(v)Any other factors relevant to promoting or preserving public or community interests.  

Because our board of directors is not required to make any determination on matters affecting potential takeovers solely based on its judgment as to the best interests of our shareholders, our board could act in a manner that would discourage an acquisition attempt or other transaction that some, or a majority, of our shareholders might believe to be in their best interests or in which such shareholders might receive a premium for their stock if aover the then market ever develops, could drop significantly. However, for as long as we remainprice of such stock. Our board presently does not intend to seek shareholder approval prior to the issuance of currently authorized stock, unless otherwise required by law or applicable stock exchange rules.

12
Table of Contents

We are no longer an “emerging growth company” as definedand therefore no longer eligible for reduced reporting requirements applicable to emerging growth companies.

It has been twelve years since our first registered sale of common stock in 2012, so we are no longer eligible for the Jumpstart Our Business Startups Act of 2012, or JOBS Act, wereduced disclosure requirements applicable to “emerging growth companies.”

Emerging growth companies may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emergingemerging growth companies”companies, including but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding an annuala nonbinding advisory vote on executive compensation and seeking nonbinding stockholdershareholder approval of any golden parachute payments not previously approved.

We may take advantageare also a smaller reporting company, and we will remain a smaller reporting company until the fiscal year following the determination that our voting and non-voting common shares held by non-affiliates is more than $250 million measured on the last business day of theseour second fiscal quarter, or our annual revenues are more than $100 million during the most recently completed fiscal year and our voting and non-voting common shares held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter. Similar to emerging growth companies, smaller reporting exemptions untilcompanies are able to provide simplified executive compensation disclosure, are exempt from the auditor attestation requirements of Section 404, and have certain other reduced disclosure obligations, including, among other things, being required to provide only two years of audited financial statements and not being required to provide selected financial data, supplemental financial information or risk factors.

Since we are no longer an “emergingeligible for emerging growth company.”




Wecompany status, we will remain an “emerging growth company” for upbe subject to five years, although we would cease to be an “emerging growth company” prior to such timethe reporting obligations of a smaller reporting company and, if we havecontinue grow, we may be subject to increased reporting requirements applicable to accelerated filers, which are more onerous than $1.0 billion in annual revenue, more than $700 million in market value of our common stock is held by non-affiliates or we issue more than $1.0 billion of non-convertible debt over a three-year period.those applicable to smaller reporting companies.


20.As a smaller reporting company and will be exempt from certain disclosure requirements, which could make our Common Stock less attractive to potential investors.

Our internal controls

Rule 12b-2 of the Exchange Act defines a “smaller reporting company” as an issuer that is not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent that is not a smaller reporting company and that:

had a public float of less than $250 million as of the last business day of our most recently completed second fiscal quarter, computed by multiplying the aggregate worldwide number of shares of our voting and non-voting common equity held by non-affiliates by the price at which the common equity was last sold, or the average of the bid and asked prices of common equity, in the principal market for the common equity; or
in the case of an initial registration statement under the Securities Act, or the Exchange Act, for shares of our common equity, had a public float of less than $250 million as of a date within 30 days of the date of the filing of the registration statement, computed by multiplying the aggregate worldwide number of such shares held by non-affiliates before the registration plus, in the case of a Securities Act registration statement, the number of such shares included in the registration statement by the estimated public offering price of the shares; or
in the case of an issuer whose public float as calculated under paragraph (1) or (2) of this definition was zero, had annual revenues of less than $100 million during the most recently completed fiscal year for which audited financial statements are available.

As a smaller reporting company, we will not be required and may become inadequate asnot include a Compensation Discussion and Analysis section in our proxy statements; we grow,will provide only two years of financial statements; and we need not provide the table of selected financial data. We also will have other “scaled” disclosure requirements that are less comprehensive than issuers that are not smaller reporting companies which could causemake our financial reportingCommon Stock less attractive to be unreliable and leadpotential investors, which could make it more difficult for our stockholders to misinformation being disseminatedsell their shares.

13
Table of Contents

If we fail to the public.


Our management is responsible for establishing and maintaining adequate internal control over financial reporting. As defined in Exchange Act Rule 13a-15(f),maintain an effective system of internal control over financial reporting is a process designed by, or underin the supervision of, the principal executive and principal financial officer and effected by the board of directors, management and other personnel,future, we may not be able to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:


·

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;


·

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and/or directors of the Company; and


·

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.


We will rely on the use of outside professionals to assist us in maintainingreport our internal controls. With growth or unmanageable increases in our business plan objectives, our internal controls may become inadequate or ineffective, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public. Investors relying upon this misinformation may make an uninformed investment decision with regards to an investment in our common stock.


In order to mitigate the risks associated with maintaining internal controls if and when the Company grows, we will engage qualified professionals on an independent contractor basis to assist in reviewing and recording transactions. When and if finances permit, we will hire an experienced financial professional to oversee our reporting and control functions.


Failure to achieve and maintain an effective internal control environment could cause us to face regulatory action and also cause investors to lose confidence in our reported financial information, either of which could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows, which may adversely affect investor confidence in us and, future prospects.as a result, the value of our common shares.


However, our auditors will not beWe are required, under Section 404 of the Sarbanes-Oxley Act, to formally attest tofurnish a report by management on, among other things, the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an “emerging growth company” as definedreporting. This assessment includes disclosure of any material weaknesses identified by our management in the JOBS Act if we take advantageour internal control over financial reporting. A material weakness is a deficiency, or combination of the exemptions available to us through the JOBS Act.


21.

The costs of being a public company could resultdeficiencies, in us being unable to continue as a going concern.


As a public company, we will have to comply with numerousinternal control over financial reporting and legal requirements, including those pertaining to audits and internal control. The coststhat results in more than a reasonable possibility that a material misstatement of maintaining the public company requirements could be significant and may preclude us from seeking financingannual or equity investment on acceptable terms. We estimate these costs will range up to $50,000 per year and may be higher if our business volume and activity ever increases. Our estimate of costs do not include the necessary compliance, documentation and reporting requirements for Section 404 as weinterim financial statements will not be subject to the full reporting requirements of Section 404 until we exceed $75 million in market capitalization if we decide to opt-out of the “emerging growth company” as defined in the JOBS Act to take advantage of the exemptions available to us through the JOBS Actprevented or we have been public for more than five years. If our revenues are insufficient or non-existent, and/or we cannot satisfy many of these costs through the issuance of our shares, we may be unable to satisfy these costs in the normal course of business which would result in our being unable to continue asdetected on a going concern.


22.

Having only one director limits our ability to establish effective independent corporate governance procedures and increases the control of our president.


We have only one director who also serves as the Company’s President. Accordingly, we cannot establish board committees comprised of independent members to oversee functions like compensation or audit issues. In addition, a vote of the board members is decided in favor of our chairman, which gives her significant control over all corporate issues.




Until we have a larger board of directors that would include some independent members, if ever, there will be limited oversight of our president’s decisions and activities and little ability for minority shareholders to challenge or reverse those activities and decisions, even if they are not in the best interests of minority shareholders.


Risks Related to Our Common Stock


23.

We are an “emerging growth company” and we cannot be certain whether the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.


We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements oftimely basis. Section 404 of the Sarbanes-Oxley Act reduced disclosure obligations regarding executive compensation inalso generally requires an attestation from our periodic reports and proxy statements, and exemptions fromindependent registered public accounting firm on the requirementseffectiveness of holding an annual non-binding advisory vote on executive compensation and nonbinding stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive becauseinternal control over financial reporting. However, for as long as we will rely on these exemptions. If some investors find our common stock less attractive asremain a result, there may be a less active trading market for our common stock and our stock price may be more volatile.


In addition, Section 107 of the JOBS Act provides that an “emerging growth company” cansmaller reporting company, we intend to take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise applyexemption permitting us not to private companies. However, we are choosing to “opt out” of such extended transition period, and as a result, we will comply with new or revisedthe independent registered public accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.firm attestation requirement.

Our compliance with Section 107 of the JOBS Act provides404 will require that our decision to opt out of the extended transition period for complying with new or revisedwe incur substantial accounting standards is irrevocable.  


24.

expense and expend significant management efforts. We may not be able to raise sufficient financingcomplete our evaluation, testing and any required remediation in a timely fashion. During the evaluation and testing process, if we identify one or resourcesmore material weaknesses in our internal control over financial reporting, we will be unable to develop, manufactureassert that our internal control over financial reporting is effective.

As of the date of our last Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, our management identified the following material weaknesses in our internal control over financial reporting, which are indicative of many small companies with small staff: (i) inadequate segregation of duties and market our products.effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.


We maycannot assure you that there will not be ablematerial weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to raise sufficient financingmaintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or resourcescash flows. This may expose us, including individual executives, to develop, manufacture and marketpotential liability which could significantly affect our products. We currently have no commitments for any funds.business. If we are unable to raise sufficient financingconclude that our internal control over financial reporting is effective, or resourcesif our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting once that firm begins its audits of internal control over financial reporting, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common shares could decline, and we could be subject to develop, manufacture and marketsanctions or investigations by FINRA, the SEC, or other regulatory authorities. Failure to remedy any material weakness in our products,internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our business will fail and investors will lose their entire investment.


future access to the capital markets.

25.

The Company is selling the shares offered in this prospectus without an underwriterOur disclosure controls and procedures may not prevent or detect all errors or acts of fraud.

Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to management, recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.

14
Table of Contents

Deficiencies in disclosure controls and procedures and internal control over financial reporting could result in a material misstatement in our financial statements.

We could be adversely affected if there are deficiencies in our disclosure controls and procedures or in our internal controls over financial reporting. The design and effectiveness of our disclosure controls and procedures and our internal controls over financial reporting may not prevent all errors, misstatements or misrepresentations. Consistent with other entities in similar stages of development, we have a limited number of employees currently in the accounting group, limiting our ability to provide for segregation of duties and secondary review. A lack of resources in the accounting group could lead to material misstatements resulting from undetected errors occurring from an individual performing primarily all areas of accounting with limited secondary review. Deficiencies in internal controls over financial reporting which may occur could result in material misstatements of our results of operations, restatements of financial statements, other required remediations, a decline in the price of our common shares, or otherwise materially adversely affect our business, reputation, results of operations, financial condition or liquidity.

Risks Related to Our Securities

We have the right to issue additional common stock and preferred stock without consent of stockholders. This would have the effect of diluting investors’ ownership and could decrease the value of their investment.

We have additional authorized, but unissued shares of our common stock that may be issued by us for any purpose without the consent or vote of our stockholders that would dilute stockholders’ percentage ownership of our company.

In addition, our certificate of incorporation authorizes the issuance of shares of preferred stock and/or the conversion of existing outstanding preferred stock into common stock, the rights, preferences, designations and limitations of which may be set by the Board of Directors. Our certificate of incorporation has authorized issuance of up 300,000,000 shares of common stock and up to 1,200,000 shares of preferred stock in the discretion of our Board.

The shares of authorized but unissued preferred stock may be issued upon Board of Directors approval; no further stockholder action is required. If issued, the rights, preferences, designations and limitations of such preferred stock would be set by our Board and could operate to the disadvantage of the outstanding common stock. Such terms could include, among others, preferences as to dividends and distributions on liquidation.

Our largest shareholders, officers and directors and related parties, Leandro Iglesias and Alvaro Cardona, have substantial control over us and our policies as a result of their holdings in Series A Preferred Stock, and will be able to sellinfluence all or anycorporate matters, which might not be in other shareholders’ interests.

There were 10,000 shares of Series A Preferred Stock outstanding as of the date of this prospectus, with Mr. Iglesias holding 7,000 shares offered herein.and Mr. Cardona the other 3,000 shares. There were 175,319,832 shares of common stock outstanding as of the date of this prospectus, with Mr. Iglesias holding 542,932 shares and Mr. Cardona holding 1,121,842 shares, which together accounts for just over 0.9% of our outstanding common stock. Holders of Series A Preferred Stock are entitled to vote together with the holders of our common stock on all matters submitted to shareholders at a rate of 51% of the total vote of shareholders, including the election of directors. Our common stock is entitled to one vote per share on all matters submitted to a vote of the stockholders, including the election of directors. By virtue of their ownership of Series A Preferred Stock and common stock, they are able to vote at a rate of approximately 51.47% of the total vote of shareholders. They are therefore able to exercise significant influence over all matters requiring approval by our stockholders, including the election of directors, the approval of significant corporate transactions, and any change of control of our company. They could prevent transactions, which would be in the best interests of the other shareholders. Their interests may not necessarily be in the best interests of the shareholders in general.

15
Table of Contents

We do not expect to pay dividends in the foreseeable future. Any return on investment may be limited to the value of our common stock.


The common shares are being offeredWe do not anticipate paying cash dividends on our behalf by Ms. Jones,common stock in the foreseeable future. The payment of dividends on our president,common stock will depend on earnings, financial condition and other business and economic factors affecting it at such time as the board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a direct primary basis. No broker-dealer has been retained as an underwriterreturn on your investment will occur only if our stock price appreciates.

Risks Related to the Offering and no broker-dealer is under any obligation to purchase any common shares. There are no firm commitments to purchase any of the shares in this offering. Consequently, there is no guarantee that the Company, through its president, is capable of selling all, or any, of the common shares offered hereby. The sale of just a small number of shares increases the likelihood of no market ever developingMarket for our shares.Stock


26.

Since there is no minimum for our offering, if only a few persons purchase shares they will lose their money without us being even able to developIf a market for our shares.


Since there is no minimum with respect to the number of shares to be sold directly by the Company in its offering, if only a few shares are sold, we willcommon stock does not develop, shareholders may be unable to even attempt to create a public market of any kind for oursell their shares. Without a public market for our shares, the limited number of shares that we may be able to sell will be highly illiquid or unable to be sold to any other potential investor(s). In such an event, it is highly likely that the entire investment by an investor in our

Our common stock would be lost.


27.

The offering price of our common stock has been determined arbitrarily.


The price of our common stock in this offering hasis quoted under the symbol “IQST” on the OTCQX operated by OTC Markets Group, Inc., an electronic inter-dealer quotation medium for equity securities. We do not been determined by any independent financial evaluation, market mechanism or by our auditors, and is therefore, to a large extent, arbitrary. Our audit firm has not reviewed management's valuation and, therefore, expresses no opinion as to the fairness of the offering price as determined by management. As a result, the price of the common stock in this offering may not reflect the value perceived by thecurrently have an active trading market. There can be no assurance that the shares offered herebyan active and liquid trading market will develop or, if developed, that it will be sustained.

Our securities are worth the price for which they are offered and investors may, therefore, lose a portion or all of their investment.




28.

Shareholdersvery thinly traded. Accordingly, it may be diluted significantly through our effortsdifficult to obtain financing and satisfy obligations through issuance of additional shares of our common stock.


We have no committed source of financing. Wherever possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that the non-cash consideration will consist of restricted shares of our common stock. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized (100,000,000) shares but unissued (90,000,000) shares assuming the sale of 2,500,000 shares in this offering. In addition, if a trading market develops for our common stock, we may attempt to raise capital by sellingsell shares of our common stock possibly at a discountwithout significantly depressing the value of the stock. Unless we are successful in developing continued investor interest in our stock, sales of our stock could continue to market. These actions will certainly result in dilutionmajor fluctuations in the price of the ownership interests of existing shareholders, further dilute common stock book value, and that this dilution may be material.stock.


29.

The proposed aggregate proceeds of the offering are less than the estimated cost of the offering, so the Company will receive no economic benefits from the completion of the offering.


The proposed maximum aggregate proceeds of the offering ($25,000) are substantially less than the proposed costs to complete the offering ($65,000). We will, therefore, receive no financial benefit from the completion of the offering and will have to pay for most of the costs of the offering from the proceeds of operations or from other sources such as loans from officer(s) or from related and unrelated parties.


30.

The interests of shareholders may be hurt because we can issue sharesmarket price of our common stock to individuals or entities that support existing management with such issuances serving to enhance existing management’s ability to maintain control of our company.


Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued common shares. Such issuances may be issued to parties or entities committed to supporting existing management and the interests of existing management which may not be the same as the interests of other shareholders. Our ability to issue shares without shareholder approval serves to enhance existing management’s ability to maintain control of our company.


31.

Our articles of incorporation provide for indemnification of officers and directors at our expense and limit their liability that may result in a major cost to us and hurt the interests of our shareholders because corporate resources may be expended for the benefit of officers and/or directors.


Our Articles of Incorporation at Article XI provide for indemnification as follows: "No director or officer of the Corporation shall be personally liable to the Corporation or any of its stockholders for damages for breach of fiduciary duty as a director or officer; provided, however, that the foregoing provision shall not eliminate or limit the liability of a director or officer: (i) for acts or omissions which involve intentional misconduct, fraud or knowing violation of law; or (ii) the payment of dividends in violation of Section 78.300 of the Nevada Revised Statutes. Any repeal or modification of an Article by the stockholders of the Corporation shall be prospective only, and shall not adversely affect any limitation of the personal liability of a director or officer of the Corporation for acts or omissions prior to such repeal or modification."


We have been advised that, in the opinion of the SEC, indemnification for liabilities arising under federal securities laws is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification for liabilities arising under federal securities laws, other than the payment by us of expenses incurred or paid by a director, officer or controlling person in the successful defense of any action, suit or proceeding, is asserted by a director, officer or controlling person in connection with our activities, we will (unless in the opinion of our counsel, the matter has been settled by controlling precedent) submit to a court of appropriate jurisdiction, the question whether indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. The legal process relating to this matter if it were to occur is likely to be very costlyhighly volatile and may resultcould fluctuate widely in us receiving negative publicity, eitherofprice in response to various factors, many of which factors is likely to materially reduce the market and price forare beyond our shares, if such a market ever develops.




32.control.

Currently, there

Our stock price is no established public market for our securities, and there can be no assurances that any established public market will ever develop or that our common stock will be quoted for trading and, even if quoted, it is likely to be subject to a number of factors, including:

Technological innovations or new products and services by us or our competitors;

Government regulation of our products and services;  

The establishment of partnerships with other telecom companies;  

Intellectual property disputes;

Additions or departures of key personnel;  

Sales of our common stock;  

Our ability to integrate operations, technology, products and services;  

Our ability to execute our business plan;  

Operating results below or exceeding expectations;  

Whether we achieve profits or not;  

Loss or addition of any strategic relationship;  

Industry developments;  

Economic and other external factors; and  

Period-to-period fluctuations in our financial results.  

Our stock price may fluctuate widely as a result of any of the above. In addition, the securities markets have from time to time experienced significant price fluctuations.


Priorand volume fluctuations that are unrelated to the dateoperating performance of this prospectus, there has not been any established tradingparticular companies. These market for our common stock,fluctuations may also materially and there is currently no established public market whatsoever for our securities. A market maker has agreed to file an application with FINRA on our behalf so as to be able to quote the shares of our common stock on the OTCBB maintained by FINRA commencing upon the effectiveness of our registration statement of which this prospectus is a part and the subsequent closing of this offering. There can be no assurance that the market maker’s application will be accepted by FINRA nor can we estimate as to the time period that the application will require. We are not permitted to file such application on our own behalf. If the application is accepted, there can be no assurances as to whether


(i)

any market for our shares will develop;


(ii)

 the prices at which our common stock will trade; or


(iii)

the extent to which investor interest in us will lead to the development of an active, liquid trading market. Active trading markets generally result in lower price volatility and more efficient execution of buy and sell orders for investors.


If we become able to have our shares of common stock quoted on the OTCBB, we will then try, through a broker-dealer and its clearing firm, to become eligible with the Depository Trust Company ("DTC") to permit our shares to trade electronically. If an issuer is not “DTC-eligible,” then its shares cannot be electronically transferred between brokerage accounts, which, based on the realities of the marketplace as it exists today (especially the OTCBB), means that shares of a company will not be traded (technically the shares can be traded manually between accounts, but this takes days and is not a realistic option for companies relying on broker dealers for stock transactions - like all companies on the OTCBB. What this boils down to is that while DTC-eligibility is not a requirement to trade on the OTCBB, it is a necessity to process trades on the OTCBB if a company’s stock is going to trade with any volume. There are no assurances that our shares will ever become DTC-eligible or, if they do, how long it will take.


In addition, our common stock is unlikely to be followed by any market analysts, and there may be few institutions acting as market makers for our common stock. Either of these factors could adversely affect the liquidity and tradingmarket price of our common stock. Until our common stock is fully distributed and an orderly market develops in our common stock, if ever,

16
Table of Contents

Because we are subject to the price at which it trades is likely to fluctuate significantly. Prices for our common stock will be determined in“Penny Stock” rules, the marketplace and may be influenced by many factors, including the depth and liquiditylevel of the market for shares of our common stock, developments affecting our business, including the impact of the factors referred to elsewhere in these Risk Factors, investor perception of BMI and general economic and market conditions. No assurances can be given that an orderly or liquid market will ever develop for the shares of our common stock.


Because of the anticipated low price of the securities being registered, many brokerage firms may not be willing to effect transactions in these securities. Purchasers of our securities should be aware that any market that developstrading activity in our stock willmay be subject to the penny stock restrictions. See “Plan of Distribution” and Risk Factor #33 below.


33.reduced.

Any market that develops in shares of our common stock will be subject to the penny stock regulations and restrictions pertaining to low priced stocks that will create a lack of liquidity and make trading difficult or impossible.


The trading of our securities, ifSecurities and Exchange Commission has adopted regulations which generally define “penny stock” to be any will be in the over-the-counter market which is commonly referred to as the OTCBB as maintained by FINRA. As a result, an investor may find it difficult to dispose of, or to obtain accurate quotations as to the price of our securities.


Rule 3a51-1 of the Exchange Act establishes the definition of a "penny stock," for purposes relevant to us, as anylisted, trading equity security that has a minimum bidmarket price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to a limited number of exceptions which are not available to us. It is likely that our shares will be considered to be penny stocks for the immediately foreseeable future. This classification severely and adversely affects any market liquidity for our common stock.


For any transaction involving a penny stock, unless exempt, thecertain exemptions. The penny stock rules require that a broker or dealer approve a person's account for transactions in penny stocks and the broker or dealer receive from the investor a written agreement to the transaction setting forth the identity and quantity of the penny stock to be purchased. In order to approve a person's account for transactions in penny stocks, the broker or dealer must obtain financial information and investment experience and objectives of the person and make a reasonable determination that the transactions in penny stocks are suitable for that person and that that person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.




The broker or dealer must also deliver,broker-dealer, prior to anya transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure schedule prepared bydocument that provides information about penny stocks and the SEC relating torisks in the penny stock market, which, in highlight form, sets forth:


·

market. The broker-dealer must also provide the basis on whichcustomer with current bid and offer quotations for the broker or dealer made the suitability determination, and


·

that the broker or dealer received a signed, written agreement from the investor prior to the transaction.


Disclosure also has to be made about the risks of investing in penny stock, in both public offerings and in secondary trading and commissions payable to boththe compensation of the broker-dealer and its salesperson in the registered representative, current quotations fortransaction, and monthly account statements showing the securities and the rights and remedies available to an investor in casesmarket value of fraud in penny stock transactions. Additionally, monthly statements have to be sent disclosing recent price information for theeach penny stock held in the accountcustomer’s account. In addition, the penny stock rules generally require that prior to a transaction in a penny stock, the broker-dealer make a special written determination that the penny stock is a suitable investment for the purchaser and information onreceive the limited market in penny stocks.


Because of these regulations, broker-dealerspurchaser’s written agreement to the transaction. These disclosure requirements may not wish to engage in the above-referenced necessary paperwork and disclosures and/or may encounter difficulties in their attempt to sell shares of our common stock, which may affect the ability of selling shareholders or other holders to sell their shares in any secondary market and have the effect of reducing the level of trading activity in anythe secondary market. These additional sales practice and disclosure requirements could impede the sale of our securities, if and when our securities become publicly traded. In addition, the liquiditymarket for our securities may decrease, with a corresponding decrease in the price of our securities. Our shares, in all probability, will bestock that becomes subject to suchthe penny stock rules forwhich may increase the foreseeable future and our shareholders will,difficulty Purchasers may experience in all likelihood, find it difficultattempting to sell theirliquidate such securities.


34.We will likely conduct further offerings of our equity securities in the future, in which case your proportionate interest may become diluted.

The market for penny stocks has experienced numerous frauds and abuses that could adversely impact investors in our stock.


We will likely be required to conduct equity offerings in the future to finance our current projects or to finance subsequent projects that we decide to undertake. If our common stock shares are issued in return for additional funds, the price per share could be lower than that paid by our current shareholders. We anticipate continuing to rely on equity sales of our common stock shares in order to fund our business operations. If we issue additional common stock shares or securities convertible into shares of our common stock, your percentage interest in us could become diluted.

Company management believes that the market for penny stocks has suffered from patterns of fraud and abuse. Such patterns include:


·

Control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer;


·

Manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases;


·

"Boiler room" practices involving high pressure sales tactics and unrealistic price projections by sales persons;


·

Excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and


·

Wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the inevitable collapse of those prices with consequent investor losses.


35.If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our share price and trading volume could decline.

Any

The trading market that may develop may be restricted by virtue of state securities “Blue Sky” laws that prohibit trading absent compliance with individual state laws. These restrictions may make it difficult or impossible to sell shares in those states.


There is currently no established public market for our common stock will, to some extent, depend on the research and there can be no assurancereports that any established public market will develop in the foreseeable future. Transfer of our common stock may also be restricted under the securities or securities regulations laws promulgated by various states and foreign jurisdictions, commonly referred to as “Blue Sky” laws. Absent compliance with such individual state laws,industry analysts publish about us or our common stock may not be traded in such jurisdictions. Because the securities registered hereunder have not been registered for resale under the blue sky laws of any state, the holders of such shares and persons who desire to purchase them in any trading market that might develop in the future, should be aware that there may be significant state blue sky law restrictions upon the ability of investors to sell the securities and of purchasers to purchase the securities. These restrictions prohibit the secondary trading of our common stock.business. We currently do not intend to and may not be able to qualify securities for resale in at least 17 states which do not offer manual exemptions (or may offer manual exemptions but may not to offer one to us if we are considered to be a shell company at the time of application) and require shares to be qualified before they can be resold by our shareholders. Accordingly, investors should consider the secondary market for our securities to be a limited one. See also “Plan of Distribution-State Securities-Blue Sky Laws.”




36.

Our board of directors (consisting of one person, our President) has the authority, without stockholder approval, to issue preferred stock with terms that may not be beneficial to common stockholders and with the ability to affect adversely stockholder voting power and perpetuate theirhave any control over us.


Our articles of incorporation allow us to issue shares of preferred stock without any votethese analysts. If one or further action by our stockholders. Our board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of directors has the authority to issue preferred stock without further stockholder approval, including large blocks of preferred stock. As a result, our board of directors could authorize the issuance of a series of preferred stock that would grant holders the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right to the redemptionmore of the analysts who cover us downgrade our shares together with a premium, prior to the redemption of our common stock.


37.

The ability of our president to control our business may limit or eliminate minority shareholders’ ability to influence corporate affairs.


Upon the completion of this offering, our president will beneficially own an aggregate of approximately 75% of our outstanding common stock assuming the sale of all shares being registered. Because of her beneficial stock ownership, our president will be in a position to continue to elect our board of directors, decide all matters requiring stockholder approval and determine our policies. The interests of our president may differ from the interests of other shareholders with respect to the issuance of shares, business transactions with or sales to other companies, selection of officers and directors and other business decisions. The minority shareholders would have no way of overriding decisions made by our president. This level of control may also have an adverse impact on the market valuechange their opinion of our shares, because our president may instituteshare price would likely decline. If one or undertake transactions, policiesmore of these analysts cease coverage of us or programs that may result in losses, may not take any stepsfail to increase ourregularly publish reports on us, we could lose visibility in the financial community and/markets, which could cause our share price or may sell sufficient numbers of sharestrading volume to significantly decrease our price per share.decline.


38.

AllMANAGEMENT

The following information sets forth the names, ages, and positions of our presently issued and outstanding common shares are restricted under rule 144 of the Securities Act, as amended. When the restriction on any or all of these shares is lifted, and the shares are sold in the open market, the price of our common stock could be adversely affected.


All of the presently outstanding shares of common stock (7,500,000 shares) are "restricted securities" as defined under Rule 144 promulgated under the Securities Act and may only be sold pursuant to an effective registration statement or an exemption from registration, if available. Rule 144 provides in essence that a person who is not an affiliate and has held restricted securities for a prescribed period of at least six (6) months if purchased from a reporting issuer or twelve (12) months (as is the case herein) if purchased from a non-reporting company, may, under certain conditions, sell all or any of her shares without volume limitation, in brokerage transactions. Affiliates, however, may not sell shares in excess of 1% of the Company’s outstanding common stock each three months. As a result of revisions to Rule 144 which became effective on February 15, 2008, there is no limit on the amount of restricted securities that may be sold by a non-affiliate (i.e., a stockholder who has not been an officer, director or control person for at least 90 consecutive days) after the restricted securities have been held by the owner for the aforementioned prescribed period of time. A sale under Rule 144 or under any other exemption from the Act, if available, or pursuant to registration of shares of common stock of present stockholders, may have a depressive effect upon the price of the common stock in any market that may develop.


All 7,500,000 issued and outstanding shares of our common stock are owned by our president which consists of 5,000,000 shares issued for organizational expenses and 2,500,000 shares issued for product formulas and may be sold commencing one year from the date the Company is no longer considered a “shell company.” See “Market for Securities.”


39.

We do not expect to pay cash dividends in the foreseeable future.


We have never paid cash dividends on our common stock. We do not expect to pay cash dividends on our common stock at any time in the foreseeable future. The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements and other factors that our board of directors will consider. Since we do not anticipate paying cash dividends on our common stock, return on your investment, if any, will depend solely on an increase, if any, in the market value of our common stock.




40.

Because we are not subject to compliance with rules requiring the adoption of certain corporate governance measures, our stockholders have limited protection against interested director transactions, conflicts of interest and similar matters.


Sarbanes-Oxley Act of 2002, as well as rule changes proposed and enacted by the SEC, the New York and American Stock Exchanges and the Nasdaq Stock Market, as a result of Sarbanes-Oxley, require the implementation of various measures relating to corporate governance. These measures are designed to enhance the integrity of corporate management and the securities markets and apply to securities that are listed on those exchanges or the Nasdaq Stock Market. Because we are not presently required to comply with many of the corporate governance provisions and because we chose to avoid incurring the substantial additional costs associated with such compliance any sooner than legally required, we have not yet adopted these measures.


Because none of our directors (currently one person) are independent directors, we do not currently have independent audit or compensation committees. As a result, these directors have the ability, among other things, to determine their own level of compensation. Until we comply with such corporate governance measures, regardless of whether such compliance is required, the absence of such standards of corporate governance may leave our stockholders without protections against interested director transactions, conflicts of interest, if any, and similar matters and investors may be reluctant to provide us with funds necessary to expand our operations.


We intend to comply with all corporate governance measures relating to director independence as and when required. However, we may find it very difficult or be unable to attract and retain qualified officers, directors and members of board committees required to provide for our effective management as a result of Sarbanes-Oxley Act of 2002. The enactment of the Sarbanes-Oxley Act of 2002 has resulted in a series of rules and regulations by the SEC that increase responsibilities and liabilities ofcurrent directors and executive officers. The perceived increased personal risk associated with these recent changes may make it more costly or deter qualified individuals from accepting these roles. Some of these corporate governance measures have been metered by the JOBS Act of 2012. See Risk Factor #23 above.


NameAgePositions and Offices Held
Leandro Iglesias58President, Chairman, Chief Executive Officer and Director
Alvaro Quintana Cardona52Chief Operating Officer, Chief Financial Officer and Director
Juan Carlos Lopez Silva56Chief Commercial Officer
Raul Perez72Director
Jose Antonio Barreto65Director
Italo Segnini58Director

41.

You may have limited access to information regarding our business because our obligations to file periodic reports with the SEC could be automatically suspended under certain circumstances.


AsSet forth below is a brief description of the effective datebackground and business experience of each of our registration statementcurrent executive officers and directors.

17
Table of Contents

Leandro Iglesias

Before founding Etelix in year 2008, where he has acted as President and CEO, Mr. Iglesias was the International Business Manager at CANTV/Movilnet (the Venezuelan biggest telecommunications services provider). He held this position between January 2003 and July 2008, while the company was under the control of which this prospectusVerizon. Previous to his position in Cantv/Movilnet Mr. Iglesias was Executive Vice President and responsible of the Latin America marketing division of American Internet Communications (August 1998 – December 2002). Leandro Iglesias has developed a career for more than 20 years in the telecommunications industry with a particular emphasis in the international long-distance traffic business, submarine cables, satellite communications and international roaming services. He is Electronic Engineer graduate from Universidad Simon Bolivar and graduated from the Management Program at IESA Business School. He also holds an MBA from Universidad Nororiental Gran Mariscal de Ayacucho.

Aside from that provided above, Mr. Iglesias does not hold and has not held over the past five years any other directorships in any company with a part, we will become subjectclass of securities registered pursuant to certain informational requirementsSection 12 of the Exchange Act as amended and we will be required to file periodic reports (i.e., annual, quarterly and material events) with the SEC which will be immediately availableor subject to the public for inspection and copying. Except during the year that our registration statement becomes effective, these reporting obligations may (in our sole discretion) be automatically suspended underrequirements of Section 15(d) of the Exchange Act if we have less than 500 shareholders and do not file a registration statement on Form 8A (of which we have no current plans to file). If this occurs after the year in which our registration statement becomes effective, we will no longer be obligated to file periodic reports with the SEC and your access to our business information would then be even more restricted. After this registration statement on Form S-1 becomes effective, we may be required to deliver periodic reports to security holders. However, we will not be required to furnish proxy statements to security holders and our directors, officers and principal beneficial owners will not be required to report their beneficial ownership of securities to the SEC pursuant to Section 16 of the Exchange Act until we have both 500 or more security holders and greater than $10 million in assets. This means that access to information regarding our business and operations will be limited.


USE OF PROCEEDS


BMI will apply the proceeds from the offering to pay for accounting fees, legal and professional fees associated with the offering. The total estimated costs of the offering ($65,000) exceed the maximum amount of offering proceeds ($25,000). The costs of the offering, which principally relate to professional costs, are estimated to consist of:


SEC Registration fee

$

2.91

NASD filing fee

 

100.00

Accounting fees and expenses

 

5,000.00

Transfer agent fees

 

2,500.00

Blue Sky fees and expenses

 

5,000.00

Miscellaneous expenses

 

2,397.09

Legal fees and expenses

 

50,000.00

 

 

 

Total

$

65,000.00





As funds are obtained from the sale of shares, offering costs will be paid in the sequence listed in the table regardless of the amount of dollars collected. If all of theany company registered shares are sold, all costs will be paid for in full other than our legal fees which currently amount to $50,000 (i.e. (only) $7,500 of the legal fees are required to be paid if the maximum offering proceeds are collected by the Company. From the maximum offering proceeds we will pay for the expenses associated with this offering which include SEC registration fee, NASD filing fees, accounting and auditing fee, transfer agent fees, and blue sky fees which amount to approximately $12,500, leaving $7,500 of the maximum offering proceeds to be used to pay our current legal counsel. We would still have the obligation to pay the legal fees for our prior legal counsel as well as our current legal counsel from our business operations or from loans to the Company.


BMI will pay all costs related to this offering. This amount in excess of the offering proceeds ($40,000) will be paid as and when necessary and required or otherwise accrued on the books and records of BMI until we are able to pay the full amount due either from revenues or loans from related or unrelated parties. Absent sufficient revenues to pay these amounts within four months from the date of this prospectus, we will seek financial assistance either from our shareholders or a third party business associate of our president who may agree to loan us the funds to cover the balance of outstanding professional and related fees relating to our prospectus to the extent that such liabilities cannot be extended or satisfied in other ways and our professionals insist upon payment. If and when loaned, the loan will be evidenced by a noninterest-bearing unsecured corporate note to be treated as a loan until repaid, if and when BMI has the financial resources to do so. No formal written arrangement exists with respect anyone’s commitment to loan funds for this purpose and, accordingly, there existed only an agreement between BMI the corporate entity, our President and our former legal counsel (filed as Exhibit 10.1) which was binding upon all parties.


Our current and former legal counsel have both agreed to defer a substantial amount of their fees until after our offering becomes effective and is, in fact, through the deferral of their fees may be asserted as financing for our offering. Our plans will not change regardless of whether the maximum proceeds are raised, except to the extent indicated in MD&A “Liquidity” section, first paragraph.


THE OFFERING


BMI will spend substantially more in costs on this offering than it will receive in proceeds. The Company will incur ongoing continuous costs to meet the reporting requirements of a public company. These costs will exceed our current or anticipated revenues. However, BMI believes that the risks are worth taking because management believes, based on its own observations which are not based on any formal studies, that potential vendors, consultants and manufacturers will have a higher regard for a public company than a small, privately-held startup company. Management’s belief is based solely on advice and informal consultation with various professionals who are known to us and have public company experience. These discussions have led us to believe that being a public company may afford the business (management and its shareholders) with a higher degree of recognition than would be typically attained as a small private (or non-public) company and may increase its ability and/or options to obtain financing for growth. In addition, by being a public company we believe increases our future opportunities to raise funds or to pay vendors by issuing restricted common stock rather than cash. We cannot predict the likelihood that our observations and conclusions about the benefits of being a public company will prove accurate or beneficial to us.


BMI is offering for sale a maximum of 2,500,000 shares of common stock at a fixed price of $0.01 per share. There is no minimum number of shares that must be sold by us for the offering to close, and we will retain and use the proceeds from the sale of any of the offered shares that are sold to pay a portion of the costs of the offering. There are no circumstances under which any offering proceeds will be released to parties other than BMI (except for proceeds refunded to investors whose subscriptions are rejected by us within 48 hours of receipt). All of the proceeds of this offering will be applied to the costs and fees associated with this offering. Moreover, in the event the Company is unable to raise the maximum proceeds under this offering, the implementation of the business plan will be extremely difficult, if not possible. The offering is being conducted on a self-underwritten, direct primary basis, which means our president and chief executive officer, Ms. Jones, will attempt to sell these shares. This prospectus permits our president and chief executive officer to sell the shares directly to the public, with no commission or other remuneration payable to her for any shares that she may sell. Ms. Jones will sell the shares and intends to offer them to friends, family members and business acquaintances. In offering the securities on our behalf, she will rely on the safe harbor provision from broker-dealer registration set out in Rule 3a4-1 under the Securities and Exchange Act of 1934. The intended methods of communication include, without limitation, telephone and personal contact.




In connection with BMI’s selling efforts in the offering, Ms. Jones will not register as a broker-dealer pursuant to Section 15 of the Exchange Act, but rather will rely upon the “safe harbor” provisions of SEC Rule 3a4-1, promulgated under the Exchange Act. Generally speaking, Rule 3a4-1 provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in an offering of the issuer’s securities. Ms. Jones is not subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act. Ms. Jones will not be compensated in connection with her participation in the offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities. Ms. Jones is not, nor has she been within the past 12 months, a broker or dealer, and she is not, nor has she been within the past 12 months, an associated person of a broker or dealer. At the end of the offering, Ms. Jones will continue to primarily perform duties for the Company or on its behalf otherwise than in connection with transactions in securities. Ms. Jones will not participate in selling an offering of securities for any issuer more than once every 12 months other than in reliance on Exchange Act Rule 3a4-1(a)(4)(i) or (iii).


The proceeds from the sale of the shares in this offering will be made payable to Quick Law Group, P.C. - COLTAF Account, BMI’s fund retention agent. Quick Law Group, P.C., acts as legal counsel for BMI and, therefore, may not be considered an independent third party. In this case, the fund retention agent holds the closing documents and funds in a transfer of money for shares of common stock of the Company , acting for both parties pursuant to their instructions. Therefore we have selected Quick Law Group, P.C. to act our  funds retention agent for this offering to hold both documents and funds pursuant to the terms of the Fund Retention Agreement .. All subscription agreements and checks are irrevocable and should be delivered to Quick Law Group, P.C. at the address provided on the Subscription Agreement. As the fund retention agent Quick Law Group, P.C. will hold all funds until the maximum proceeds are received or management determines that the offering is complete and accepts receipt of subscription agreements and monies for less than the maximum amount of the offering. The Company believes that this arrangement is beneficial and efficient for both management and investors in that the fund retention agent oversees the intake of offering proceeds , the approval of subscriptions by the Company, issuance of shares of common stock, and the distribution of proceeds to the Company in an orderly manner. The fund retention agent holds all funds received in payment of the Subscription Price in a segregated account, and distributes the offering proceeds to the Company once the offering is completed, withdrawn or terminated.


We will receive all proceeds from the sale of up to 2,500,000 shares being offered. No proceeds will be received by any other entity other than the Company. The price per share is fixed at $0.01 for the duration of this offering.


All subscription funds will be held in a noninterest-bearing account pending the completion of the offering. The offering will be completed 180 days from the effective date of this prospectus (or such earlier date when all 2,500,000 shares are sold), unless extended by our board of directors for an additional 180 days. There is no minimum number of shares that must be sold. All subscription agreements and checks for payment of shares are irrevocable (except as to any states that require a statutory cooling-off period or provide for rescission rights).


The Company will deliver stock certificates attributable to the shares of common stock purchased by the investors within 30 days of the close of the offering or as soon thereafter as practicable.


We have the right to accept or reject subscriptions in whole or in part, for any reason or for no reason. All monies from rejected subscriptions will be returned immediately by us to the subscriber, without interest or deductions. Subscriptions for securities will be accepted or rejected within 48 hours after we receive them.


The offering may terminate on the earlier of:


i.

the date when the sale of all 2,500,000 shares is completed, or

ii.

180 days from the effective date of this document or any extension thereto.


The offering price of the common stock has been determined arbitrarily and bears no relationship to any objective criterion of value. The price does not bear any relationship to our assets, book value, historical earnings or net worth.


The purchase of the common stock in this offering involves a high degree of risk. The common stock offered in this prospectus is for investment purposes only, and currently no market for our common stock exists. While a market maker has agreed to file a Rule 211 application with FINRA in order to apply for the inclusion of our common stock in the OTCBB, such efforts may not be successful, and our shares may never be quoted and owners of our common stock may not have a market in which to sell the shares. Also, no estimate may be given as to the time that this application process will require.




If we become able to have our shares of common stock quoted on the OTCBB, we will then try, through a broker-dealer and its clearing firm, to become eligible with the DTC to permit our shares to trade electronically. If an issuer is not “DTC-eligible,” then its shares cannot be electronically transferred between brokerage accounts, which, based on the realities of the marketplace as it exists today (especially the OTCBB), means that shares of a company will not be traded (technically the shares can be traded manually between accounts, but this takes days and is not a realistic option for companies relying on broker dealers for stock transactions - like all the companies on the OTCBB). What this boils down to is that while DTC-eligibility is not a requirement to trade on the OTCBB, it is a necessity to process trades on the OTCBB if a company’s stock is going to trade with any volume. There are no assurances that our shares will ever become DTC-eligible or, if they do, how long it will take.


Please refer to the sections of this prospectus entitled "Risk Factors" and "Dilution" before making an investment in this stock.


DETERMINATION OF OFFERING PRICE


The offering price of the common stock has been arbitrarily determined and bears no relationship to any objective criterion of value. The price does not bear any relationship to our assets, book value, any historical earnings or net worth. In determining the offering price, management considered such factors as the prospects, if any, for similar companies, anticipated results of operations, present financial resources and the likelihood of acceptance of this offering. No valuation or appraisal has been prepared for our business. We cannot assure you that a public market for our securities will develop or continue or that the securities will ever trade at a price higher than the offering price.


DILUTION


“Dilution” represents the difference between the offering price of the shares of common stock hereby being offered and the net book value per share of common stock immediately after completion of this offering. "Net book value" is the amount that results from subtracting total liabilities from total assets. In this offering, the level of dilution is increased as a result of the relatively low net book value of our issued and outstanding common stock and because the proceeds of the offering are substantially less than our estimated costs. Assuming all of the shares of common stock offered herein are sold, the purchasers in this offering will lose the entire value of their shares purchased in that each purchased share will have a negative net book value of ($0.0054). Net book value of existing shareholders’ shares will also decrease from $(0.0019) to ($0.0054) because estimated costs will exceed the proceeds received from this offering.


The following table illustrates the dilution to the purchasers of the common stock in this offering:


 

Assuming the sale of:

 

625,000

shares

(25% of the

maximum

offering)

1,250,000

shares

(50% of the

maximum

offering)

1,875,000

shares

(75% of the

maximum

offering)


2,500,000

shares

(maximum

offering)

 

 

 

 

 

Offering Price Per Share

$ 0.01

$ 0.01

$ 0.01

$ 0.01

 

 

 

 

 

Book Value Per Share Before the Offering

$(0.00185)

$(0.00185)

$(0.00185)

$(0.00185)

 

 

 

 

 

Book Value Per Share After the Offering

$(0.00894)

$(0.00759)

$(0.00642)

$(0.00539)

 

 

 

 

 

Net Decrease to Original Shareholders

$(0.00709)

$(0.00574)

$(0.00456)

$(0.00354)

 

 

 

 

 

Decrease in Investment to New Shareholders

$(0.01894)

$(0.01759)

$(0.01642)

$(0.01539)

 

 

 

 

 

Dilution to New Shareholders (%)

100%

100%

100%

100%





The following table summarizes the number and percentage of shares purchased the amount and percentage of consideration paid and the average price per Share paid by our existing stockholders and by new investors in this offering:


 

Price

Per Share

Number of

Shares Held

Percentage of

Ownership

Consideration

Paid

2,500,000 shares sold

 

 

 

 

Existing shareholders

$0.001

7,500,000

75%

$7,500

Investors in this offering

$0.01

2,500,000

25%

$25,000

 

 

 

 

 

1,875,000 shares sold

 

 

 

 

Existing shareholders

$0.001

7,500,000

80%

$7,500

Investors in this offering

$0.01

1,875,000

20%

$18,750

 

 

 

 

 

1,250,000 shares sold

 

 

 

 

Existing shareholders

$0.001

7,500,000

86%

$7,500

Investors in this offering

$0.01

1,250,000

14%

$12,500

 

 

 

 

 

625,000 shares sold

 

 

 

 

Existing shareholders

$0.001

7,500,000

92%

$7,500

Investors in this offering

$0.01

625,000

8%

$6,250


DIVIDEND POLICY


We have never paid cash or any other form of dividend on our common stock, and we do not anticipate paying cash dividends in the foreseeable future. Moreover, any future credit facilities might contain restrictions on our ability to declare and pay dividends on our common stock. We plan to retain all earnings, if any, for the foreseeable future for use in the operation of our business and to fund the pursuit of future growth. Future dividends, if any, will depend on, among other things, our results of operations, capital requirements and on such other factors as our board of directors, in its discretion, may consider relevant.


MARKET FOR SECURITIES


There is no established public market for our common stock, and a public market may never develop. A market maker has agreed to file an application with FINRA so as to be able to quote the shares of our common stock on the OTCBB maintained by FINRA commencing upon the effectiveness of our registration statement of which this prospectus is a part and the subsequent closing of this offering. There can be no assurance as to whether such market maker’s application will be accepted by FINRA nor can we estimate the time period that will be required for the application process. Even if our common stock were quoted in a market, there may never be substantial activity in such market. If there is substantial activity, such activity may not be maintained, and no prediction can be made as to what prices may prevail in such market.


If we become able to have our shares of common stock quoted on the OTCBB, we will then try, through a broker-dealer and its clearing firm, to become eligible with the DTC to permit our shares to trade electronically. If an issuer is not “DTC-eligible,” its shares cannot be electronically transferred between brokerage accounts, which, based on the realities of the marketplace as it exists today (especially the OTCBB), means that shares of a company will not be traded (technically the shares can be traded manually between accounts, but this takes days and is not a realistic option for companies relying on broker dealers for stock transactions - like all the companies on the OTCBB). What this boils down to is that while DTC-eligibility is not a requirement to trade on the OTCBB, it is a necessity to process trades on the OTCBB if a company’s stock is going to trade with any volume. There are no assurances that our shares will ever become DTC-eligible or, if they do, how long it will take.


The Company does not havecommon stock or equity subject to outstanding options or warrants to purchase or securities convertible into our common stock or equity. Also, all current shares of our outstanding common stock are held by Ms. Jones, our president (7,500,000 shares). In general, under Rule 144, a holder of restricted common shares who is an affiliate at the time of the sale or any time during the three months preceding the sale can resell shares, subject to the restrictions described below.


If we become a public reporting company under the ExchangeInvestment Company Act for at least 90 days immediately before the sale, then at least six months must have elapsed since the shares were acquired from us or an affiliate, and we must remain current in our filings for an additional period of one year; in all other cases, at least one year must have elapsed since the shares were acquired from us or an affiliate.




The number of shares sold by such person within any three-month period cannot exceed the greater of:


·

1% of the total number of our common shares then outstanding; or


·

The average weekly trading volume of our common shares during the four calendar weeks preceding the date on which notice on Form 144 with respect to the sale is filed with the SEC (or, if Form 144 is not required to be filed, the four calendar weeks preceding the date the selling broker receives the sell order).(This condition is not currently available to the Company because its securities do not trade on a recognized exchange.)


Conditions relating to the manner of sale, notice requirements (filing of Form 144 with the SEC) and the availability of public information about us must also be satisfied.


All of the presently outstanding shares of our common stock are "restricted securities" as defined under Rule 144 promulgated under the Securities Act and may only be sold pursuant to an effective registration statement or an exemption from registration, if available. The SEC has adopted final rules amending Rule 144 which have become effective on February 15, 2008. Pursuant to the new Rule 144, one year must elapse from the time a “shellcompany,” as defined in Rule 405 of the Securities Act and Rule 12b-2 of the Exchange Act, ceases to be a “shellcompany” and files a Form 8-K addressing Item 5.06 with such information as may be required in a Form 10 Registration Statement with the SEC, before a restricted shareholder can resell their holdings in reliance on Rule 144. The Form 10 information or disclosure is equivalent to the information that a company would be required to file if it were registering a class of securities on Form 10 under the Exchange Act. Under amended Rule 144, restricted or unrestricted securities, initially issued by a reporting or non-reportingshellcompany or a company that was at anytime previously a reporting or non-reportingshellcompany, can only be resold in reliance on Rule 144 if the following conditions are met:


1)

the issuer of the securities that was formerly a reporting or non-reportingshellcompany has ceased to be ashellcompany;


2)

the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;


3)

the issuer of the securities has filed all reports and material required to be filed under Section 13 or 15(d) of the Exchange Act, as applicable, during the preceding twelve months (or shorter period that the Issuer was required to file such reports and materials), other than Form 8-K reports; and


4)

at least one year has elapsed from the time the issuer filed the current Form 10 type information with the SEC reflecting its status as an entity that is not ashellcompany.


At the present time, we are classified as a “shellcompany” under Rule 405 of the Securities Act Rule 12b-2 of the Exchange Act. As such, all restricted securities presently held by our sole stockholder may not be resold in reliance on Rule 144 until: (1) we file a Form 8-K addressing Item 5.06 with such information as may be required in a Form 10 Registration Statement with the SEC when we cease to be a “shellcompany”; (2) we have filed all reports as required by Section 13 and 15(d) of the Securities Act for twelve consecutive months; and (3) one year has elapsed from the time we file the Form 8-K with the SEC reflecting our status that we are no longer ashellcompany.


Current Public Information


In general, for sales by affiliates and non-affiliates, the satisfaction of the current public information requirement depends on whether we are a public reporting company under the Exchange Act:


·

If we have been a public reporting company for at least 90 days immediately prior to the sale, then the current public information requirement is satisfied if we have filed all our periodic reports (other than Form 8-K) required to be filed under the Exchange Act during the 12 months immediately prior to the sale (or such shorter period as we have been required to file).


·

If we have not been a public reporting company for at least 90 days immediately prior to the sale, then the requirement is satisfied if specific types of basic information about us (including our business, management and our financial condition and results of operations) is made publicly available.




However, no assurance can be given as to:


·

the likelihood of a market for our common shares developing,


·

the liquidity of any such market,


·

the ability of the shareholders to sell the shares, or


·

the prices that shareholders may obtain for any of the shares.


No prediction can be made as to the effect, if any, that future sales of shares or the availability of shares for future sale will have on the market price prevailing from time to time. Sales of substantial amounts of our common shares, or the perception that such sales could occur, may adversely affect prevailing market prices of the common shares.


NOTE REGARDING FORWARD-LOOKING STATEMENTS


Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this prospectus which is a part of our registration statement involve risks and uncertainties, including statements as to:


·

our future operating results;


·

our business prospects;


·

any contractual arrangements and relationships with third parties;


·

the dependence of our future success on the general economy;


·

any possible financings; and


·

the adequacy of our cash resources and working capital.


These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe," “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated as of the date of this prospectus. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this prospectus, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION


Operations


We were incorporated on June 24, 2011 and acquired our product formulas and sample products on June 27, 2011. All of the activity through March 31, 2012 involved incorporation efforts, planning and acquiring the formulas, developing our E-Scentual product line, as well as preparation for this offering.


We are a development stage company and have extremely limited financial resources. We have not established a source of equity or debt financing. Our independent registered public accounting firm has included an explanatory paragraph in their report emphasizing the uncertainty of our ability to remain a going concern. At the time of this filing, we are a “shell company” as such term is defined by Rule 405 of the Securities Act and Rule 12b-2 of the Exchange Act.


BMI is in the business of developing, manufacturing, marketing and selling the E-Scentual Skin Care Collection, a skin care line combining science with nature to form an effective beauty treatment. BMI owns the rights to its intellectual property, E-Scentual, what we believe to be an anti-aging formula that is the main ingredient in the E-Scentual Skin Care Collection.




BMI intends to develop a full spectrum of skin care products designed to naturally improve skin wellness and provide anti-aging properties through our E-Scentual Skin Care Collection. The E-Scentual product line will combine science with nature to form an advanced beauty treatment, using a variety of essential oils and other naturally produced ingredients. Utilizing aromatherapy, a variety of specific actives, and our botanically-based formulas that include our proprietary process, E-Scentual products are intended to deliver a dramatic improvement in general health, well-being and increased vitality for great looking skin. We believe that BMI’s products, when available, will stimulate cell renewal, prevent and reduce the appearance of wrinkle and fine lines, dark circles, spider veins, rosacea, varicose veins and reduce under eye puffiness.1940.

 

We believe that E-Scentual,Mr. Iglesias is qualified to serve on our intellectual property, is a unique formula madeBoard of essential oils and other all natural ingredients that provide nourishment to the skin. These product mixtures rapidly penetrate the skin delivering essential nutrients beneath the top layerDirectors because of skin that the body useshis wealth of experience in the natural processtelecom industry.

Alvaro Quintana Cardona

Alvaro Quintana has developed a career of collagen regeneration. Anecdotal stories and feedback from over 75 end-users that are currently testing our products have described a dramatic decreasemore than twenty years of experience in the appearance of fine lines and wrinkles after regular use of essential oils and other all natural ingredients that are used in our formulas.


Our plan to continue as a going concern is to reach the point where we begin generating sufficient revenue from our skincare products to meet our obligationstelecommunication industry with particular focus on a timely basis. In the early stages of our operations, we will keep costs to a minimum, and we intend to introduce products gradually, beginning in fall of 2012; however there can be no assurance that we will be successful in achieving or adhering to this schedule. The cost to develop the various products could be in excess of $100,000. We will need at least an additional $50,000 to $100,000 to purchase initial raw material inventory and introduce marketing and advertising programs that will educate as well as excite our customer demographics.


Our only source of capital at this time is investment by others in this offering. We must raise capital or debt financing in order to implement our business strategy. Upon becoming a public company, we will contact private equity funds, angel investors and others known to our president and the professionals with whom we deal in order to raise the necessary financing. As stated throughout this prospectus the Company, in order to fully develop its product line, will need to seek additional capital through debt or equity. The Company believes that if it can raise at least 50% or more of its financing requirements , it will be able to move forward with the first phase of its business plan.


Management believes that if it is successful in raising the necessary funds, of which there can be no assurances, we may generate sales revenue within 12 months of receiving those funds. However, while we hope that we will be successful in these efforts, additional equity financing may not be available to us on acceptable terms or at all, and thus we could fail to satisfy our future cash requirements.


Despite the aforementioned in order to execute on our plan, we must finalize our offering andseek additional financing. Even if we receive 75%, 50%, 25% or 10% of the offering amount, our plans to execute our business plan are limited until we seek additional financing. The maximum offering proceeds are a necessary step in execution however critical to the following timeline is the seeking and securing of additional financing. If and when we obtain the required financing, we will be able to undertake our business plan through the following phases. We will seek to engage or hire employees or outside consultants to enhance the abilities of our founder in the development and execution of her business plan. As mentioned above these costs could be in excess of $100,000 and will be needed as payment for certainregulatory affairs, strategic planning, value added services and costs projectedinternational interconnection agreements. Before joining Etelix in year 2013 as Chief Operation Officer and Chief Financial Officer, Mr. Quintana acted between June 2004 and May 2013 as Interconnection and Value-Added Services Manager at Digitel (a mobile service provider in Venezuela, formerly a Telecom Italia Mobile subsidiary). He holds a Bachelor Degree in Business Administration and a Specialist Degree in Economics, both from the Universidad Catolica Andres Bello. He also holds a Master in Telecommunications from the EOI Business School in Spain.

Aside from that provided above, Mr. Cardona does not hold and has not held over the next 12 months as we move forward with our business plan.


Months 1 – 3 ($15,000 est. costs)


·

initial product formula program combined with local (grass roots) promotional efforts, simple but effective method of getting product out there

·

Web site offering primarily static content and “brochure-ware” to support advertising, promotion and marketing communications efforts the E-Scentual products

·

simple feedback mechanisms, typically using email or product surveys from customers who participate in sampling and beta development

·

market prospecting and outside sales professional training


Months 3 – 5 ($15,000 est. costs)


·

interactive Web applications for real-time content capture and delivery

·

leverage progressive formula development from existing and potential:

o

sources – beta and sample users

o

manufacturing – building with world class efforts and quality control

o

clients, prospects, suppliers, partners, stakeholders

·

a framework for collaboration and community interest in our products – all natural




Months 6 – 8 ($30,000 est. costs)


·

develop transaction-based systems to enhance product sales and target marketing

·

customer profile building, using geographic, demographic, psychographic, and transaction behavior data to pinpoint ‘ideal customer’

·

targeted one to one delivery with retail operations using distributors

·

integrated information and communications environments, combining voice, image, and data to assist with product sales and target marketing

·

simple system-to-system exchanges for routine transactions


Month 9 - 12 ($40,000 est. costs)


·

real-time dynamic information exchange while building psychodynamic customer profiles and ‘world class’ product development

·

advanced system-to-system exchanges for all transactions

·

real-time performance support systems – sales, production, marketing


We believe that our products may begin to generate limited revenues by selective placement and grass roots marketing efforts within the Southern California market within 120 to 150 days after we have completed our offering and receive additional financing. These product placement and marketing efforts are conditional upon us receiving additional financing as our current financial resources are not enough to pursue these actions.  


The above time-line estimates (or stages of development) are predicated upon the Company obtaining the necessary financing either through equity or debt. If we are not able to obtain the necessary levels of financing as determined by the above stages , we will not be able to meet or achieve any of the time-line objectives. If we complete 75%, 50%, 25% or even 10% of our additional financing objectives, we will not be able to pursue any of our time-line goals or action steps .. In that case the Company will be forced to proceed on a piecemeal basis using primarily the services of our president, and chief executive officer and limited use of outside contractors when and if limited funds are obtained. Our president, and chief executive officer devotes in excess of twenty (20) hours a week to our continued business efforts. There is no realistic way to predict the timing or completion of our business plans based upon those scenarios ..


Without additional financing to the offering proceeds, we will not be able to pursue our business plan or its time-line objectives, and the Company may fail entirely.


It is our plan to seek financing from either equity financing or through debt instruments. This effort will occur after our offering is complete and the proceeds have been received. Company’s management will, through relationships with professionals throughout the industry, continue to work on and refine the product formulas as well as other health and beauty products using the same basic products of essential oils. Completing these tasks will require the hiring of several employees and/or outside consultants. With the level of sophistication and expertise that our founder has, as well as other variouscosmeceutical (which represent a “marriage” between cosmetics and pharmaceuticals) professionals that she knows, the Company should make progress in its product development and eventually achieve sales of the these products, but currently no timeframe can be provided. Most if not all of these actions will be predicated on the Company obtaining the necessary financing to accomplish these steps. If financing is not available on terms reasonable to the Company and its shareholders, then the progression steps for this business plan will not occur as planned and may never occur.


We currently have no sources of financing and no commitments for financing. We will seek to obtain the necessary financing by contacting potential funding sources known to the professional and business contacts of our president. There are no assurances that we will obtain sufficient financing or resources to enter into agreements with product manufacturers, developers or sales/marketing firms. We do not have any cash or other resources to commence the use of outside consultants. If we do not receive funding or financing, including that from this offering, our business we believe could be maintained with extremely limited operations for at least 12 months because our president will continue providing her services without compensation (accrued or otherwise) and rely on short term loans from her friends and family members. However, failure to obtain financing under this offering or as frompast five years any other sources would severely impair our ability to implement our plans and likely resultdirectorships in our ceasing operations. We do not currently have a formal agreement in place with our president covering this period; however, our president’s current plan is to provide substantially all of our administrative and planning work as well as basic product formulation/production and marketing work on her own without cash compensation while she seeks other sources of funding. We do not have any plans to accrue any compensation for these services and our president, who is management of the Company, agrees with that action while we seek other sources of financing. We do not have any formal plans or agreements in place to continue receiving short term financing from our president, her friends or family members. To date this financing has been as needed for working capital purposes.




Other


As a corporate policy,we will not incur any cash obligations that we cannot satisfy with known resources, of which there are currently none except for our legal fees which will become due and payable upon completion of this offering which is further described in “Liquidity” below and/or elsewhere in this prospectus. We will not incur any significant obligations that need to be satisfied with cash payments in the short-term unless we have a secure funding source to pay the obligations when due. We believe that the perception that many people have of a public company may make it more likely that they will accept restricted securities from a public company as consideration for indebtedness owed to them than they would from a private company. We have not performed any studies of this matter. Management’s belief is based solely on advice and informal consultation with various professionals who are known to us and have public company experience. These discussions have led us to believe that being a public company may afford the business (management and its shareholders) with a higher degreeclass of recognition than would be typically attained as a small private (or non-public) company and may increase its ability and/or optionssecurities registered pursuant to obtain financing for growth. In addition, by being a public company we believe increases our future opportunities to raise funds or to pay vendors by issuing restricted common stock rather than cash.


However, there can be no assurances that we will be successful in any of those efforts even if we are a public entity. Additionally, issuance of restricted shares would necessarily dilute the percentage of ownership interest of our stockholders.


Liquidity


All amounts received from this offering will be used to pay expenses of the offering. BMI will pay all costs relating to this offering estimated at $65,000. These amounts will be paid when they become due and payable (upon submission to management) or otherwise accrued on the books and records of BMI until we are able to pay the amounts in full either from revenues or loans that may be obtained from related or unrelated parties. Our obligations for these expenses, when recorded as liabilities for lengthy periods of time, could preclude us from receiving financial assistance from other sources or, as a minimum, make getting other financing more difficult. Absent sufficient revenues to pay these amounts (primarily for estimated legal fees of $50,000) within four months from the date of our engagement with our legal counsel, we will be in technical default. With a technical default on the outstanding payments owed to our counsel there are no penalties and the debt will not be senior to any other debt we owe. There can be no assurance that we will be able to obtain a noninterest-bearing unsecured corporate note or any other type of financing to settle these obligations when they become due.


BMI entered into a financial agreement with our former legal counsel to prepare and assist the Company in order to seek assistance in lending funds to us if necessary (Exhibit 10.1) with all of the requisite documentation and filings to cover our legal expenses associated with this offering. Upon termination of our legal representation agreement with our former legal counsel we sought to determine the amount owed. The amount of $20,000 was agreed to in settlement owing under this agreement as of January 11, 2012. A summary of Exhibits 10.1 and 10.3 may be found in the “Management’s Discussion and Analysis or Plan of Operation” section of this prospectus. Both Exhibits 10.1 and 10.3 are filed as part of our registration statement of which this prospectus is a part. We terminated our agreement with Gary B. Wolff, P.C. as of January 23, 2012 as disclosed in Exhibit 10.3. As of March 7, 2012 we entered into a legal services agreement with new legal counsel, Quick Law Group, P.C. Our agreement with new legal counsel provides for a fee of $30,000, payable as $7,500 from the maximum offering proceeds, and the balance of $22,500 within four months from the date of our engagement with the Quick Law Group, P.C.


Since acquiring the product formulas and sample products, most of our resources and work have been devoted to planning our business, implementing systems and controls, and completing our registration statement. When those procedures are done, which we believe will occur over the next four months, we will continue to work on updating and improving our product formulas , and the development of packaging and labeling for our intended products. We will then need to commence inventory production and marketing efforts to provide for the initial sales of our products. We believe that the work needed to complete our product development, stock inventory, and initiate our marketing plans, including the development of a comprehensive ecommerce website, will range from $100,000 to $200,000 if outside contractors and experts are used. Based on conversations we have had to date with various distributors of natural beauty care products, we believe we can obtain funding to outsource these procedures. Although there can be no assurances whatsoever that we will obtain this funding, we believe that if we do we can commence the launch of our product line to the public beginning in late 2012, while there is no assurance that this time frame will be met, or that we will ever be able to commence the launch of our product line even if funding is obtained. If we have to use our internal resources only, the process will take much longer and our launch may be limited to a much smaller target market and produce less sales than anticipated. If we are unable to raise any funds, the cash costs may have to be provided by our president to the extent that she is capable and willing to provide such funds. We do not currently have any oral or written agreements to raise any funds in place with our president and founder or any third parties and cannot provide any assurances that we will obtain any funds. Our goal would be to have sufficient inventory and our distribution channels up and running within one year, but there is no way of estimating what the likelihood of achieving that goal would be.




On January 20, 2012, we entered into an International Distribution Agreement with ELVIE Corporation, an import and export company located in California. Pursuant to the terms of the agreement, ELVIE Corporation will have the right to exclusively distribute our product lines when available for sale in the Pacific Rim region. The agreement is for a period of one year expiring on the first anniversary with an option by both parties to extend for an additional period of two years. However, either we or ELVIE Corporation may terminate the agreement for any reason upon ninety days written notice.


Private capital, if sought, will most likely be sought from former business associates of our founder or private investors referred to us by those business associates. To date, we have not sought any funding source , other than the investors that have previously provided loans to the Company, and have not authorized any person or entity to seek out funding on our behalf. If a market for our shares ever develops, of which there can be no assurances, we may use restricted shares of our common stock to compensate employees/consultants and independent contractors wherever possible. We cannot predict the likelihood or source of raising capital or funds that may be needed to complete our planned business operations from the product formulas that we have acquired.


We have embarked upon an effort to become a public company and, by doing so, have incurred and will continue to incur additional significant expenses for legal, accounting and related services. Once we become a public entity, subject to the reporting requirementsSection 12 of the Exchange Act of '34, we will incur ongoing expenses associated with professional fees for accounting, legal and a host of other expenses including annual reports and proxy statements, if required. We estimate that these costs will range up to $50,000 per year for the next few years and will be higher if our business volume and activity increases but lower during the first year of being public because our overall business volume will be lower, and we will not yet beor subject to the requirements of Section 404 until we exceed $75 million in market capitalization , if we decide to opt-out15(d) of the “emerging growth company” qualificationExchange Act or any company registered as definedan investment company under the Investment Company Act of 1940.

We believe that Mr. Quintana is qualified to serve on our Board of Directors because of his wealth of experience in the JOBS Acttelecom industry.

Juan Carlos Lopez Silva

Juan Carlos Lopez Silva is an Engineer graduated from Universidad de Los Andes, with a Master degree in Project Management from the Pontificia Universidad Javeriana; and MBA from EADA Business School; with more than 20 years of experience in project management, negotiation, business development and management on international companies. Previous to take advantagejoining Etelix in August 2011 as Chief Commercial Officer, Juan Carlos was International Carrier Relations Manager at Colombia Telecomunicaciones S.A. Esp. a subsidiary of Telefonica of Spain, between September 2003 and June 2011.

Aside from that provided above, Mr. Silva does not hold and has not held over the past five years any other directorships in any company with a class of securities registered pursuant to Section 12 of the exemptions available to us through the JOBSExchange Act or fivesubject to the requirements of Section 15(d) of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.

18

Raul A Perez

From December 1, 2014 to present, Mr. Perez serves as CFO of Deerbrook Family Dentistry, PC, Dental Practice in Humble, Texas. From November 1, 2017 to January 31, 2019, he served as Senior Accountant to Principrin School, PC, Day Care in Houston, Texas.

Mr. Perez has been in finance for more than 40 years, has resulted from usstarting in 1970 as analyst in treasury and finance departments and progressively assuming different positions up to corporate treasurer for large corporations. He served for Sudamtex of Venezuela, C.A for 5 years and Polar Brewery in Caracas, Venezuela for 10 year. Beginning in 2000, he accepted a position as a Director of the Security and Exchange Commission of Venezuela to have the surveillance of Venezuelan stock market participants. Also, in 2004 he completed the requirements and received his certification as a Venezuelan Investment Advisor. Later, as an independent contractor for three years, he was selected as the Corporate Compliance Officer for an especially important stock market broker dealer in Venezuela, Activalores Casa de Bolsa, in which he developed the Compliance Unit and manuals required by local and international anti money laundering laws. He also taught Advanced Institute of Finance (IAF) in Caracas being a public company. These obligations will reduceprofessor of Corporate Finance and Managerial Accounting for 5 years.

Mr. Perez has a Bachelor’s degree in accounting (1976), and MBA Finance (1982), gave me the overall knowledge of finance and how to plan, start up, run, and control a business.

We have selected Mr. Perez to serve as an independent director because of his education, skills and experience in finance and his regulatory history.

Jose Antonio Barreto

From 2006 to the present, Mr. Barreto has been Chief Business Development Officer of Xpectra Remote Management / Mexico. There he was in charge of directing all aspects of account development and sales effort to close specific private and government opportunities and developing strategic accounts in Mexico and the LATAM region. From 2020 to present, he has been an advisor to our abilityBoard of Directors.

Mr. Barreto has more than 30 years of experience working in telecommunications and resourcestechnology companies. He has been directly responsible of leading the business development and operational in several telecommunication and technology companies’ acquisition activity, with the responsibility of leading the technical, operation and financial analysis. Over the last 14 years, Jose Antonio has been the North and Central American leader, spanning from Mexico to expand our business. Panama, in the development of commercial processes in the technology security field, artificial intelligence, Internet of Things (IoT) platforms, as well as cutting edge technology solutions and software systems.

He studied Electronic Engineering at the Universidad Simón Bolivar followed by a Master of Science Degree in Electrical and Computer Engineering at Rice University. He also completed the Master in Telecommunications Management offered by Universidad Simon Bolivar and the Telecom SudParis Institute.

We hopehave selected Mr. Barreto to be ableserve as an independent director because of his education, skills and experience in technology companies.

Italo R. Segnini

From March 2020 to use our statusthe present, Mr. Segnini has been serving as Global Carrier Partnership Director of Sierra Wireless. From June 2019 to February 2020, he served as an Independent Telecom Consultant. From 2017 to 2019, he served as Director of International Carrier Business for Televisa Telecom. From 2012 to 2019, he served as Director International Carrier Business for Millicom.

Mr. Segnini is a public companylong time Telecommunicaction industry professional who has had high level positions at Global Tier Ones for more than 20 years, Telefonica, Millicon and Televisa, Sierra Wireless to increase our abilitymention a few. Mr. Segnini has extensive executive experience in the Telecom areas like Voice, A2P, SMS, Data, Roaming, Mobility Services, B2B, MNO, MVNO, IoT, Interconnection, etc., and a solid business performance record spanning multiple functions including International commercial negotiations, management, sales, business development, sales, regulatory and operations. Italo R. Segnini holds a Juris Doctor degree from the Andres Bello Catholic University, a Telecommunication Masters Degree from Madrid Pontificia Comillas University and an MBA from IESA Business School

19

Term of Office

Our Directors are appointed for a one-year term to use noncash means of settling obligations (i.e. issuance of restricted shareshold office until the next annual general meeting of our common stock)stockholders or until removed from office in accordance with our bylaws. Our officers are appointed by our board of directors and compensate independent contractors who provide professional serviceshold office until removed by the board, subject to us, although there can betheir respective employment agreements.

Significant Employees

We have no assurances that we will be successful in any of those efforts. We will reduce compensation levels paid to management (ifsignificant employees other than our officers and when we do compensate management which for the foreseeable future is limited) if there is insufficient cash generated from operations to satisfy these costs.directors.


Family Relationships

There are no current plans to seek private investment. We do not have any current plans to raise funds throughfamily relationships between or among the sale of securities except as set forth herein. We hope to be able to use our status as a public company to enable us to use non-cash means of settling obligations and compensatedirectors, executive officers or persons and/nominated or firms providing services to us, although there can be no assurances that we will be successful in any of those efforts. We believe that the perception that many people have of a public company make it more likely that they will accept restricted securities from a public company as consideration for indebtedness to them than they would from a private company. We have not performed any studies of this matter. Our conclusion is based on our own beliefs. Issuing shares of our common stock to such persons instead of paying cash to them may increase our chances to establish and expand our business. Having shares of our common stock may also give persons a greater feeling of identity with us which may result in referrals. However, these actions, if successful, will result in dilution of the ownership interests of existing shareholders, may further dilute common stock book value, and that dilution may be material. Such issuances may also serve to enhance existing management’s ability to maintain control of BMI because the shares may be issued to parties or entities committed to supporting existing management. BMI may offer shares of its common stock to settle a portion of the professional fees incurred in connection with its registration statement. No negotiations have taken place with any professional and no assurances can be made as to the likelihood that any professional will accept shares in settlement of obligations due them.


As of March 31, 2012, we owed $44,434 in connection with organizational costs, product development costs and expenses associated with this offering, particularly our settlement with our former legal counsel. We have not entered into any formal agreements, written or oral, with any vendors or other providers for payment of services or expenses. There are no other significant liabilities as of March 31, 2012.


As of March 31, 2012, we owed $11,626 in connection with an interest-free demand loan from two unrelated parties and $908 from Ms. Jones a related party to the Company. The proceeds were used for basic working capital purposes. We owe our former legal counsel $20,000 as settlement for professional services which we agreed to pay when we have the available funds or working capital.


Recently Issued Accounting Pronouncements


The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.




Critical Accounting Policies


The preparation of financial statements and related notes requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities.


An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the financial statements.


Financial Reporting Release No. 60 requires all companies to include a discussion of critical accounting policies or methods used in the preparation of financial statements. There are no critical policies or decisions that rely on judgments that are based on assumptions about matters that are highly uncertain at the time the estimate is made. Note 2to the financial statements, included elsewhere in this prospectus, includes a summary of the significant accounting policies and methods used in the preparation of our financial statements.


Seasonality


We have not started revenue producing activities so we have no direct experience with seasonality. However, we understand that other business entities in our industry have experienced seasonal impacts. Many skin products sell better during the summer months because of the impact on skin from the exposure to sun and others during the winter months because of the dryness associated with winter weather.


Off-Balance Sheet Arrangements


We have no off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K, obligations under any guarantee contracts or contingent obligations. We also have no other commitments, other than the costs of being a public company that will increase our operating costs or cash requirements in the future.


BUSINESS


BMI was incorporated under the laws of the State of Nevada on June 24, 2011, at which time it acquired the product formulas and sample products from our president. The Company at this time believes that these formulas can be used to develop at least eight distinct products. At May 11, 2012, we had one employee, our founder and president, Anna C. Jones. During the period June 24, 2011 (date of inception) through March 31, 2012, Ms. Jones has devoted a minimum of five (5) hours per week to in excess of thirty (30) hours per week as necessary for the business and its development. For calendar year 2012, Ms. Jones will commit to providing at least fifteen (15) hours a week to us but may increase that number as necessary to continue to develop the business. As of this date and through calendar year 2012 , Ms. Jones will continue to provide her services at no cost to the Company. It is expected that Ms. Jones will devote as much time as necessary to us as we begin to near product launch.


At the time of this filing, BMI a “shell company” as such term is defined by Rule 405 of the Securities Act and Rule 12b-2 of the Exchange Act.


The Company issued 5,000,000 shares of its common stock to Ms. Jones at inception in exchange for organizational expenses incurred upon incorporation. Following our formation, we issued an additional 2,500,000 shares of our common stock to Ms. Jones, in exchange for various product formulas and sample materials. (See “Certain Relationships and Related Transactions”, and Note 1 to the Company’s financial statements.) These product formulas contain specific quantity and mixture measurements, preparation and production instructions for a wide variety of ingredients that will be used in our development of up to eight initial products. The formulas are specific to ‘butters’ (semi-solid), lotions, creams and toners which are the base for our intended products. The formulas provide for an exacting mix of ingredients, temperature, insertion or placement of ingredients with other ingredients to provide the necessary product results.


BMI is a development stage company and has no financial resources. We have not established or attempted to establish a source of equity or debt financing. Our independent registered public accounting firm has included an explanatory paragraph in their report emphasizing the uncertainty of our ability to remain a going concern.




As of March 31, 2012, we had limited assets which consisted of; cash of $1,708, raw materials inventory of $547, prepaid expense of $350, deferred offering costs of $26,724 and intangible assets relating to product formulas valued at $1,562, net of accumulated amortization. In order to fund the development of our new skincare business and our working capital needs over the next 12 months, we intend to attempt to secure funding from the sale of common stock or debt financing either from third-party investors or distributors and manufactures involved in the natural beauty product industry. We have begun such conversations with a number of distributors and manufacturers and, while the conversations have been fruitful to date, there can be no assurance that we will be able to obtain any funds or that such funds will be offered on terms acceptable to us.


We are currently developing an initial line of men’s and women’s skincare and cosmetic products. Our chief executive officer, Ms. Jones, has limited professional and industry experience in developing skincare products, and it is our goal to re-formulate some of these acquired formulas and to develop new products with the help of independent contractors. After our initial products have been fully developed and ready for market , we will arrange for these products to be manufactured for us by third-party commercial cosmetics manufacturers. We do not intend to establish our own manufacturing capabilities. We will identify, through our executive officer or other professionals in the skincare business, manufacturers that may be willing to engage in the manufacture and packaging of new skincare products through a sole-source manufacturing agreement or on a contract manufacturing basis based on our limited quantities. We will seek the assistance of designers or packaging consultants to develop the packaging for our initial products. We currently anticipate that our first line of skincare products, expected to consist of up to eight separate products, will be available for commercial sale during late 2012 although no assurances can be given that we will achieve or come close to achieving that goal.


Commercial sale of our products will be dependent upon us achieving additional financing as well as completing the development, formulation and production of our various products. These products will consist initially of a men’s line and women’s line of facial ‘butter,’ facial cream, lotion, and toner specific to the gender, with a hint of scent and colors that are indicative of the intended line. We have initially identified several local skincare product distributors, and one international skincare distributor, that may be willing to offer our skincare to their clientele when products are available, although no commitments have been made as of the date of this prospectus.


While we have just started our business operations, discussions have been limited to advice and direction from other industry veterans. Any discussions that we may have cannot be formulated into a firm or even an oral agreement for services until we have completed our offering and pursued other financing sources or alternatives. Our intent is to further our discussions with these independent contractors, manufacturers, and distributors or other professionals, beyond just the casual stage of information sharing.


In order to be able to implement the foregoing plan of operations, we anticipate that we will need to secure minimal financing of between $50,000 and $100,000 before the end of third quarter calendar year 2012. If we are not successful in raising this initial financing, we will not be able to proceed with our business plan. Our plan of operations requires us to complete our offering and establish sources of financing in order to be able to fulfill our capital needs to develop, produce and furnish products for the commercial markets and ultimately generate sales. Upon successful completion of our offering, we will pursue along with development of our product line, obtaining a source of financing as well as establishing a public market for our common stock, which may then allow us to seek access to financing from sources that would not be available to us as a private company. This may then allow us to negotiate with strength in pursuing financing or strategic agreements with vendors, manufacturers, and financial institutions. We cannot predict the likelihood or timing of success in this area.


The Company has no current plans to be acquired or to merge with any other entity; nor does the Company or any of its shareholders have any plans to enter into a change of control or similar transaction.


Proposed Business


Our goal is to develop a skincare/cosmetics business based on a series of an all-natural essential oils-based branded skincare products marketed under the “E-Scentual” and “B-Maven” brand names. Our goal is to develop, manufacture and market a line of quality skincare products that are sold as prestige products principally through limited distribution channels to complement the images associated with the “E-Scentual” and “B-Maven” brands. Our business plan contemplates the sale of the E-Scentual products primarily through upscale department stores, specialty retailers, prestige hotels, salons and spas. In addition, our goal is to have our products available for sale through a website which we will create, in stores on cruise ships, high-end luxury hotels/resorts, in-flight and duty-free shops, as well as through established foreign branded retail operations.


We will use independent marketing professionals to gain introductions to our targeted markets. Our target market will consist of men and women who are seeking an all-natural product with soothing effects upon their complexion and age-related signs.


We have not yet entered into contracts with nor approached any industry or marketing consultants or independent contractors. We currently have no sources of financing and no commitments for financing. There are no assurances that we will obtain sufficient financing or resources to enter into agreements with independent contractors, manufacturers, distributors or marketing firms.




Proposed Products


We are developing a new line of skin care products. Management has contacted an independent cosmetics formulator for the purpose of assisting in the development of these formulations with a proprietary bio complex blend of ten different raw materials, which we will be the foundation of all of the products that we develop. These materials contain anti-oxidant properties that are believed by many to help fight free radical damage caused by sunlight, stress and other environmental factors. Other ingredients that we will use in these formulas will be selected for their efficacy in helping to correct existing skin damage and age-related signs (such as wrinkles, reduced skin firmness and poor elasticity). Our goal is to develop a line of crèmes that use natural, renewable ingredients that are desired by consumers and incorporated into skin care products using the latest technology, to distinguish our products from those brands that rely on petrochemical and/or undesirable synthetic ingredients.


Our discussions with the independent cosmetics formulator have been limited, and we currently do not have a legally-binding or any other formal agreement with them. If an agreement is reached in the future, we believe that it will provide for their services on a professional consulting basis which will be billed hourly. The independent formulator has been provided samples of our product formulas, as well as has worked with our founder, chief executive officer and president in a limited workspace environment in developing product samples upon with which to work with and to distribute to our samples to potential end-users or customers .. The independent formulator has to date provided its services and assistance on an ad-hoc basis and does not expect to receive compensation for its time to date. The product samples, formulas and any further product samples or derivations of such are the property of the Company and is considered proprietary intellectual property. Part of this intellectual property that is unique to the formulas is the exact ingredient amounts, and the specific method of mixing or producing of the products. The consistency and quality control of the products is essential to a successful product for the skin care market. We cannot predict the likelihood of entering into an acceptable contractual arrangement with any independent formulator.


We have provided an independent formulator, with whom we have no formal, ongoing arrangement or commitment, with the product profile for each of products in development which involve a list of ingredients along with product features and benefits. This independent formulator, along with our founder, has developed numerous samples based on these product specifications, and we are always evaluating and making adjustments to these formulations. In addition to developing products that incorporate natural ingredients believed to contain anti-aging properties, our goal is for our products to provide consumers with a pleasurable sensory experience, most particularly smell, color and touch that they cannot get from other facial products ..


Based on information provided to us by the formulator, we hope to have completed the formulation and development process for our initial products by the end of our first quarter for fiscal year 2012 ( i.e. August 2012), so that we can commence testing of the various products before manufacturing is set to begin. We believe that testing will be conducted by the business that we intend to engage to manufacture our products. We intend to test all of the products for stability and compliance with the Cosmetic Toiletry Fragrance Association (" CTFA ") standards, a self-regulatory organization for the cosmetic industry. This will include various types of tests, including product safety, preservative efficacy, package stability, and assay testing for all products, including over the counter ingredients. Testing stability involves a three month period where analysts are looking for changes in viscosity (thickness), appearance and odor at various temperatures to help determine shelf life, expiry dates, and other things. Although it is our intent to engage a manufacturer to provide all of these services, we may not be able to contract or hire a manufacturer to provide these services, or at a cost that is available to us. If we are unable to hire or contract a manufacturer, then we will pursue the necessary testing on a per-piece basis with a specialist in the field, and produce products on a small scale that will not necessarily fulfill our needs for commercial sales, but will provide us with product that may be available for sale through alternative channels such as Internet commerce, direct sales, smaller retail events specific to the industry and possibly retail placement of the products on a limited basis.


As the products are expected to be sold over the counter, we do not anticipate needing or obtaining any Federal Food and Drug Administration or other regulatory approvals, and we do not plan on doing any clinical testing of any kind. Any products containing sun protection factor (SPF) or any other non-over the counter ingredients, however, will need to meet FDA testing regulations and the global standards for sales in countries other than the United States. We do not anticipate having any products that contain SPF in our initial skincare line.


Our goal is to eventually offer a broad range of skin care products that address various skin care needs for women and men. Our planned products include moisturizers, creams, lotions, cleansers, and other cosmetic products, a number of which will be developed for use on particular areas of the body, such as the face or the hands or around the eyes. Initially, the products that our formulator is currently creating based on our criteria are, however, limited to the following series of skin crème products for women and men:




Women’s line:


·

E-Scentual – face cream

·

E-Scentual – antioxidant anti-aging

·

E-Scentual – purifying cleanser

·

E-Scentual – exfoliating cleanser


Men’s line:


·

E-Scentual – face cream

·

E-Scentual – exfoliating cleanser

·

E-Scentual – purifying cleanser


Proposed Manufacturing


We do not intend to manufacture our products in our own facilities. Rather, we intend to outsource the manufacture of our products to one or more independent cosmetics manufacturers that also manufacture cosmetics for a number of other cosmetics lines. The manufacturer will be expected to test our initial product formulations during a four to six week period. During this testing, we expect to be making further adjustments to our formulations, requiring that new batches of each product be produced following each change. While we believe that we may be able to contract or engage a manufacturer to perform these functions, we may not be able to do so. As discussed above (inProposed Products), we will modify our plan of operations in a manner consistent with our at-that-time financial situation.


Once the formula is fixed for each product, the manufacturer will create a commercial batch of each product, bottle and package the products for us. We are also in the process of choosing all the peripheral items involved in the manufacturing and marketing process, including the:


·

shape and size of the product containers;

·

types of caps;

·

packaging;

·

logo and label designs; and

·

unit cartons.


We currently have no arrangements with any manufacturer.


Marketing and Distribution


We intend to seek an exclusive arrangement, at least initially, with high-end retailers in the U.S. for the initial sale of our products. We also intend to pursue exclusive relationships as a product amenity provider for luxury hotels, resorts and airlines, as well as international distribution. These efforts will be undertaken with the assistance of marketing professionals. We currently have no arrangements with any marketing professional; however, we have had numerous discussions with several international distributors of consumer goods and products directly into China and other Pacific Rim countries that wish to represent BMI’s products. Product samples were provided to these international distributors and the Company is still waiting feedback from one of these international distributors relative to their interest in carrying BMI’s products, placement terms and pricing, initial anticipated order quantities, and labeling requirements .. The results from the feedback from one of the international distributor is listed below ..


Effective January 20, 2012, we entered into an International Distribution Agreement with ELVIE Corporation, an established import/export business. Pursuant to the terms of the agreement, ELVIE Corporation will have the right to exclusively distribute our product lines when available for sale in the Pacific Rim region. The agreement is for a period of one year expiring on the first anniversary with an option by both parties to extend for an additional period of two years. However, either we or ELVIE Corporation may terminate the agreement for any reason upon ninety days written notice.


We anticipate that we will have completed our initial manufacturing of the products during our first half of fiscal year 2012 (i.e. November or December 2012), provided that we obtain the necessary financing. There are no assurances that we will be successful in obtaining financing or in completing the development of our products within this timeframe or otherwise.




Competition


The skincare and cosmetic products business is highly competitive. We will be competing with hundreds of large and small cosmetics companies, including such companies as L’Oreal S.A., The Procter & Gamble Company, The Estée Lauder Companies Inc. and numerous other multi-national manufacturers. Most of our competitors market products that are well known and trusted by the consumer marketplace. Since virtually all of our competitors have significantly greater financial and other resources than we do, our competitors have the ability to spend more aggressively on advertising and marketing, spend more on product development and testing, and have more flexibility than we do to respond to changing business and economic conditions. Competition in the skincare business is based on pricing of products, the quality of the products, innovation, perceived value, promotional activities, advertising, new product introductions, name recognition, and other factors. It is difficult for us to predict how we will be able to effectively compete with our competitors’ actions in these areas.


We believe that, through the efforts of independent marketing and advertising professionals, we will prepare marketing materials and other consumer-directed materials that will help inform the consumers as to the potential benefits of our products, when fully developed. We have produced samples of our various intended products for more than 12 months, which includes time prior to our founding, and have received positive results from a significant percentage of “potential” consumers or end-users of our products. These results and responses have been elicited from the sample users in a non-scientific manner and include before and after pictures of the users facial complexion which includes strong age-related signs from both age and sun damage due to the Southern California weather. These results although anecdotal have provided our founder with the incentive to improve upon the initial product formulas and to pursue the retail market of these products for the mass consumer. With the spread of the results by the “potential” consumers to their friends and family, the need for the product has begun to generate through what is considered anecdotal marketing. Even without a retail product available, our founder has received repeated requests to produce products for consumption.


We will compete using our contacts to develop opportunities to meet potential distributors that we will be able to take advantage of as quickly as our limited resources will permit. These opportunities will come from contacts and referrals that we make through our independent consultants and our president. The ability to take advantage of these opportunities will depend upon our ability to secure sufficient funding for our product development and manufacturing and marketing and advertising professionals. However, we cannot predict the likelihood or timing for our success.No assurances can be given that our competitive strategy will have any success.


Intellectual Property


We have no patents or trademarks or applications pending.


Government Regulation and Industry Standards


We believe that our business is not subject to material regulation under the laws of the United States or any of the states in which we plan to sell our products. Laws and regulations often differ materially between states and within individual states such laws and regulations are subject to amendment and reinterpretation by the agencies charged with their enforcement. If we become subject to any licensing or regulatory requirements, the failure to comply with any such requirements could lead to a revocation, suspension or loss of licensing status, termination of contracts and legal and administrative enforcement actions. We cannot be sure that a review of our current and proposed operations will not result in a determination that could materially and adversely affect our business, results of operations and financial condition. Moreover, regulatory requirements are subject to change from time to time and may in the future become more restrictive, thereby making compliance more difficult or expensive or otherwise affecting or restricting our ability to conduct our business as now conducted or proposed to be conducted.


Employees


As of May 11 , 2012, we had one employee, our founder and president, Ms. Jones. During the period June 24, 2011 (date of inception) through March 31, 2012, Ms. Jones has devoted a minimum of five (5) hours per week to in excess of thirty (30) hours per week as necessary for the business and its development. For the remainder of calendar year 2012, Ms. Jones will commit to providing at least fifteen (15) hours a week to us but may increase that number as necessary to continue to develop the business. As of this date and throughout calendar year 2012 , Ms. Jones will continue to provide these services at no cost to the Company. We have no plans to compensate Ms. Jones for her efforts. For the immediate future, we intend to use independent contractors and consultants to assist in many aspects of our business on an as needed basis pending financial resources being available. We may use independent contractors and consultants once we receive sufficient funding to hire additional employees. Even then, we will principally rely on independent contractors for substantially all of our technical and manufacturing needs.




There is no written employment contract or agreement. Currently, we are not actively seeking additional employees or engaging any consultants through a formal written agreement or contract. Services are provided on an as-needed basis to date. This may change in the event that we are able to secure financing through equity or loans to the Company.


Property


Our office and mailing address is 3272 Reynard Way, San Diego, CA 92103. The space is provided to us by Ms. Jones. Ms. Jones incurs no incremental costs as a result of our using the space. Therefore, she does not charge us for its use. There is no written lease agreement.


Litigation


We are not party to any pending, or to our knowledge, threatened litigation of any type.


DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS


Our management consists of:


Name

Age

Title

Anna C. Jones

35

President, CEO, principal executive officer, treasurer, chairman, principal financial officer and principal accounting officer


Anna Celeste Jones – founded the Company in June 2011. Ms. Jones through various family members over the past two decades has been exposed to the world of herbology; which began early in her upbringing as well as being taught about effective facial creams, sports balms and tinctures and their development. Ms. Jones has studied physiology, rehabilitation, nutrition and derma-care through a variety of programs available in Southern California. Ms. Jones currently works as a special cases manager with Work Comp Medical Services, Inc., a physicians scheduling and billing company based in San Diego. She has been with this organization for more than ten years. Ms. Jones is a self trained entrepreneur who has been involved with several projects and programs that have focused on internal as well as external processes that support healthy skin, which provides significant research for local universities. Ms. Jones has not held any executive positions in any public company nor does Ms. Jones have any accounting, financial reporting or legal education or experience that would be necessary as the business grows.


Possible Potential Conflicts


The OTCBB on which we plan to have our shares of common stock quoted does not currently have any director independence requirements.


No member of management will be requiredchosen by us to work on a full time basis. Accordingly, certain conflicts of interest may arise between us and our officer(s) and director(s) in that they may have other business interests in the future to which they devote their attention, and they may be expected to continue to do so although management time must also be devoted to our business. As a result, conflicts of interest may arise that can be resolved only through their exercise of such judgment as is consistent with each officer's understanding of his/her fiduciary duties to us.


Currently we have only one officer and one director (both of whom are the same person), and will seek to add additional officer(s) and/become directors or director(s) as and when the proper personnel are located and terms of employment are mutually negotiated and agreed, and we have sufficient capital resources and cash flow to make such offers.


In an effort to resolve potential conflicts of interest, we have entered into a written agreement with Ms. Jones specifying that any business opportunities that she may become aware of independently or directly through her association with us (as opposed to disclosure to her of such business opportunities by management or consultants associated with other entities) would be presented by her solely to us.


We cannot provide assurances that our efforts to eliminate the potential impact of conflicts of interest will be effective.




Code of Business Conduct and Ethics


In June 2011 we adopted a Code of Ethics and Business Conduct which is applicable to our future employees and which also includes a Code of Ethics for our chief executive and principal financial officers and any persons performing similar functions. A code of ethics is a written standard designed to deter wrongdoing and to promote:


·

honest and ethical conduct,

·

full, fair, accurate, timely and understandable disclosure in regulatory filings and public statements,

·

compliance with applicable laws, rules and regulations,

·

the prompt reporting violation of the code, and

·

accountability for adherence to the code.


A copy of our Code of Business Conduct and Ethics has been filed with the Securities and Exchange Commission as Exhibit 14.1 to our Registration Statement of which this prospectus is a part.


Board of Directors


All directors will hold office until the completion of their term of office, which is not longer than one year, or until their successors have been elected. Our current directors’ term of office expires on June 30, 2012. All officers are appointed annually by the board of directors, subject to existing employment agreements (of which there are currently none) and serve at the discretion of the board. Currently, directors receive no compensation for their role as directors but may receive compensation for their role as officers.

As long as we have no additional directors besides our Chief Executive Officer and Chairman, all votes on issues are resolved in favor of the chairman’s vote.


Involvement in Certain Legal Proceedings


Except as described below, duringDuring the past ten10 years, no present director,none of our current directors, nominees for directors or current executive officer or person nominated to become a director or an executive officerofficers has been involved in any legal proceeding identified in Item 401(f) of BMI:Regulation S-K, including:


1.

had a Any petition under the federalFederal bankruptcy laws or any state insolvency law filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he or she was a general partner at or within two years before the time of such filing, or any corporation or business association of which he or she was an executive officer at or within two years before the time of such filing;


2.

was convicted Any conviction in a criminal proceeding or being named a subject toof a pending criminal proceeding (excluding traffic violations and other minor offenses);


3.

was Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him or her from, or otherwise limiting, her involvement in any of the following activities:


i.

acting Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;


ii.

engaging Engaging in any type of business practice; or


iii.

engaging Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of federalFederal or stateState securities laws or federalFederal commodities laws; or


4.

was the Being subject ofto any order, judgment or decree, not subsequently reversed, suspended or vacated, of an federalany Federal or stateState authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (3)(i), above,type of business regulated by the Commodity Futures Trading Commission, securities, investment, insurance or banking activities, or to be associated with persons engaged in any such activity; or


5.

was Being found by a court of competent jurisdiction (inin a civil action),action or by the SecuritiesSEC to have violated any Federal or State securities law, and Exchangethe judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

20

6. Being found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated a federal or state securities orany Federal commodities law, and for which the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated.vacated;




7. Being subject to, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

i.Any Federal or State securities or commodities law or regulation; or
ii.Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or
iii.Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

8. Being subject to, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Director Independence

The Board of Directors reviews the independence of our directors on the basis of standards adopted by the NASDAQ Stock Market (“NASDAQ”). As a part of this review, the Board of Directors considers transactions and relationships between our company, on the one hand, and each director, members of the director’s immediate family, and other entities with which the director is affiliated, on the other hand. The purpose of such a review is to determine which, if any, of such transactions or relationships were inconsistent with a determination that the director is independent under NASDAQ rules. As a result of this review, the Board of Directors has determined that each of Messrs. Perez, Barreto and Segnini are “independent directors” within the meaning of applicable NASDAQ listing standards.

Committees of the Board

On August 25, 2021, the Board authorized the creation of Directorsan Audit Committee. Raul Perez (chair), Italo Segnini and Jose Antonio Barreto were appointed to serve on the Audit Committee.


ConcurrentEach of Messrs Perez, Segnini and Barreto have been determined by the Board to be independent directors within the meaning of NASDAQ Rule 5605. Mr. Perez was identified and designated by the Board as an “audit committee financial expert,” as defined by the SEC in Item 407 of Regulation S-K. 

On November 17, 2022, we authorized the creation of a Compensation Committee. The Compensation Committee’s responsibilities, which are discussed in detail in its Charter, include the following:

In consultation with our senior management, establish our general compensation philosophy and oversee the development and implementation of our compensation programs;
Recommend the base salary, incentive compensation and any other compensation for our Chief Executive Officer to the Board of Directors and review and approve the Chief Executive Officer’s recommendations for the compensation of all other officers of our company and its subsidiary;
Administer our incentive and stock-based compensation plans, and discharge the duties imposed on the Compensation Committee by the terms of those plans;
Review and approve any severance or termination payments proposed to be made to any current or former officer of our company; and
Perform other functions or duties deemed appropriate by the Board of Directors.

21

The Committee is comprised of, Raul Perez, Jose Antonio Barreto, and Italo Segnini, with having sufficient membersMr. Segnini serving as Chairperson. Each of Messrs. Perez, Barreto and resources,Segnini have been determined by the BMIBoard to be an independent director within the meaning of NASDAQ Rule 5605.

On June 12, 2023, our Board of Directors adopted a charter for our newly created Nominating and Governance Committee (the “Committee”). The Committee is responsible for the oversight of our director nominations process, including recommending nominees to the Board of Directors for approval and for the development and maintenance of our corporate governance policies.

Our Board of Directors appointed the following persons to the Committee: Raul Perez, Jose Antonio Barreto and Italo Segnini, with Mr. Barreto serving as Chairperson.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our directors and executive officers and persons who beneficially own more than ten percent of a registered class of the Company’s equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent beneficial stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. To the best of our knowledge based solely on a review of Forms 3, 4, and 5 (and any amendments thereof) received by us, no persons have failed to file, on a timely basis, the identified reports required by Section 16(a) of the Exchange Act during fiscal year ended December 31, 2023.

Code of Ethics

On October 31, 2022, our Board of Directors approved and adopted a Code of Business Conduct and Ethics (the “Code of Ethics”). The Code of Ethics is applicable to all directors, officers and employees of our company, our company’s subsidiaries and any subsidiaries that may be formed in the future. The Code of Ethics addresses such individuals’ conduct with respect to, among other things, conflicts of interests; compliance with applicable laws, rules, and regulations; full, fair, accurate, timely, and understandable disclosure; competition and fair dealing; corporate opportunities; confidentiality; insider trading; protection and proper use of our assets; fair treatment; and reporting suspected illegal or unethical behavior.

A copy of our Code of Ethics is posted on our website at http://iqstel.com/. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our Code of Business Conduct and Ethics on our website. The reference to the iQSTEL website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be part of this prospectus.

22

EXECUTIVE COMPENSATION

The table below summarizes all compensation awarded to, earned by, or paid to our former or current executive officers for the fiscal years ended December 31, 2023 and 2022.

Name and principal

Position

YearSalary ($)

Bonus

($)

Stock

Awards

($)

Option

Awards

($)

All Other

Compensation

($) (1)(2)

Total

($)

Leandro Iglesias

President, CEO and Director

2023

2022

268,000

204,000

-

-

-

-

-

-

-

-

268,000

204,000

Alvaro Quintana

Treasury, Secretary and Director

2023

2022

156,000

144,000

-

-

-

-

-

-

-

-

156,000

144,000

Juan Carlos López

Chief Commercial Officer

2023

2022

60,000

120,000

-

-

-

-

-

-

-

-

60,000

120,000

On May 2, 2019, the Company entered into Employment Agreements with the following persons: (i) Leandro Iglesias as President, CEO and Chairperson of the Company’s Board of Directors with an annual salary of $168,000 with an annual bonus of 3% of our net income; (ii) Juan Carlos Lopez Silva as Chief Commercial Officer with an annual salary of $120,000 with an annual bonus of 3% of our net income; and Alvaro Quintana Cardona as Chief Operating Officer and Chief Financial Officer with an annual salary of $144,000 with an annual bonus of 3% of our net income. The Employment Agreements have a term of 36 months, are renewable automatically for 24-month periods, unless the Company gives written notice at least 90 days prior to termination of the initial 36-month term. The Company shall have the right to terminate any of the employment agreements at any time without prior notice, but in that event, the Company shall pay these persons salaries and other benefits they are entitled to receive under their respective agreements for three years. The above executive officers agreed to two year non-compete and non-solicit restrictive covenants with the Company. If any of the executive officers are terminated for cause they shall forfeit any rights to severance.

On November 1, 2020, our board of directors will establish an audit committee and a compensation committee. We believe that we will need a minimumapproved amended employments in favor of five directors to have effective committee systems. The audit committee will review the results and scope of the audit and other services provided by the independent auditors and review and evaluate the system of internal controls. The compensation committee will manage any stock option plan we may establish and review and recommend compensation arrangements for the officers. No final determination has yet been made as to the memberships of these committees or when we will have sufficient members to establish committees. See “Executive Compensation” hereinafter.


All directors will be reimbursed by BMI for any expenses incurred in attending directors' meetings provided that BMI has the resources to pay these fees. BMI will consider applying for officers and directors liability insurance at such time when it has the resources to do so.


Summary Executive Compensation Table


The following table shows, for the period from June 24, 2011 (inception) to June 30, 2011, compensation awarded to or paid to, or earned by, our Chief Executive Officer, (the “Named Executive Officer”).Leandro Iglesias, our Chief Financial Officer, Alvaro Quintana, and our Chief Commercial Officer, Juan Carlos Lopez Silva.


SUMMARY COMPENSATION TABLE

Name and

Principal position (a)

Year

(b)

Salary

($)

(c)

Bonus

($)

(d)

Stock

Awards

($)

(e)

Option

Awards

($)

(f)

Non-Equity

Incentive

Plan

Compensation

($)

(g)

Nonqualified

Deferred

Compensation

Earnings

($)

(h)

All Other

Compensation

($)

(i)

Total

($)

(j)

1 Anna C. Jones CEO, CFO and Director

 2011

-

-

-

-

-

-

5,000

5,000


ThereThe amended employment agreement in favor of Mr. Iglesias extended the term of employment from 36 months to 60 months. The now five year employment agreement with Mr. Iglesias provides that we will compensate him with a salary of $17,000 monthly and he is no formal employment arrangement with Ms. Jones at this time. Ms. Jones’s compensation haseligible for quarterly bonus of 250,000 shares of our common stock. If we do not been fixedhave the cash available, the agreement provides that Mr. Iglesias may convert his accrued salary/bonus into shares of our common stock or based on any percentage calculations. She makes all decisions determiningnewly created Series A Preferred Stock. For common shares, the amount of accrued salary to be converted into shares must be determined by considering the average price per share of the Company’s common stock on the OTC Markets during the last 10 days and timingapplying a discount of her compensation25%.” For Series A Preferred Shares, the amount of accrued salary to be converted into shares is the per share conversion price for common shares multiplied by ten US Dollars ($10). Mr. Iglesias has a further right to convert any common shares under his control into Series A Preferred shares at any time at a rate of ten (10) common shares for each Series A Preferred share.

The amended employment agreement in favor of Mr. Quintana extended the term of employment from 36 months to 60 months. The now five year employment agreement with Mr. Quintana provides that he is eligible for quarterly bonus of 200,000 shares of our common stock. If we do not have the cash available, the agreement provides that Mr. Quintana may convert his accrued salary/bonus into shares of our common stock or newly created Series A Preferred Stock. For common shares, the amount of accrued salary to be converted into shares must be determined by considering the average price per share of the Company’s common stock on the OTC Markets during the last 10 days and applying a discount of 25%.” For Series A Preferred Shares, the amount of accrued salary to be converted into shares is the per share conversion price for common shares multiplied by ten US Dollars ($10). Mr. Quintana has a further right to convert any common shares under his control into Series A Preferred shares at any time at a rate of ten (10) common shares for each Series A Preferred share.

23

The amended employment agreement in favor of Mr. Silva extended the immediate future, doesterm of employment from 36 months to 60 months. Mr. Silva is eligible for quarterly bonuses of 150,000 shares of our common stock. If we do not have the cash available, the agreement provides that Mr. Iglesias may convert his accrued salary/bonus into shares of our common stock at the average price of our common stock during the last 10 days after applying a discount of 25%.

Option Grants

We have not granted any options or stock appreciation rights to our named executive officers or directors since inception. We do not have any stock option plans.

Compensation of Directors

All Directors shall receive any compensationreimbursement for her services. Ms. Jones’s compensation amounts in the future mayreasonable travel expenses incurred to attend Board and committee meetings.

Effective on July 1, 2021 and thereafter, all Directors shall be formalized if and when her services are considered full-time in nature, i.e. in excess of 2080 hours per year and the Company has the necessary finances in ordercompensated monthly up to pay her.


1Ms. Jones received 5,000,0004,000 shares of common stock cash of $1,000 for their service as Directors. The Chairman and Secretary of the Company for organizational servicesBoard shall receive an additional $2,000 per month in addition to the Director compensation.

In lieu of the cash compensation set forth above, each Director may elect to receive shares of the Corporation's Common Stock equal to the total cash compensation divided by the average market value of the Company's Common Stock during the last 10 trading days and applying a discount of 25%.

Pension, Retirement or Similar Benefit Plans

There are no arrangements or plans in which was valuedwe provide pension, retirement or similar benefits to our directors or executive officers. We have no material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at $5,000.the discretion of the board of directors or a committee thereof.

Compensation Committee

We do not currently have a compensation committee of the board of directors or a committee performing similar functions. The Company does not intend on issuing any additional shares to Ms. Jones for further organizational services or for her activitiesboard of directors as ana whole participates in the consideration of executive officer or director.and director compensation.


GrantsIndebtedness of Plan-Based Awards TableDirectors, Senior Officers, Executive Officers and Other Management

 

None of our nameddirectors or executive officers receivedor any grantsassociate or affiliate of stock, option awardsour company during the last two fiscal years is or has been indebted to our company by way of guarantee, support agreement, letter of credit or other plan-based awards duringsimilar agreement or understanding currently outstanding.

24

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Other than described below or the period ended June 30, 2011. The Company has no activitytransactions described under the heading “Executive Compensation” (or with respect to these awards.which such information is omitted in accordance with SEC regulations), there have not been, and there is not currently proposed, any transaction or series of similar transactions to which we were or will be a participant in which the amount involved exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years, and in which any director, executive officer, holder of 5% or more of any class of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest.

 

Options Exercised and Stock Vested TableDue from related parties

 

NoneAs of September 30, 2023 and December 31, 2022, the Company had amounts due from related parties of $427,194 and $326,324, respectively. The loans are unsecured, non-interest bearing and due on demand.

Due to related parties

As of September 30, 2023 and December 31, 2022, the Company had amounts due to related parties of $26,613. The amounts are unsecured, non-interest bearing and due on demand.

PRINCIPAL STOCKHOLDERS

The following table sets forth, as of February 12, 2024, certain information as to shares of our namedvoting stock owned by (i) each person known by us to beneficially own more than 5% of our outstanding voting stock, (ii) each of our directors, and (iii) all of our executive officers exercised any stock options, and no restricted stock units if any, held bydirectors as a group.

Unless otherwise indicated below, to our named executive officers vested during the period ended June 30, 2011. The Company has no activityknowledge, all persons listed below have sole voting and investment power with respect to their shares of voting stock, except to the extent authority is shared by spouses under applicable law. Unless otherwise indicated below, each entity or person listed below maintains an address of 300 Aragon Avenue, Suite 375, Coral Gables, FL 33134.

The number of shares beneficially owned by each stockholder is determined under rules promulgated by the SEC. The information is not necessarily indicative of beneficial ownership for any other purpose. Under these awards.rules, beneficial ownership includes any shares as to which the individual or entity has sole or shared voting or investment power and any shares as to which the individual or entity has the right to acquire beneficial ownership within 60 days through the exercise of any stock option, warrant or other right. The inclusion in the following table of those shares, however, does not constitute an admission that the named stockholder is a direct or indirect beneficial owner.


  Common Stock
Name of Beneficial Owner 

Number of Shares Owned

(1)

 

Percent of Class

(2) 

Leandro Iglesias  542,932   0.310%
Alvaro Quintana Cardona  1,121,842   0.640%
Juan Carlos Lopez Silva  925,497   0.528%
Raul Perez  8,000   0.005%
Jose Antonio Barreto  8,000   0.005%
Italo Segnini  8,000   0.005%
All Directors and Executive Officers as a Group (6 persons)  2,614,271   1.491%

Outstanding Equity Awards at Fiscal Year-End Table

25

  Series A Preferred Stock(4)
Name of Beneficial Owner 

Number of Shares Owned

(1)

 

Percent of Class

 (3)

Leandro Iglesias  7,000   70.00%
Alvaro Quintana Cardona  3,000   30.00%
Juan Carlos Lopez Silva  —     —   
Raul Perez  —     —   
Jose Antonio Barreto  —     —   
Italo Segnini  —     —   
All Directors and Executive Officers as a Group (6 persons)  10,000   100.00%

 

None

   Total Voting Power 
Name of Beneficial Owner  

Number of Votes

(5)

   

Percent of Vote

 (5)

 
Leandro Iglesias  128,275,952   35.85%
Alvaro Quintana Cardona  55,864,565   15.61%
Juan Carlos Lopez Silva  925,497   * 
Raul Perez  8,000   * 
Jose Antonio Barreto  8,000   * 
Italo Segnini  8,000   * 
All Directors and Executive Officers as a Group (6 persons)  185,090,015   51.73%
         
* Less than 1%        

(1) Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power (or shares that power with that person’s spouse) with respect to all shares of voting stock listed as owned by that person or entity.

(2) Pursuant to Rules 13d-3 and 13d-5 of the Exchange Act, beneficial ownership includes any shares as to which a shareholder has sole or shared voting power or investment power, and also any shares which the shareholder has the right to acquire within 60 days, including upon exercise of common shares purchase options or warrants. The percent of class is based on 175,319,832 voting shares as of February 12, 2024

(3) Pursuant to Rules 13d-3 and 13d-5 of the Exchange Act, beneficial ownership includes any shares as to which a shareholder has sole or shared voting power or investment power, and also any shares which the shareholder has the right to acquire within 60 days, including upon exercise of common shares purchase options or warrants. The percent of class is based on 10,000 voting shares as of February 12, 2024.

(4) Under the Certificate of Designation, holders of Series A Preferred Stock will participate on an equal basis per-share with holders of our named executive officers hadcommon stock in any outstandingdistribution upon winding up, dissolution, or liquidation. Holders of Series A Preferred Stock are entitled to vote together with the holders of our common stock or option awards ason all matters submitted to shareholders at a rate of June 30, 2011 that would be compensatory to51% of the officer. The Company has not issued any awards to its named executive officers. The Company and its Boardtotal vote of Directors may grant awards as it sees fit to its employees as well as key consultants.


shareholders.

PRINCIPAL SHAREHOLDERS


As of May 11, 2012 we had 7,500,000(5) There are 175,319,832 total shares of common stock outstanding whichentitled to one vote per share. Holders of Series A Preferred Stock are held byentitled to vote together with the holders of our common stock on all matters submitted to shareholders at a rate of 51% of the total vote of shareholders, including the election of directors. Our common stock is entitled to one shareholder. The chart below sets forthvote per share on all matters submitted to a vote of the ownership, or claimed ownership,stockholders, including the election of certain individuals and entities. This chart discloses those persons knowndirectors. As a result of voting feature of the Series A Preferred Stock, there are 175,319,832 votes represented by the board of directorscommon stock, which means that there are approximately 182,475,744 votes available to have, or claim to have, beneficial ownership of more than 5%the holders of the outstanding10,000 shares of Series A Preferred Stock for 51% of the total vote. Combining the common stock and the Series A Preferred Stock, there are a total of 357,795,576 votes that may be cast.

26

DESCRIPTION OF CAPITAL STOCK

Our authorized capital stock consists of 300,000,000 shares of common stock, with a par value of $0.001 per share, and 1,200,000 shares of preferred stock, with a par value of $0.001 per share. As of the date of this prospectus, there were 175,319,832 shares of our common stock asissued and outstanding, 10,000 shares of May 11, 2012;Series A Preferred Stock issued and outstanding, 31,080 shares of all directorsSeries B Preferred Stock issued and executive officersoutstanding , 0 shares of BMI;Series C Preferred Stock issued and outstanding and 0 shares of our directorsSeries D Preferred Stock issued and officers asoutstanding. Our shares of common stock are held by 16 stockholders of record.

Common Stock

Our common stock is entitled to one vote per share on all matters submitted to a group.




Title Of Class

Name, Title and Address of Beneficial Owner of Shares(a)

Amount of Beneficial Ownership(b)

Percent of Class

 

 

 

Before Offering

After Offering(d)

Common

Anna C. Jones (c)

7,500,000

100.00%

75.00%

 

 

 

 

 

 

 

 

 

 

 

 All Directors and Officers as a group (1 person)


7,500,000


 100.00%


75.00%


(a) The address for purposes of this table is the Company’s address which is 3272 Reynard Way, San Diego, California, 92103.

(b) Unless otherwise indicated, BMI believes that all persons named in the table have sole voting and investment power with respect to all shares of the common stock beneficially owned by them. A person is deemed to be the beneficial owner of securities which may be acquired by such person within 60 days from the date indicated above upon the exercise of options, warrants or convertible securities. Each beneficial owner’s percentage ownership is determined by assuming that options, warrants or convertible securities that are held by such person (but not those held by any other person) and which are exercisable within 60 days of the date indicated above, have been exercised.

(c) Ms. Jones received 2,500,000 shares for selling the product formulas and products samples to the Company on June 27, 2011. These product formulas are critical to our business.

(d) Assumes the sale of the maximum amount of this offering (2,500,000 shares of common stock). The aggregate amount of shares to be issued and outstanding after the offering will be 10,000,000 based upon such assumption.


CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS


The only promotersvote of the Company wouldstockholders, including the election of directors. The holders of our common stock possess all voting power. Generally, all matters to be Ms. Jones, founder, president, and chief executive officer, and principal financial officer, and up until January 23, 2012 whereby Gary B. Wolff, P.C.,voted on by stockholders must be approved by a majority (or, in the Company’s former securities counselcase of election of directors, by virtuea plurality) of the fact that Mr. Wolff’s firm was effectively financing this offering as a result of their agreement set forth in Exhibit 10.1votes entitled to the registration statement of which this prospectus is a part. The Company on January 23, 2012 terminated its legal representation agreement with Gary B. Wolff, P.C., a copy of which is attached as Exhibit 10.3 to the registration statement of which this prospectus is a part. The Company retained the services of Quick Law Group, P.C. as new legal counsel on March 7, 2012. Our agreement with new legal counsel provides for a fee of $30,000, $7,500 payable from the maximum offering proceeds, and the balance of $22,500 within four months of the date of our agreement entered into with the Quick Law Group.


While it may be asserted that the Quick Law Group, P.C. may be considered a “promoter”cast by virtue of the fact that Mr. Quick’s law firm may be effectively financing this offering through the deferral of legal fees, the Company and Mr. Quick believe these activities do not constitute the taking of an "initiative in founding and organizing the business or enterprise of an issuer," as set forth in the definition of "promoter" in Rule 405.


Our office and mailing address is 3272 Reynard Way, San Diego, CA 92103. The space is provided to us by Ms. Jones. Ms. Jones incurs no incremental costs as a result of our using the space. Therefore, she does not charge us for its use. There is no written lease agreement.


The Company issued 5,000,000 shares of its common stock to its President, Chief Executive Officer and Chief Financial Officer in exchange for organizational services incurred upon incorporation in June 2011. These services were valued at $5,000.


Ms. Jones developed our formulas. Ms. Jones received 2,500,000all shares of our common stock that are present in person or represented by proxy, subject to any voting rights granted to holders of any preferred stock. Holders of our common stock representing a majority of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of our stockholders. A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to our Articles of Incorporation. Our Articles of Incorporation do not provide for sellingcumulative voting in the product formulas and product samples to us. The valueelection of the product formulas and product samples we purchased was $2,500 which approximates the cost incurred in developing the various formulas.directors.


AsPreferred Stock

Our board of March 31, 2012, we owed $11,626 in connection with an interest-free demand loan from two unrelated parties and $908 in connection with an interest-free demand loan from a related party. The proceeds were used for basic working capital purposes.




DESCRIPTION OF CAPITAL STOCK


Introduction


We were incorporated under the laws of the State of Nevada on June 24, 2011. BMI isdirectors may become authorized to issue 100,000,000authorize preferred shares of common stock and 1,000,000to divide the authorized shares of our preferred stock.


Preferred Stock


Our certificatestock into one or more series, each of incorporation authorizeswhich must be so designated as to distinguish the issuanceshares of 1,000,000 shareseach series of preferred stock with designations, rights and preferences determined from time to time by our board of directors. Nothe shares of preferred stock have been designated, issued or are outstanding. Accordingly, ourall other series and classes. Our board of directors is empowered, without stockholder approval,authorized, within any limitations prescribed by law and our articles of incorporation, to issue up to 1,000,000fix and determine the designations, rights, qualifications, preferences, limitations and terms of the shares of any series of preferred stock with voting, liquidation, conversion, or other rights that could adversely affectincluding, but not limited to, the rights of the holders of the common stock. Although we have no present intention to issue any shares of preferred stock, there can be no assurance that we will not do so in the future.following:


Among other rights, our board of directors may determine, without further vote or action by our stockholders:


·

the1. The number of shares constituting that series and the distinctive designation of the series;that series, which may be by distinguishing number, letter or title;  

·

whether to pay dividends2. The dividend rate on the shares of that series, and, if so, the dividend rate, whether dividends will be cumulative, and if so, from which date or dates,date(s), and the relative rights of priority, if any, of payment of dividends on shares of thethat series;

·

whether the3. Whether that series will have voting rights, in addition to the voting rights provided by law, and, if so, the terms of thesuch voting rights;

·

whether the4. Whether that series will be convertible into or exchangeable for shares of any other class or series of stockhave conversion privileges, and, if so, the terms and conditions of such conversion, or exchange;including provision for adjustment of the conversion rate in such events as the Board of Directors determines;  

·

whether5. Whether or not the shares of thethat series will be redeemable, and, if so, the dates, terms and conditions of such redemption, including the date or date upon or after which they are redeemable, and whether therethe amount per share payable in case of redemption, which amount may vary under different conditions and at different redemption dates;  

6. Whether that series will behave a sinking fund for the redemption or purchase of shares of that series, and, if so, the terms and amount of thesuch sinking fund;  and

·

the7. The rights of the shares of thethat series in the event of our voluntary or involuntary liquidation, dissolution or winding up of the corporation, and the relative rights orof priority, if any, of payment of shares of thethat series; and  

8. Any other relative rights, preferences and limitations of that series.


27

We presently do not have plans

Series A Preferred Stock

On November 1, 2020, pursuant to issue any sharesArticle III of preferred stock. However, preferred stock could be usedour Articles of Incorporation, our Board of Directors voted to dilutedesignate a potential hostile acquirer. Accordingly, any future issuanceclass of preferred stock entitled Series A Preferred Stock, consisting of up 10,000 shares, par value $0.001. Under the Certificate of Designation, holders of Series A Preferred Stock will participate on an equal basis per-share with holders of our common stock in any distribution upon winding up, dissolution, or any rightsliquidation. Holders of Series A Preferred Stock are entitled to purchase preferred shares may have the effect of making it more difficult for a third party to acquire control of us. This may delay, defer or prevent a change of control in our Company or an unsolicited acquisition proposal. The issuance of preferred stock also could decrease the amount of earnings attributable to, and assets available for distribution to,vote together with the holders of our common stock and could adversely affect the rights and powers, including voting rights,on all matters submitted to shareholders at a rate of 51% of the total vote of shareholders.

Series B Preferred Stock

On November 11, 2020, pursuant to Article III of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series B Preferred Stock, consisting of up 200,000 shares, par value $0.001. Under the Certificate of Designation, holders of our common stock.


CommonSeries B Preferred Stock


Our certificate of incorporation authorizes the issuance of 100,000,000 shares of common stock. There are 7,500,000 shares of our common stock issued and outstanding at March 31, 2012 held by one shareholder, our President. will receive $81 per share in any distribution upon winding up, dissolution, or liquidation before junior security holders. Holders of our common stock:


·

have equal ratable rightsSeries B Preferred Stock are entitled to dividends from funds legally available for payment of dividendsreceive as, when, as and if declared by the boardBoard of directors;

·

are entitledDirectors, dividends in kind at an annual rate equal to twenty four percent (24%) of $81 per share ratably in allfor each of the assets available for distributionthen outstanding shares of Series B Preferred Stock, calculated on the basis of a 360-day year consisting of twelve 30-day months. Holders of Series B Preferred Stock do not have voting rights but may convert into common stock after twelve months from the issuance date. Upon conversion, the shares are subject to holdersa one-year leak-out restriction on sales into the market of no more than 5% previous month’s stock liquidity.

On January 15, 2021, we entered into Conversion Agreements with Leandro Iglesias, our Chief Executive Officer and director, Alvaro Quintana, Chief Financial Officer and director, and Juan Carlos Lopez, our Chief Commercial Officer, pursuant to which we agreed to convert 21,000,000 shares of common stock from each officer into 21,000 shares of our Series B Preferred Stock, as follows:

Shareholders

Number of Shares of Common

Stock Converting Into Series B Preferred Stock

Number of shares of Series B Preferred Stock acquired in conversionNumber of shares of Serie B Preferred Stock received as dividend
Leandro Iglesias12,200,00012,2005,856
Alvaro Cardona5,300,0005,3002,544
Juan Carlos Lopez3,500,0003,5001,680
Total21,000,00021,00010,080

The parties entered into these Conversion Agreements to, among other things, allow more common stock to be available for future issuances in connection with note conversions and as a means to lock-up the shares of common stock underlying the Series B Preferred held by our officers from trading and to establish a leak-out agreement upon liquidation,any future conversions back to common stock.

Series C Preferred Stock

On January 7, 2021, pursuant to Article III of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series C Preferred Stock, consisting of up 200,000 shares, par value $0.001. Under the Certificate of Designation, holders of Series C Preferred Stock will rank junior to the Series B Preferred Stock, but on par with common stock and Series A Preferred Stock in any distribution upon winding up, dissolution, or winding upliquidation of our affairs;

·

the company, as provided in the designation. The holders of shares of Series C Preferred Stock have no dividend rights except as may be declared by the Board in its sole and absolute discretion, out of funds legally available for that purpose. Holders of Series C Preferred Stock do not have preemptive, subscription or conversionvoting rights or redemption or access to any sinking fund; and

·

are entitled to one non-cumulative vote per share on all matters submitted to stockholders for a vote at any meeting of stockholders


See also Plan of Distribution regarding negative implications of being classified as a “Penny Stock.”


Authorized but Un-issued Capital Stock


Nevada law does not require stockholder approval for any issuance of authorized shares. These additional shares may be used for a variety of corporate purposes, including future public offerings to raise additional capital or to facilitate corporate acquisitions.




One of the effects of the existence of un-issued and unreservedconvert into common stock (and/or preferred stock) may beafter twenty four months from the issuance date, at a conversion rate of one thousand (1,000) shares of Common Stock for every one (1) share of Series C Preferred Stock. Upon conversion, the shares are subject to enable our boarda one-year leak-out restriction on sales into the market of directorsno more than 5% previous month’s stock liquidity.

28

Series D Preferred Stock

On November 3, 2023, pursuant to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain controlArticle III of our board by meansArticles of Incorporation, our Board of Directors voted to designate a merger, tender offer, proxy contest or otherwise, and thereby protectclass of preferred stock entitled Series D Preferred Stock, consisting of up 75,000 shares, par value $0.001. Under the continuityCertificate of our management and possibly deprive the stockholders of opportunities to sell their shares of our common stock at prices higher than prevailing market prices.


Shareholder Matters


As an issuer of "penny stock" the protection provided by the federal securities laws relating to forward looking statements does not apply to us if our shares are considered to be penny stocks which they currently are and probably will be for the foreseeable future. Although the federal securities law provide a safe harbor for forward-looking statements made by a public company that files reports under the federal securities laws, this safe harbor is not available to issuers of penny stocks. As a result, we will not have the benefit of this safe harbor protectionDesignation, in the event of any claim thatdissolution, liquidation or winding up of the material provided by us, including this prospectus, contained a material misstatementCorporation, the Holders of fact or was misleadingSeries D Preferred Stock shall be entitled to participate in any material respect becausedistribution out of the assets of the Corporation before the holders of the Common Stock, Series A Preferred Stock and Series C Preferred Stock, but shall be considered on parity to the liquidation rights of the Series B Preferred Stockholders. The holders of shares of Series D Preferred Stock have no dividend rights except as may be declared by the Board in its sole and absolute discretion, out of funds legally available for that purpose. Holders of Series D Preferred Stock do not have voting rights but may convert into common stock at a conversion rate of one thousand (1,000) shares of Common Stock for every one (1) share of Series D Preferred Stock.

Dividend Policy

We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings, if any, to finance the expansion of our failure to include any statements necessary to make the statements not misleading.


business. As a result, we do not anticipate paying any cash dividends in the foreseeable future. 

Nevada corporation, we are subject to theNevada Revised Statutes ("NRS" or "Nevada law"). Certain provisions ofNevada law described below create rights that might be deemed material to our shareholders. Other provisions might delay or make more difficult acquisitions of our stock or changes in our control or might also have the effect of preventing changes in our management or might make it more difficult to accomplish transactions that some of our shareholders may believe to be in their best interests.Anti-Takeover Laws


Directors' Duties. Section 78.138 of the Nevada law allows our directors and officers, in exercising their powers to further our interests, to consider the interests of our employees, suppliers, creditors and customers. They can also consider the economy of the state and the nation, the interests of the community and of society and our long-term and short-term interests and shareholders, including the possibility that these interests may be best served by our continued independence. Our directors may resist a change or potential change in control if they, by a majority vote of a quorum, determine that the change or potential change is opposed to or not in our best interest. Our board of directors may consider these interests or have reasonable grounds to believe that, within a reasonable time, any debt which might be created as a result of the change in control would cause our assets to be less than our liabilities, render us insolvent, or cause us to file for bankruptcy protection


Dissenters' Rights. Among the rights granted underNevada law which might be considered material is the right for shareholders to dissent from certain corporate actions and obtain payment for their shares (seeNevada Revised Statutes ("NRS") 92A.380-390). This right is subject to exceptions, summarized below, and arises in the event of mergers or plans of exchange. This right normally applies if shareholder approval of the corporate action is required either byNevada law or by the terms of the articles of incorporation.


A shareholder does not have the right to dissent with respect to any plan of merger or exchange, if the shares held by the shareholder are part of a class of shares which are:


·

listed on a national securities exchange,

·

included in the national market system by the Financial Industry Regulator Authority (FINRA), or

·

held of record by not less than 2,000 holders.


This exception notwithstanding, a shareholder will still have a right of dissent if it is provided for in the articles of incorporation or if the shareholders are required under the plan of merger or exchange to accept anything but cash or owner's interests, or a combination of the two, in the surviving or acquiring entity, or in any other entity falling in any of the three categories described above in this paragraph.


Inspection Rights.Nevada law also specifies that shareholders are to have the right to inspect company records (see NRS 78.105). This right extends to any person who has been a shareholder of record for at least six months immediately preceding his or her demand. It also extends to any person holding, or authorized in writing by the holders of, at least 5% of outstanding shares. Shareholders having this right are to be granted inspection rights upon five days' written notice. The records covered by this right include official copies of:


i.

the articles of incorporation, and all amendments thereto,


ii.

bylaws and all amendments thereto; and




iii.

a stock ledger or a duplicate stock ledger, revised annually, containing the names, alphabetically arranged, of all persons who are stockholders of the corporation, showing their places of residence, if known, and the number of shares held by them, respectively.


In lieu of the stock ledger or duplicate stock ledger, Nevada law provides that the corporation may keep a statement setting out the name of the custodian of the stock ledger or duplicate stock ledger, and the present and complete post office address, including street and number, if any, where the stock ledger or duplicate stock ledger specified in this section is kept.


Control Share Acquisitions. Sectionssections 78.378 to 78.3793 of Nevada law contain provisions that may prevent any person acquiring a controlling interest in a Nevada-registered company from exercising voting rights. To the extent that these rights support the voting power of minority shareholders, these rights may also be deemed material. These provisions will be applicable to us as soon as we have 200 shareholders of record with at least 100 of these having addresses in Nevada as reflected on our stock ledger. While we do not yet have the required number of shareholders in Nevada or elsewhere, it is possible that at some future point we will reach these numbers and, accordingly, these provisions will become applicable. We do not intend to notify shareholders when we have reached the number of shareholders specified under these provisions of Nevada law. Shareholders can learn this information pursuant to the inspection rights described above and can see the approximate number of our shareholders by checking under Item 5 of our annual reports on Form 10-K. This form is filed with the Securities and Exchange Commission within 90 days after the close of each fiscal year hereafter. You can view these and our other filings at www.sec.gov in the "EDGAR" database.


Under NRS Sections 78.378 to 78.3793, an acquiring person who acquires a controlling interest in company shares may not exercise voting rights on any of these shares unless these voting rights are granted by a majority vote of our disinterested shareholders at a special shareholders' meeting held upon the request and at the expense of the acquiring person. If the acquiring person's shares are accorded full voting rights and the acquiring person acquires control shares with a majority or more of all the voting power, any shareholder, other than the acquiring person, who does not vote for authorizing voting rights for the control shares, is entitled to demand payment for the fair value of their shares, and we must comply with the demand. An "acquiring person" means any person who, individually or acting with others, acquires or offers to acquire, directly or indirectly, a controlling interest in our shares. "Controlling interest" means the ownership of our outstanding voting shares sufficient to enable the acquiring person, individually or acting with others, directly or indirectly, to exercise one-fifth or more but less than one-third, one-third or more but less than a majority, or a majority or more of the voting power of our shares in the election of our directors. Voting rights must be given by a majority of our disinterested shareholders as each threshold is reached or exceeded. "Control shares" means the company's outstanding voting shares that an acquiring person acquires or offers to acquire in an acquisition or within 90 days immediately preceding the date when the acquiring person becomes an acquiring person.


These Nevada statutes do not apply if a company's articles of incorporation or bylaws in effect on the tenth day following the acquisition of a controlling interest by an acquiring person78.379 provide that these provisions do not apply.


According to NRS 78.378, the provisions referred to above will not restrict our directors from taking action to protect the interests of our Company and its shareholders, including without limitation, adopting or executing plans, arrangements or instruments that deny rights, privileges, power or authority to a holder of a specified number of shares or percentage of share ownership or voting power. Likewise, these provisions do not prevent directors or shareholders from including stricter requirements in our articles of incorporation or bylaws relating tostate regulation over the acquisition of a controlling interest in certain Nevada corporations unless the Company.


articles of incorporation or bylaws of the corporation provide that the provisions of these sections do not apply. Our articles of incorporation and bylaws do not exclude us from the restrictions imposed by NRS 78.378 to 78.3793, nor do they impose any more stringent requirements.


Certain Business Combinations. Sections 78.411 to 78.444 of the Nevada law may restrict our ability to engage in a wide variety of transactions with an "interested shareholder." As was discussed above in connection with NRS 78.378 to 78.3793,state that these provisions could be considered materialdo not apply. The statute creates a number of restrictions on the ability of a person or entity to our shareholders, particularly to minority shareholders. They might also have the effectacquire control of delaying or making more difficult acquisitions of our stock or changes in our control. These sections of NRS are applicable to anya Nevada company withby setting down certain rules of conduct and voting restrictions in any acquisition attempt, among other things. The statute is limited to corporations that are organized in the state of Nevada and that have 200 or more stockholders, at least 100 of whom are stockholders of record and that has a class of securities registered under Section 12residents of the 1934 Securities Exchange Act, unlessState of Nevada; and does business in the company's articles of incorporation provide otherwise. By this registration statement, we are not registering our common stock under Section 12(g) of the Exchange Act. Accordingly, upon the effectiveness of this registration statement on Form S-1 we will not be subject to these statutes.




These provisionsState of Nevada law prohibit us from engaging in any "combination" with an interested stockholder for three years after the interested stockholder acquired the shares that cause him/her to become an interested shareholder, unless she had prior approval of our board of directors. The term "combination" is described in NRS 78.416 and includes, among other things, mergers, sales or purchases of assets, and issuances or reclassifications of securities. If the combination did not have prior approval, the interested shareholder may proceed after the three-year period only if the shareholder receives approval from a majority of our disinterested shares or the offer meets the requirements for fairness that are specified in NRS 78.441-42. For the above provisions, "resident domestic corporation" means a Nevada corporation that has 200 or more shareholders. An "interested stockholder" is defined in NSR 78.423 as someone who is either:


§

the beneficial owner, directly or indirectly,through an affiliated corporation. Because of 10% or morethese conditions, the statute currently does not apply to our company.

Listing of Common Stock

Our Common Stock is currently quoted on the voting power of our outstanding voting shares; orOTCQX under the trading symbol “IQST.”


§

our affiliate or associate and who within three years immediately before the date in question, was the beneficial owner, directly or indirectly, of 10% or more of the voting power of our outstanding shares at that time.


Amendments to Bylaws -Our articles of incorporation provide that the power to adopt, alter, amend, or repeal our bylaws is vested exclusively with the board of directors. In exercising this discretion, our board of directors could conceivably alter our bylaws in ways that would affect the rights of our shareholders and the ability of any shareholder or group to effect a change in our control; however, the board would not have the right to do so in a way that would violate law or the applicable terms of our articles of incorporation.


Transfer Agent and Registrar


The transfer agent and registrar of our Common Stock is VStock Transfer, LLC.

Penny Stock Regulation

The SEC has adopted regulations which generally define “penny stock” to be any equity security that has a market price (as defined) of less than $5.00 per share or an exercise price of less than $5.00 per share. Such securities are subject to rules that impose additional sales practice requirements on broker-dealers who sell them. For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchaser of such securities and have received the purchaser’s written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a disclosure schedule prepared by the SEC relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, among other requirements, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. As the Shares immediately following this Offering will likely be subject to such penny stock rules, purchasers in this Offering will in all likelihood find it more difficult to sell their Shares in the secondary market.

29

PRIVATE PLACEMENT OF NOTE AND OPTION

On January 24, 2024, we entered into a securities purchase agreement (the “SPA”) with M2B Funding Corp., a Florida corporation, for it to purchase up to the principal amount of US $3,888,888.89 in a 12 moth secured convertible promissory notes for an aggregate purchase price of US $3,500,000.00 (the “Purchase Price”), which notes are convertible into shares of our common stock with an initial conversion price of $0.11 per share. Each noteholder shall receive shares of common stock (“Kicker Shares”) in an amount equal to ten percent of the principal amount of any Note issued divided by $0.11. The notes are secured by all of our assets under a Security Agreement signed with the SPA.

The initial tranche will be for US $2,222,222.22 in face value of notes and Kicker Shares, with an original issue discount of US $222,222.22, and the second tranche will be for US $1,666,666.67 in face value of Notes and Kicker Shares, with an original issue discount of US $166,666.67. Each one-year note bears interest at 18% per annum.

Provided no default has occurred, we may prepay the notes at 110% of the outstanding principal amounts plus all other sums due and owing.

We have agreed with certain covenants in connection with the financing, including a prohibition on us entering any variable rate transactions, restrictions on future offerings or incurring indebtedness, and a most favored nation clause, among other provisions.

We have also agreed, pursuant to a Registration Rights Agreement, to register the shares of common stock underlying the notes and the Kicker Shares with the Securities and Exchange Commission in a registration statement. 

We have received the initial tranche under the Note, and we have registered 20,202,020 shares of common stock issuable upon conversion of the Note and 2,020,202 Kicker Shares in favor of the selling shareholder as required by the Registration Rights Agreement.

On February 12, 2024, we issued a Common Stock Purchase Option (the “Option”) to ADI Funding LLC (“ADI Funding”) for $100,000 that expires on December 31, 2024, for the right to acquire up to 10,000,000 shares of common stock. The exercise price per share of the common stock under the Option shall be (i) 70% of the VWAP of the common stock during the then 10 Trading Days immediately preceding, but not including the date of exercise if the VWAP is below $2.00 or (ii) seventy five percent (75%) of the VWAP of the common stock during the then 10 Trading Days immediately preceding, but not including the date of exercise if the VWAP is equal or above $2.00.

ADI Funding has the right and the obligation to exercise, on a “ cash basis”, not less than (i) 2,000,000 of the shares of common stock underlying the option not later than the later of March 31, 2024 or the date on which there is an effective registration statement permitting the resale of the shares by ADI Funding. From and after the occurrence of the above-referenced exercise, each additional exercise of the Option shall be in an amount not less than 1,000,000 shares, which shall occur every thirty (30) days and shall be exercised only on a cash basis. ADI Funding’s obligation to exercise each specified portion of the Option is subject to the exercise price being not less than $0.11 per share on the relevant option exercise date.

Exercises are required to be made in recognition of ADI Funding’s beneficial ownership limitation of 4.99% of our outstanding common stock, which upon notice may be increased to 9.99%.

If we issued securities less than the exercise price option, ADI Funding has a right to also use that lesser price in the exercise of its Option. The Option also contains rights to any company distributions and consideration in fundamental transactions, subject to the beneficial ownership limitation.

USE OF PROCEEDS

We will not receive any of the proceeds from the sale of the shares of common stock pursuant to this prospectus. We will not receive any proceeds from the conversion of Note. We will receive cash from the sale of the Option, if exercised, which we intend to use as working capital.

30

SELLING SHAREHOLDERS

The shares of common stock being offered by the selling shareholders are those currently held by the selling shareholders and those issuable to the selling shareholders pursuant to the terms of the Note and Option.

For purposes of this prospectus, “selling shareholders” mean the shareholders listed below and their permitted transferees, pledgees, assignees, distributees, donees or successors or others who later hold any of the selling shareholders’ interests in the securities. To the extent required, we will file a supplement to this prospectus (or a post-effective amendment hereto, if necessary) to name successors to the named selling shareholder who are able to use this prospectus to resell the common shares registered hereby.

Except for the ownership of the Note and Option, the selling shareholders have not had any material relationship with us within the past three years.

The table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by the selling shareholders, based on their ownership of the shares of common stock, the Note and Option, as of the date of this prospectus, assuming full conversion of the Note and full exercise of the Option held by the selling shareholders on that date, without regard to any limitation on conversion.

In accordance with the terms of the Registration Rights Agreement with the holder of the Note and the agreement to register the shares underlying the Option, this prospectus generally covers the resale of that number of shares of common stock equal to the number of shares of common stock currently held by the selling shareholders and the number of shares of common stock issuable upon conversion and exercise of the Note and Option, respectively, until all of the shares may be sold without any restrictions pursuant to Rule 144 of the Securities Act.

The amounts listed in the third and fourth columns reflect the number of shares being offered by the selling shareholders and the number of shares remaining following the sale of such shares, respectively.

Under the terms of the Note and Option, the selling shareholders may not convert or be issued shares of common stock to the extent such conversion or issuance would cause such selling shareholder, together with its affiliates and attribution parties and any group of which it is a member, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock following such conversion or issuance. The number of shares in the second and fourth columns do not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

Name and Address of Selling Shareholder Number of Shares of Common Stock
Owned Prior to Offering (1)
  Maximum
Number of Shares of Common Stock to be Sold Pursuant to this Prospectus
  Shares of
Common Stock to be Owned After Offering (1)
 
M2B Funding Corp. (2)  3,235,702   22,222,222   0% 
ADI Funding LLC (3)  0   10,000,000   0% 

(1)

“Beneficial ownership” is a term broadly defined in Rule 13d-3 under the Exchange Act and includes more than the typical form of stock ownership, that is, stock held in a person’s name. The term also includes what is referred to as “indirect ownership,” meaning ownership of shares as to which a person has or shares investment power. For purposes of this column, a person or group of persons is deemed to have “beneficial ownership” of any shares that are currently exercisable or exercisable within 60 days of the date of this prospectus.

The amounts listed do not give effect to any limitation on conversion or the issuance of shares pursuant to the terms of the Note or Option (including the limitations on beneficial ownership discussed above).

(2)Mr. Daniel Kordash holds voting and dispositive power over the shares of common stock beneficially owned by M2B Funding Corp. Includes (i) 3,235,705 shares of common stock and (ii) 20,202,020 shares issuable upon conversion of the Note held by the selling stockholder (but without giving effect to the limitation on beneficial ownership contained therein).
(3)Mr. Yohan Naraine holds voting and dispositive power over the shares of common stock beneficially owned by ADI Funding LLC. Includes 10,000,000 shares issuable upon exercise of the Option held by the selling stockholder (but without giving effect to the limitation on beneficial ownership contained therein).

31

PLAN OF DISTRIBUTION

We are registering the shares of common stock described in this prospectus to permit the resale of these shares of common stock by the selling shareholders from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale of the shares of common stock or conversion of the Note by the selling shareholders. We will receive cash from the sale of the Option, if exercised, which we intend to use as working capital. We will bear all fees and expenses incident to our obligation to register the shares of common stock.

Sales of shares of our common stock by the selling shareholders named in this prospectus may be made from time to time in one or more transactions in the over-the-counter market, on any exchange or quotation system on which shares of our common stock may be listed or quoted, in negotiated transactions or in a combination of any such methods of sale, at fixed prices that may be changed, at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. The shares may be offered directly, to or through agents designated from time to time or to or through brokers or dealers, or through any combination of these methods of sale. The methods by which the shares may be sold include:

block trades (which may involve crosses) in which the broker or dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
purchases by a broker or dealer as principal and resales by the broker or dealer for its own account pursuant to this prospectus;
exchange distributions or secondary distributions in accordance with the rules of the applicable exchange;
ordinary brokerage transactions and transactions in which the broker or dealer solicits purchasers;
privately negotiated transactions;
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
the settlement of short sales;
a combination of any of the foregoing methods of sale; and
any other method permitted by applicable law.

An agent, broker or dealer may receive compensation in the form of discounts, concessions or commissions from the selling shareholders or the purchasers of the shares for whom such brokers or dealers may act as agents or to whom they sell as principals, or both (which compensation as to a particular broker or dealer might be in excess of customary commissions). A member firm of an exchange on which our common stock is Action Stock Transfer Company, 2469 E. Fort Union Blvd, Suite 214, Salt Lake City, UT 84121. Its telephone number is 801-274-1088.


PLAN OF DISTRIBUTION


There is no public market for our common stock. Our common stock is currently held by one shareholder. Therefore, the current and potential market for our common stock is limited and the liquidity of our sharestraded may be severely limited. While a market maker has agreedengaged to file an application on our behalfact as the selling shareholder’s agent in the sale of shares by the selling shareholders.

In connection with FINRA so as to be able to quotedistributions of the shares of our common stock on the OTCBB maintainedoffered by FINRA commencing upon the effectiveness of our registration statement of which this prospectus is a part andor otherwise, the subsequent closingselling shareholders may enter into hedging transactions with brokers or dealers or other financial institutions with respect to our common stock. In connection with these transactions, the brokers or dealers or other financial institutions may engage in short sales of this offering , we do not have a formal or written agreement in place with them. There can be no assurance as to whether such market maker’s application will be accepted by FINRA nor can we estimate the time period that will be required for the application process. In the absence of quotation or listing, no market is available for investors in our common stock toin the course of hedging the positions they assume with the selling shareholder. The selling shareholder may also sell their shares. We cannot provide any assurance that a meaningful trading market will ever develop or that our common stock will ever be quotedshort to effect its hedging transactions and deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling shareholder may also loan or listed for trading.pledge shares of common stock to broker-dealers that in turn may sell such shares.


32

If the

In addition, any shares of our common stock ever become tradable, the trading price of our common stock could be subject to wide fluctuations in response to various events or factors, many of which are beyond our control. As a result, investors may be unable to sell their shares at or greater than the price at which they are being offered.


This offering will be conducted on a direct primary basis utilizing the efforts of Ms. Jones, president of the Company. Potential investors include, but are not limited to, family, friends and acquaintances of Ms. Jones. The intended methods of communication include, without limitation, telephone calls and personal contact. In her endeavors to sellcovered by this offering, Ms. Jones will not use any mass advertising methods such as the internet or print media.


Funds received in connection with theprospectus that qualify for sale of our securities will be transmitted immediately into a trust account. There can be no assurance that all, or any, of the shares will be sold.


Ms. Jones will not receive commissions for any sales originated on our behalf. We believe that Ms. Jones is exempt from registration as a broker-dealer under the provisions of Rule 3a4-1 promulgated under the Exchange Act. In particular, Ms. Jones:


1.

Is not subject to a statutory disqualification, as that term is defined in Section 3(a) 39 of the Act, at the time of her participation;


a.

Is not to be compensated in connection with her participation by the payment of commissions or other remuneration based either directly or indirectly on transactions in securities;


b.

Is not an associated person of a broker or dealer; and

c.

Meets the conditions of the following:




i.

Primarily performs, or is intended primarily to perform at the end of the offering, substantial duties for or on behalf of the issuer otherwise than in connection with transactions in securities;

ii.

Was not a broker or dealer, or associated persons of a broker or dealer, within the preceding 12 months; and

iii.

Did not participate in selling an offering of securities for any issuer more than once every 12 months other than in reliance on paragraphs within this section, except that for securities issued pursuant to Rule 415 under144 of the Securities Act of 1933,may be sold under Rule 144 rather than pursuant to this prospectus.

The aggregate proceeds to the 12 months shall begin with the last sale of any security included within a Rule 415 registration


No officers or directors of the Company may purchase any securities in this offering.


There can be no assurance that all, or any, of the shares will be sold. As of this date, we have not entered into any agreements or arrangements forselling shareholders from the sale of the shares of common stock offered by them pursuant to this prospectus will be the purchase price of the shares less discounts or commissions, if any. The selling shareholders reserve the right to accept and, together with its agents from time to time, to reject, in whole or in part, any proposed purchase of shares of common stock to be made directly or through agents.

To the extent required, the shares to be sold, the name of the selling shareholders, the respective purchase prices and public offering prices, the names of any agents, dealers or underwriters, any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

Each broker-dealer that receives our common stock for its own account pursuant to this prospectus must acknowledge that it will deliver the prospectus in connection with any broker/dealersale of our common stock. If required, this prospectus may be amended or sales agent. However,supplemented on a continual basis to describe a specific plan of distribution. We will make copies of this prospectus available to the selling shareholder, brokers and dealers for purposes of satisfying the prospectus delivery requirements of the Securities Act, if we were to enter into such arrangements, we will file a post effective amendment to disclose those arrangements because any broker/dealer participating in the offering would be acting as an underwriter and would have to be so named herein. applicable.

In order to comply with the applicable securities laws of certainsome states, if applicable, the shares of common stock offered by this prospectus may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the securitiesshares may not be offered or sold unless they have been registered or qualified for sale in such states or an exemption from such registration or qualification requirement is available and with which we have complied. The purchasers in this offering and in any subsequent trading market must be residents of such states where the shares have been registered or qualified for sale or an exemption from such registration or qualification requirementrequirements is available. Asavailable and is complied with as part of this date, we have not identified the specific states where the offeringsuch sale.

The selling shareholders and any other person participating in such distribution will be sold.subject to certain provisions of the Exchange Act. The Exchange Act rules include Regulation M, which may limit the timing of purchases and sales of any of our common stock by the selling shareholders and any other such person. In addition, Regulation M of the Exchange Act may restrict the ability of any person engaged in the distribution of our common stock to engage in market-making activities with respect to the common stock. In addition, the anti-manipulation rules under the Exchange Act may apply to sales of the securities in the market. All of the foregoing may affect the marketability of the securities and the ability of any person to engage in market-making activities with respect to the securities.


The proceeds fromselling shareholders and any brokers, dealers, agents or others that participate with the saleselling shareholders in the distribution of the shares inoffered by this offeringprospectus may be deemed to be “underwriters” within the meaning of the Securities Act, and any underwriting discounts, commissions or fees received by such persons and any profit on the resale of the shares purchased by such persons may be deemed to be underwriting commissions or discounts under the Securities Act. If the selling shareholders are deemed to be an “underwriters” within the meaning of the Securities Act, they will be payable to Quick Law Group, P.C. – COLTAF ("Fund Retention Account") and will be deposited in a noninterest-bearing account until the subscription agreements are accepted by the Company. Failure to do so will result in checks being returnedsubject to the investor who submitted the check. No interest will be paid to any shareholder or the Company. All subscription agreements and checks are irrevocable (except as to any states that require a statutory cooling-off period or provide for rescission rights). All subscription funds will be held in the Fund Retention Account pending acceptanceprospectus delivery requirements of the subscription bySecurities Act. We will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the Company,selling shareholders, brokers and funds shalldealers for the purpose of satisfying the prospectus delivery requirements of the Securities Act, if applicable.

There can be released to BMI as received and cleared fromno assurance that the Fund Retention Account, untilselling shareholders will sell any or all of the maximum offering is fully subscribed for, or the offering is closed, withdrawn or terminated. Thereafter, the fund retention agreement shall terminate.


Investors can purchaseshares of our common stock offered hereby.

We will bear all fees and expenses in this offering by completing a Subscription Agreement, a copyconnection with the preparation and filing of which is filed as Exhibit 99.1a to the registration statement of which this prospectus is a part,part. The fees and sending it togetherexpenses of registration to be borne by us referred to in the foregoing sentence shall include registration, filing and qualification fees, word processing, duplicating, printers’ and accounting fees, listing fees, messenger and delivery expenses, all fees and expenses of complying with paymentstate securities or blue sky laws, fees and disbursements of our counsel. We will indemnify the selling shareholder against liabilities, including certain liabilities under the Securities Act. We may be indemnified by the selling shareholder against liabilities, including certain liabilities under the Securities Act, that may arise from any written information furnished to us by the selling shareholder specifically for use in full. All payments must be madethis prospectus.

Any underwriter, dealers and agents engaged by the selling shareholders may engage in United States currency either by personal check, bank draft,transactions with us or cashier check. There is no minimum subscription requirement. All subscription agreements and checks are irrevocable. the selling shareholders, or perform services for us or the selling shareholders, in the ordinary course of business.

33

LEGAL MATTERS

The Company expressly reserves the right to either accept or reject any subscription. Any subscription rejected will be returned to the subscriber within five business daysvalidity of the rejection date which is 48 hours fromrights and the dateshares of common stock offered by this prospectus have been passed upon for us by The Doney Law Firm, Las Vegas, Nevada.

EXPERTS

The financial statements of IQSTEL Inc. as of December 31, 2022 and 2021, and for the subscriptionyears then ended, appearing in iQSTEL Inc.’s Annual Report on Form 10-K for the year ended December 31, 2022, have been audited by Urish Popeck & Co., LLC, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph describing conditions that raise substantial doubt about the Company’s ability to continue as a going concern), included therein, and fundsincorporated herein by reference. The financial statements of Qxtel Limited as of December 31, 2022 and 2021, and for the years then ended, appearing in iQSTEL Inc.’s Current Report on Form 8-K, have been audited by Urish Popeck & Co., LLC, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph describing conditions that raise substantial doubt about the Company’s ability to continue as a going concern), included therein, and incorporated herein by reference. Such financial statements are receivedincorporated herein by reference in reliance upon such report of Urish Popeck & Co., LLC pertaining to such financial statements given on the authority of such firm as experts in auditing and accounting.

MATERIAL CHANGES

There have been no material changes in the Fund Retention Account. Furthermore, once a subscription agreement is accepted, it will be executed without reconfirmation to or fromregistrant’s affairs which have occurred since the subscriber. Once we accept a subscription, the subscriber cannot withdraw it.


Any purchasers of our securities should be aware that any market that develops in our common stock will be subject to “penny stock” restrictions.


We will pay all expenses incident to the registration, offering and saleend of the shares other than commissionslatest fiscal year ended December 31, 2022 for which audited financial statements were included in the latest Form 10-K and that have not been described in a Form 10-Q or discounts to underwriters, broker-dealers or agents.Form 8-K filed under the Exchange Act.


DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers andor persons controlling persons,us pursuant to the foregoing provisions, we have been advisedinformed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.


Any purchasers of our securities should be aware that any market that develops in our stock will be subject to the penny stock restrictions.


The trading of our securities, if any, will be in the over-the-counter markets which are commonly referred to as the OTCBB as maintained by FINRA (once and if and when quoting thereon has occurred). As a result, an investor may find it difficult to dispose of, or to obtain accurate quotations as to the price of, our securities.


OTCBB Considerations


OTCBB securities are not listed and traded on the floor of an organized national or regional stock exchange. Instead, OTCBB securities transactions are conducted through a telephone and computer network connecting dealers in stocks. OTCBB stocks are traditionally smaller companies that do not meet the financial and other listing requirements of a regional or national stock exchange.




To be quoted on the OTCBB, a market maker must file an application on our behalf in order to make a market for our common stock. We are not permitted to file such application on our own behalf. A market maker has agreed to file an application with FINRA on our behalf so as to be able to quote the shares of our common stock on the OTCBB maintained by FINRA commencing upon the effectiveness of our registration statement of which this prospectus is a part. There can be no assurance that the market maker’s application will be accepted by FINRA, nor can we estimate as to the time period that the application will require.


The OTCBB is separate and distinct from the NASDAQ stock market. NASDAQ has no business relationship with issuers of securities quoted on the OTCBB. The SEC’s order handling rules, which apply to NASDAQ-listed securities, do not apply to securities quoted on the OTCBB.


Although the NASDAQ stock market has rigorous listing standards to ensure the high quality of its issuers, and can delist issuers for not meeting those standards, the OTCBB has no listing standards. Rather, it is the market maker who chooses to quote a security on the system, files the application, and is obligated to comply with keeping information about the issuer in its files. FINRA cannot deny an application by a market maker to quote the stock of a company assuming all FINRA questions relating to its Rule 211 process are answered accurately and satisfactorily. The only requirement for ongoing inclusion in the OTCBB is that the issuer be current in its reporting requirements with the SEC.


Although we anticipate that quotation on the OTCBB will increase liquidity for our stock, investors may have difficulty in getting orders filled because trading activity on the OTCBB in general is not conducted as efficiently and effectively as with NASDAQ-listed securities. As a result, investors’ orders In addition, indemnification may be filled at a price much different than expected when an order is placed.


Investors must contact a broker-dealer to trade OTCBB securities. Investors do not have direct access to the bulletin board service. For bulletin boardlimited by state securities there only has to be one market maker.


OTCBB transactions are conducted almost entirely manually. Because there are no automated systems for negotiating trades on the OTCBB, they are conducted via telephone. In times of heavy market volume, the limitations of this process may result in a significant increase in the time it takes to execute investor orders. Therefore, when investors place market orders - an order to buy or sell a specific number of shares at the current market price - it is possible for the price of a stock to go up or down significantly during the lapse of time between placing a market order and getting execution.


If we become able to have our shares of common stock quoted on the OTCBB, we will then try, through a broker-dealer and its clearing firm, to become eligible with the DTC to permit our shares to trade electronically. If an issuer is not “DTC-eligible,” then its shares cannot be electronically transferred between brokerage accounts, which, based on the realities of the marketplace as it exists today (especially the OTCBB), means that shares of a company will not be traded (technically the shares can be traded manually between accounts, but this takes days and is not a realistic option for companies relying on broker dealers for stock transactions - like all the companies on the OTCBB). What this boils down to is that while DTC-eligibility is not a requirement to trade on the OTCBB, it is a necessity to process trades on the OTCBB if a company’s stock is going to trade with any volume. There are no assurances that our shares will ever become DTC-eligible or, if they do, how long it will take.


Because OTCBB stocks are usually not followed by analysts, there may be lower trading volume than for NASDAQ-listed securities.


Section 15(g) of the Exchange Actlaws.

 

Our shares will be covered by Section 15(g) of the Exchange Act, and Rules 15g-1 through 15g-6 promulgated thereunder. They impose additional sales practice requirements on broker-dealers who sell our securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses).

 

Rule 15g-1 exempts a number

32,222,222 Shares of specific transactions from the scope of the penny stock rules (but is not applicable to us).Common Stock


Rule 15g-2 declares unlawful broker-dealer transactions in penny stocks unless the broker-dealer has first provided to the customer a standardized disclosure document.


Rule 15g-3 provides that it is unlawful for a broker-dealer to engage in a penny stock transaction unless the broker-dealer first discloses and subsequently confirms to the customer current quotation prices or similar market information concerning the penny stock in question.




Rule 15g-4 prohibits broker-dealers from completing penny stock transactions for a customer unless the broker-dealer first discloses to the customer the amount of compensation or other remuneration received as a result of the penny stock transaction.


Rule 15g-5 requires that a broker-dealer executing a penny stock transaction, other than one exempt under Rule 15g-1, disclose to its customer, at the time of or prior to the transaction, information about the sales persons compensation.


Rule 15g-6 requires broker-dealers selling penny stocks to provide their customers with monthly account statements.

 

Rule 3a51-1 of the Exchange Act establishes the definition of a "penny stock," for purposes relevant to us, as any equity security that has a minimum bid price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to a limited number of exceptions. It is likely that our shares will be considered to be penny stocks for the immediately foreseeable future. For any transaction involving a penny stock, unless exempt, the penny stock rules require that a broker or dealer approve a person's account for transactions in penny stocks and the broker or dealer receive from the investor a written agreement to the transaction setting forth the identity and quantity of the penny stock to be purchased.


In order to approve a person's account for transactions in penny stocks, the broker or dealer must obtain financial information and investment experience and objectives of the person and make a reasonable determination that the transactions in penny stocks are suitable for that person and that that person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.


The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prepared by the SEC relating to the penny stock market, which, in highlight form, sets forth:


·

the basis on which the broker or dealer made the suitability determination, and

·

that the broker or dealer received a signed, written agreement from the investor prior to the transaction


Disclosure also has to be made about the risks of investing in penny stock in both public offerings and in secondary trading and commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Additionally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.


Many brokers have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited. If the Company remains subject to the penny stock rules for any significant period, which is likely, it could have an adverse effect on the market, if any, for the Company’s securities. If the Company’s securities are subject to the penny stock rules, investors will find it difficult to dispose of the Company’s securities.


State Securities – Blue Sky Laws


There is no established public market for our common stock, and there can be no assurance that any market will develop in the foreseeable future. Transfer of our common stock may also be restricted under the securities or securities regulations laws promulgated by various states and foreign jurisdictions, commonly referred to as "Blue Sky" laws. Absent compliance with such individual state laws, our common stock may not be traded in such jurisdictions. Because the securities registered hereunder have not been registered for resale under the blue sky laws of any state, the holders of such shares and persons who desire to purchase them in any trading market that might develop in the future, should be aware that there may be significant state blue-sky law restrictions upon the ability of investors to sell the securities and of purchasers to purchase the securities. Accordingly, investors may not be able to liquidate their investments and should be prepared to hold the common stock for an indefinite period of time.


We will consider applying for listing in Mergent, Inc., a leading provider of business and financial information on publicly listed companies, which, once published, will provide BMI with “manual” exemptions in approximately 33 states as indicated in CCH Blue Sky Law Desk Reference at Section 6301 entitled “Standard Manuals Exemptions.” However, we may not be accepted for listing in Mergent or similar services designed to obtain manual exemptions if we are considered to be a "shell company" at the time of application.




Thirty-three states have what is commonly referred to as a "manual exemption" for secondary trading of securities such as those to be resold by selling stockholders. In these states, so long as we obtain and maintain a listing in Mergent, Inc. or Standard and Poor's Corporate Manual, secondary trading of our common stock can occur without any filing, review or approval by state regulatory authorities in these states. These states are: Alaska, Arizona, Arkansas, Colorado, Connecticut, District of Columbia, Florida, Hawaii, Idaho, Indiana, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, Texas, Utah, Washington, West Virginia and Wyoming. We cannot secure this listing, and thus this qualification, until after our registration statement is declared effective. Once we secure this listing (assuming that being a development stage and shell company is not a bar to such listing), secondary trading can occur in these states without further action.


Upon effectiveness of this Prospectus, the Company intends to consider (but may not) becoming a “reporting issuer” under Section 12(g) of the Exchange Act, as amended, by way of filing a Form 8-A with the SEC. A Form 8-A is a “short form” of registration whereby information about the Company will be incorporated by reference to the Registration Statement on Form S-1, of which this prospectus is a part. Upon filing of the Form 8-A, if done, the Company’s shares of common stock will become “covered securities,” or “federally covered securities” as described in some states’ laws, which means that unless you are an “underwriter” or “dealer,” you will have a “secondary trading” exemption under the laws of most states (and the District of Columbia, Guam, the Virgin Islands and Puerto Rico) to resell the shares of common stock you purchase in this offering. However, four states do impose filing requirements on the Company: Michigan, New Hampshire, Texas and Vermont. The Company may, at its own cost, make the required notice filings in Michigan, New Hampshire, Texas and Vermont immediately after filing its Form 8-A with the SEC.


We currently do not intend to and may not be able to qualify securities for resale in other states which require shares to be qualified before they can be resold by our shareholders.


Limitations Imposed by Regulation M


Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the shares may not simultaneously engage in market making activities with respect to our common stock for a period of two business days prior to the commencement of such distribution.


LEGAL MATTERS


The validity of the issuance of the shares of common stock offered hereby will be passed upon for us by Quick Law Group, P.C., 1035 Pearl Street, Suite 403, Boulder, Colorado 80302.


EXPERTS


The financial statements of BMI as of June 30, 2011 and for the period June 24, 2011 (inception) to June 30, 2011 included in this prospectus have been audited by independent registered public accountants and have been so included in reliance upon the report of PLS CPA, a Professional Corporation given on the authority of such firm as experts in accounting and auditing.


UNAUDITED INTERIM STATEMENTS


The information for the interim period ended March 31, 2012 is unaudited; however, it includes all adjustments considered necessary by management for a fair presentation of our financial condition and results of operations.




WHERE YOU CAN FIND MORE INFORMATION


We have filed with the Securities and Exchange Commission a registration statement on Form S-1, including exhibits, schedules and amendments, under the Securities Act with respect to the shares of common stock to be sold in this offering. This prospectus does not contain all the information included in the registration statement. For further information about us and the shares of our common stock to be sold in this offering, please refer to our registration statement.


As of the effective date of our registration statement of which this prospectus is a part, we will become subject to certain informational requirements of the Exchange Act, as amended and we will be required to file periodic reports (i.e., annual, quarterly and material events) with the SEC which will be immediately available to the public for inspection and copying. Except during the year that our registration statement becomes effective, these reporting obligations may (in our sole discretion) be automatically suspended under Section 15(d) of the Exchange Act if we have less than 500 or more security holders and $10 million in assets and do not file a registration statement on Form 8-A (of which we have no current plans to file). If this occurs after the year in which our registration statement becomes effective, we will no longer be obligated to file such periodic reports with the SEC and your access to our business information would then be even more restricted. After this registration statement on Form S-1 becomes effective, we may be required to deliver periodic reports to security holders as proscribed by the Exchange Act, as amended. However, we will not be required to furnish proxy statements to security holders and our directors, officers and principal beneficial owners will not be required to report their beneficial ownership of securities to the SEC pursuant to Section 16 of the Exchange Act until we have both 500 or more security holders and greater than $10 million in assets. This means that access to information regarding our business and operations will be limited.


You may read and copy any document we file at the SEC's public reference room at 100 F Street, N. E., Washington, D.C. 20549. You should call the SEC at 1-800-SEC-0330 for further information on the public reference rooms. Our SEC filings will also be available to the public at the SEC's web site at "http:/www.sec.gov."


You may request, and we will voluntarily provide, a copy of our filings, including our annual report which will contain audited financial statements, at no cost to you, by writing or telephoning us at the following address:


B-Maven, Inc.

3272 Reynard Way

San Diego, CA 92103

619-846-4614







B-MAVEN, INC.

(a Development Stage Company)

June 30, 2011


INDEX TO FINANCIAL STATEMENTS


Contents

Page(s)

Report of Independent Registered Public Accounting Firm

F-2

Balance Sheet at June 30, 2011

F-3

Statement of Operations for the Period June 24, 2011 (inception) to June 30, 2011

F-4

Statement of Stockholders’ Equity for the Period June 24, 2011 (inception)

to June 30, 2011

F-5

Statement of Cash Flows for the Period June 24, 2011 (inception) to June 30, 2011

F-6

Notes to the Financial Statements

F-7

Unaudited Interim Financial Statements for the Period Ended March, 31, 2012

F-12






PLS CPA, A PROFESSIONAL CORP.

t 4725 MERCURY STREET #210t SAN DIEGOt CALIFORNIA 92111t

t TELEPHONE (858)722-5953t FAX (858) 761-0341  t FAX (858) 433-2979

t E-MAIL changgpark@gmail.comt


Report of Independent Registered Public Accounting Firm


To the Board of Directors and Stockholders

B-Maven, Inc.


We have audited the accompanying balance sheet of B-Maven, Inc. (A Development Stage “Company”) as of June 30, 2011 and the related statements of operations, changes in shareholders’ equity and cash flows for the period from June 24, 2011 (inception) to June 30, 2011. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statements presentation. We believe that our audit provides a reasonable basis for our opinion.


In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of B-Maven, Inc. as of June 30, 2011, and the result of its operations and its cash flows for the period from June 24, 2011 (inception) to June 30, 2011 in conformity with U.S. generally accepted accounting principles.


The financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s losses from operations raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.


/s/PLS CPA


PLS CPA, A Professional Corp.

August 17, 2011

San Diego, CA. 92111



Registered with the Public Company Accounting Oversight Board






B-MAVEN, INC.

(a Development Stage Company)

Balance Sheet

June 30, 2011



ASSETS

 

 

 

 

 

CURRENT ASSETS:

 

 

Cash

$

-

 

 

 

OTHER ASSETS:

 

 

Intangible asset – Product formulas

 

2,500

TOTAL ASSETS

$

2,500

 

 

 

 LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

CURRENT LIABILITIES:

 

 

Accrued expenses

$

665

TOTAL LIABILITIES

 

665

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued or outstanding

 


-

Common stock, $0.001 par value; 100,000,000 shares authorized; 7,500,000 shares issued and outstanding

 


7,500

 Deferred offering costs

 

-

 Deficit accumulated during development stage

 

(5,665)

TOTAL STOCKHOLDERS’ EQUITY

 

1,835

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

2,500


See notes to the financial statements.





B-MAVEN, INC.

(a Development Stage Company)

Statement of Operations

For the Period June 24, 2011 (inception) through June 30, 2011


Revenue

$

-

Expenses:

Organization expenses

5,665

Loss before provision for income taxes

5,665

Provision for income tax

-

Net loss

$

(5,665)

Basic and diluted loss per share

$

(0.00)

Weighted average common shares outstanding - basic and diluted

4,285,714


See notes to the financial statements.





B-MAVEN, INC.

(a Development Stage Company)

Statement of Stockholders’ Equity


 


Common

Stock

 

Common

Stock

Amount

 

Additional

Paid-in-

capital

 

Deferred

Offering

Costs

 


Retained

Deficit

 



Total

Balance - June 24, 2011 (date of inception)

-

$

-

$

-

$

-

$

-

$

-

Shares issued for organizational costs on June 27, 2011

5,000,000

 

5,000

 

-

 

-

 

-

 

5,000

Shares issued to acquire product formula and samples on June 27, 2011

2,500,000

 

2,500

 

-

 

-

 

-

 

2,500

Net loss

-

 

-

 

-

 

-

 

(5,665)

 

(5,665)

Balance - June 30, 2011

7,500,000

$

7,500

$

-

$

-

$

$(5,665)

$

1,835


See notes to the financial statements.





B-MAVEN, INC.

(a Development Stage Company)

Statement of Cash Flows

For the Period June 24, 2011 (inception) through June 30, 2011PROSPECTUS

 

CASH FLOW FROM OPERATING ACTIVITIES:

 

 

Net loss

$

(5,665)

Accrued expenses, increase in

 

665

Shares issued for organizational expense

 

5,000

Net Cash Provided by Operating Activities

 

-

CASH FLOW FROM FINANCING ACTIVITIES

 

-

CASH FLOW FROM INVESTING ACTIVITIES

 

-

CHANGE IN CASH

 

-

CASH AT BEGINNING OF PERIOD

 

-

CASH AT END OF PERIOD

$

-

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

Cash paid for:

 

 

Interest

$

-

Income taxes

$

-

Non-cash investing and financing activities:

 

 

Stock issuance for acquiring formulas and product samples

$

2,500


See notes to the financial statements.






B-MAVEN, INC.

(a Development Stage Company)

Notes to the Financial Statements

June 30, 2011


NOTE 1 – ORGANIZATION


B-Maven, Inc. (the Company) was incorporated under the laws of the State of Nevada on June 24, 2011. The Company issued 5,000,000 shares of its common stock to its founder at inception in exchange for organizational costs incurred upon incorporation. Following its formation, the Company issued 2,500,000 shares of its common stock to our founder, as consideration for the purchase of product formulas and additional product samples. Our founder paid approximately $2,500 for product formulas and other product materials to develop further formulas. The acquisition was valued at $2,500.


The Company plans to be engaged in the business of developing, manufacturing, marketing and selling of a collection of cosmetic products, a skin care line combining science with nature to form an advanced beauty treatment. The Company owns the rights to its intellectual property, E-Scentual, an anti-aging formula that is the main ingredient in the E-Scentual Skin Care Collection.


The Company has not generated revenues from its planned principal operations and is considered a development stage company as that term is defined by Financial Accounting Standard Board ("FASB") Accounting Standards Codification ("ASC") 915,Development Stage Entities.


NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


a. Basis of Accounting


The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a June 30, year-end.


b. Cash Equivalents


For purposes of the balance sheet and statement of cash flows, the Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.


c. Stock-based Compensation


The Company follows ASC 718-10,Stock Compensation, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options.


d. Use of Estimates and Assumptions


Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. The Company has adopted the provisions of ASC 260.


e. Earnings (Loss) per Share


The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.






f. Income Taxes


Income taxes are provided in accordance with ASC 740,Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carry forwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.


Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.


No provision was made for Federal income tax.


g. Advertising


Advertising will be expensed in the period in which it is incurred. There has been no advertising expense in the reporting period presented.


h. Intangible assets


Intangible assets with finite lives are amortized over their estimated useful life. The Company monitors conditions related to these assets to determine whether events and circumstances warrant a revision to the remaining amortization period. The Company tests its intangible assets with finite lives for potential impairment whenever management concludes events or changes in circumstances indicate that the carrying amount may not be recoverable. The original estimate of an asset's useful life and the impact of an event or circumstance on either an asset's useful life or carrying value involve significant judgment.


i. Recently Issued Accounting Pronouncements


In April 2010, new accounting guidance was issued for the milestone method of revenue recognition. Under the new guidance, an entity can recognize revenue from consideration that is contingent upon achievement of a milestone in the period in which the milestone is achieved only if the milestone meets all criteria to be considered substantive. This guidance is effective prospectively for milestones achieved in fiscal years, and interim periods within those years, beginning on or after June 15, 2010. The Company adopted the provisions of this guidance which does not have a material impact on its financial statements.


In February 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-09,Amendments to Certain Recognition and Disclosure Requirements (“ASU 2010-09”), which is included in the FASB Accounting Standards Codification (the “ASC”) Topic 855Subsequent Events. ASU 2010-09 clarifies that an SEC filer is required to evaluate subsequent events through the date that the financial statements are issued. ASU 2010-09 is effective upon the issuance of the final update and did not have a significant impact on the Company’s financial statements.


In January 2010, the FASB issued ASU 2010-06, “Fair Value Measurements and Disclosures (ASC 820): Improving Disclosures about Fair Value Measurements.” This update will require (1) an entity to disclose separately the amounts of significant transfers in and out of Levels 1 and 2 fair value measurements and to describe the reasons for the transfers; and (2) information about purchases, sales, issuances and settlements to be presented separately (i.e. present the activity on a gross basis rather than net) in the reconciliation for fair value measurements using significant unobservable inputs (Level 3 inputs). This guidance clarifies existing disclosure requirements for the level of disaggregation used for classes of assets and liabilities measured at fair value and require disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements using Level 2 and Level 3 inputs. The new disclosures and clarifications of existing disclosure are effective for fiscal years beginning after December 15, 2009, except for the disclosure requirements for related to the purchases, sales, issuances and settlements in the roll-forward activity of Level 3 fair value measurements. Those disclosure requirements are effective for fiscal years ending after December 31, 2010. The Company does not believe the adoption of this guidance will have a material impact to its financial statements. Management does not believe that other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants or the SEC have a material impact on the Company’s present or future financial statements.






In June 2009, the FASB issued guidance now codified as ASC 105,Generally Accepted Accounting Principles as the single source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP, aside from those issued by the SEC. ASC 105 does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all authoritative literature related to a particular topic in one place. The adoption of ASC 105 did not have a material impact on the Company’s financial statements, but did eliminate all references to pre-codification standards.


The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.


NOTE 3 – GOING CONCERN


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As reflected in the accompanying financial statements, the Company had negative working capital of $665 and a deficit accumulated during the development stage of $5,665 at June 30, 2011. As of June 30, 2011, it had not generated any revenue and had no committed sources of capital or financing.


While the Company is attempting to generate revenues from product formulas, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes that the actions presently being taken to further implement its business plan and generate additional products and revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to realize revenues and in its ability to raise additional funds, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to achieve profitable operations or obtain adequate financing.


The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


NOTE 4 – SHARE CAPITAL


The Company is authorized to issue 100,000,000 shares of common stock and 1,000,000 shares of preferred stock. The Company issued 5,000,000 shares of its common stock to its incorporator, chief executive officer and president for organization costs/services. These services were valued at $5,000. Following its formation, the Company issued 2,500,000 shares of our common stock to our incorporator, chief executive officer and president, as consideration for the purchase of various product formulas and sample products. This individual paid approximately $2,500 in product purchases and labor costs to develop the formulas. The acquisition of the formulas and sample products was valued at $2,500.


At June 30, 2011, there are 7,500,000 shares of common stock issued and outstanding.


NOTE 5 – COMMITMENTS


The Company is obligated to certain professionals for costs related to its direct public offering. The Company’s in its capacity is solely obligated for these fees.






NOTE 6 – INCOME TAXES


As of June 30, 2011, the Company had net operating loss carry forwards of $5,665 that may be available to reduce future years’ taxable income through 2031.


 

 

As of

June 30,

2011

 

 

 

Deferred tax assets:

 

 

Net operating tax carryforwards

$

2,209

Other

 

-

Gross deferred tax assets

 

2,209

Valuation allowance

 

(2,209)

 

 

 

Net deferred tax assets

$

-


Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carryforwards are expected to be available to reduce taxable income. As the achievement of required future taxable income is uncertain, the Company recorded a valuation allowance.


NOTE 7 - SUBSEQUENT EVENTS


In accordance with ASC 855,Subsequent Events, the Company has evaluated subsequent events occurring after June 30, 2011 through August 17, 2011. During this period, the Company did not have any material recognizable subsequent events that required disclosure in these financial statements.







B-MAVEN, INC.

(a Development Stage Company)

Balance Sheets


 

 

March 31,

2012

(unaudited)

 

June 30,

2011

(audited)

ASSETS

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

Cash

$

1,708

$

-

Prepaid expense

 

350

 

-

Inventory

 

547

 

-

Total Current Assets

 

2,605

 

-

 

 

 

 

 

OTHER ASSETS:

 

 

 

 

Deferred offering costs

 

26,724

 

-

Intangible asset – Product formulas, net

 

1,562

 

2,500

Total Other Assets

 

28,286

 

2,500

TOTAL ASSETS

$

30,891

$

2,500

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

Accrued expenses

$

32,250

$

665

Loans – related party

 

908

 

-

Loans – unrelated parties  

 

11,626

 

-

TOTAL LIABILITIES

 

44,784

 

665

 

 

 

 

 

STOCKHOLDERS’ EQUITY (DEFICIT):

 

 

 

 

Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued or outstanding

 

-

 

-

Common stock, $0.001 par value; 100,000,000 shares authorized; 7,500,000 shares issued and outstanding

 

7,500

 

7,500

 Additional paid in capital

 

-

 

-

 Deficit accumulated during development stage

 

(21,393)

 

(5,665)

TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)

 

(13,893)

 

1,835

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

$

30,891

$

2,500


See notes to the financial statements.





B-MAVEN, INC.

(a Development Stage Company)

Statements of Operations

(unaudited)


 

 

For the

three months

ended

March 31,

2012

 

For the nine

months ended

March31,

2012

 

For the period

June 24, 2011

(inception)

through

March 31,

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

-

$

-

$

-

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

Samples/marketing expense

 

116

 

1,204

 

1,204

Consulting and other expense

 

5,222

 

13,586

 

13,586

Amortization expense

 

313

 

938

 

938

Organization expenses

 

-

 

-

 

5,665

Loss before provision for income taxes

 

5,651

 

15,728

 

21,393

 

 

 

 

 

 

 

Provision for income tax

 

-

 

-

 

-

 

 

 

 

 

 

 

Net loss

$

(5,651)

$

(15,728)

$

(21,393)

 

 

 

 

 

 

 

Basic and diluted loss per share

$

(0.00)

$

(0.00)

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic and diluted

 

7,500,000

 

7,500,000

 

 


See notes to the financial statements.






B-MAVEN, INC.

(a Development Stage Company)

Statements of Cash Flows13, 2024

 (unaudited)

 

 



For the nine

months ended

March 31,

2012

 

For the period

June 24, 2011

(inception)

through

March 31,

2012

 

 

 

 

 

CASH FLOW FROM OPERATING ACTIVITIES:

 

 

 

 

Net loss

$

(15,728)

$

(21,393)

Amortization

 

938

 

938

Shares issued for organizational expense

 

-

 

5,000

Adjustments to reconcile net loss to cash (used in) operating activities:

 

 

 

 

Change in inventory

 

(547)

 

(547)

Change in prepaid expense

 

(350)

 

(350)

Change in accrued expenses

 

31,585

 

32,250

Change in deferred offering costs

 

(26,724)

 

(26,724)

Net Cash Provided by (Used in) Operating Activities

 

(10,826)

 

(10,826)

 

 

 

 

 

CASH FLOW FROM INVESTING ACTIVITIES

 

-

 

-

CASH FLOW FROM FINANCING ACTIVITIES:

 

 

 

 

Loans from unrelated parties

 

16,626

 

16,626

Repayment of loan from unrelated party

 

(5,000)

 

(5,000)

Loan from related party

 

908

 

908

Net Cash Provided by (Used In) Financing Activities

 

12,534

 

12,534

CHANGE IN CASH

 

1,708

 

1,708

CASH AT BEGINNING OF PERIOD

 

-

 

-

CASH AT END OF PERIOD

$

1,708

$

1,708

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

Cash paid for:

 

 

 

 

Interest

$

-

$

-

Income taxes

$

-

$

-

Non-cash investing and financing activities:

 

 

 

 

Stock issuance for acquiring formulas and product samples

$

-

$

2,500


See notes to the financial statements.





B-MAVEN, INC.

(a Development Stage Company)

Notes to the Financial Statements (unaudited)

March 31, 2012


NOTE 1 – ORGANIZATION


B-Maven, Inc. (the Company) was incorporated under the laws of the State of Nevada on June 24, 2011. The Company issued 5,000,000 shares of its common stock to its founder at inception in exchange for organizational costs incurred upon incorporation. Following its formation, the Company issued 2,500,000 shares of its common stock to our founder, as consideration for the purchase of her product formulas and additional product samples. Our founder paid approximately $2,500 for product formulas and other materials to develop further formulas. The acquisition was valued at $2,500.


The Company plans to be engaged in the business of developing, manufacturing, marketing and selling of a collection of cosmetic products, a skin care line combining science with nature to form an advanced beauty treatment of all natural products. The Company owns the rights to its intellectual property, E-Scentual, an anti-aging formula that is the main ingredient in the E-Scentual Skin Care Collection. The Company has distributed over 1,000 samples of its products to potential end-users in the Southern California and New England region, including New York.


The Company has not generated revenues from its planned principal operations and is considered a development stage company as that term is defined by Financial Accounting Standard Board ("FASB") Accounting Standards Codification ("ASC") 915,Development Stage Entities.


NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Interim Financial Statements and Basis of Presentation


The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) set forth in Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Unaudited interim results are not necessarily indicative of the results for the full fiscal year.  These financial statements should be read in conjunction with the financial statements of the Company for the period ended June 30, 2011 and notes thereto contained elsewhere in this Prospectus.

a. Basis of Accounting


The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected a June 30, year-end.


b. Cash Equivalents


For purposes of the balance sheet and statement of cash flows, the Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.


c. Inventory


Inventory consists of containers and raw materials to be used for our skin care products and is valued at the lower of cost (first-in, first-out) or net realizable value. The Company evaluates its inventory for excess and obsolescence on a regular basis. In preparing the evaluation the Company will look at the expected demand for the product, as well as any changes in technology, in order to determine whether or not a reserve is necessary to record the inventory at net realizable value. No such reserve has been deemed necessary as of March 31, 2012. The Company expenses in the period that it disburses finished goods product as samples or testers to end users for evaluation. The Company for the three month and nine month period ended March 31, 2012 recognized $116 and $1,204, respectively, in sample expense.






d. Stock-based Compensation


The Company follows ASC 718-10,Stock Compensation, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options.


e. Use of Estimates and Assumptions


Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures.  Accordingly, actual results could differ from those estimates.  The Company has adopted the provisions of ASC 260.  


f. Earnings (Loss) per Share


The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.


g. Income Taxes


Income taxes are provided in accordance with ASC 740,Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carry forwards.  Deferred tax expense (benefit) results  from  the net  change  during  the  year of  deferred  tax  assets  and liabilities.


Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.


No provision was made for Federal income tax.  


h. Advertising


Advertising will be expensed in the period in which it is incurred. There has been no advertising expense in the reporting period presented.


i. Intangible assets


Intangible assets with finite lives are amortized over their estimated useful life. The Company monitors conditions related to these assets to determine whether events and circumstances warrant a revision to the remaining amortization period. The Company tests its intangible assets with finite lives for potential impairment whenever management concludes events or changes in circumstances indicate that the carrying amount may not be recoverable. The original estimate of an asset's useful life and the impact of an event or circumstance on either an asset's useful life or carrying value involve significant judgment.


For the three month and nine month period ended March 31, 2012 we recognized $313 and $938, respectively, in amortization expense. Our product formulas were determined to have been placed in service through the distribution of sample products to potential customers. We amortize our product formulas over 24 months.


j. Recently Issued Accounting Pronouncements


The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.






NOTE 3 – GOING CONCERN


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As reflected in the accompanying financial statements, the Company had negative working capital of $42,179 and a deficit accumulated during the development stage of $21,393 at March 31, 2012.  As of March 31, 2012, the Company had not generated any revenue and had no committed sources of capital or financing.


While the Company is attempting to begin the generation of revenues from the sale of products from our formulas, the Company’s cash position may not be significant enough to support the Company’s daily operations. The Company is actively seeking the assistance of a distribution and packaging business to assist in the generation of revenues. Management believes that the actions presently being taken to further implement its business plan and generate products and revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to realize revenues and in its ability to raise additional funds, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to achieve profitable operations or obtain adequate financing.


The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


NOTE 4 – SHARE CAPITAL


The Company is authorized to issue 100,000,000 shares of common stock and 1,000,000 shares of preferred stock. The Company issued 5,000,000 shares of its common stock to its incorporator, chief executive officer and president for organization costs/services. These services were valued at $5,000. Following its formation, the Company issued 2,500,000 shares of our common stock to our incorporator, chief executive officer and president, as consideration for the purchase of various product formulas and sample products. This individual paid approximately $2,500 in product purchases and labor costs to develop the formulas. The acquisition of the formulas and sample products was valued at $2,500.


At March 31, 2012, there are 7,500,000 shares of common stock issued and outstanding.


NOTE 5 – LOANS - RELATED PARTIES


As of March 31, 2012 the Company received $908 in loan proceeds from our shareholder and founder in order to fund working capital expenses. This loan is unsecured and carries no interest rate or repayment terms.


NOTE 6 – LOANS - UNRELATED PARTIES


As of March 31, 2012 the Company received $11,626 in loan proceeds from two unrelated parties who are business acquaintances of our shareholder and founder in order to fund working capital expenses. These loans are unsecured and carry no interest rate or repayment terms.


NOTE 7 – DEFERRED OFFERING COSTS


Deferred offering costs consist principally of accounting fees, legal fees and other fees incurred through the balance sheet date that are related to the proposed common stock offering. Deferred offering costs related to the common stock offering will offset proceeds recorded as equity if the transaction is completed or charged to expense if the common stock offering is not completed. As of March 31, 2012, deferred offering costs are $26,724. The Company incurred $20,000 in deferred offering costs for legal services performed by our former securities counsel.


The Company entered into an arrangement with its former legal counsel in order to seek assistance in lending funds necessary to cover legal expenses associated with the filing of its Prospectus and direct public offering. Legal services were estimated to be approximately $60,000 and due and payable only upon Notice of Effectiveness by the Securities Exchange Commission. We terminated this arrangement and representation by our former securities counsel as of January 23, 2012. It was agreed that $20,000 was earned by our former securities counsel as settlement under this arrangement terminated on January 23, 2012. On March 7, 2012 we retained the services of new securities counsel to assist in the filing of the Company’s direct public offering.






NOTE 8 – INCOME TAXES


As of March 31, 2012, the Company had net operating loss carry forwards of $21,393 that may be available to reduce future years’ taxable income through 2031.


 

 

As of

March 31,

2012

 

 

 

Deferred tax assets:

 

 

Net operating tax carryforwards

$

8,343

Other

 

-

Gross deferred tax assets

 

8,343

Valuation allowance

 

(8,343)

 

 

 

Net deferred tax assets

$

-


Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carryforwards are expected to be available to reduce taxable income.  As the achievement of required future taxable income is uncertain, the Company recorded a valuation allowance.


NOTE 9 - SUBSEQUENT EVENTS


In accordance with ASC 855,Subsequent Events, the Company has evaluated subsequent events occurring after March 31, 2012 through April 3, 2012, the date the financial statements were available to be issued. The Company entered into an arrangement with an import/export business to exclusively distribute the Company’s products when available for sale in the Pacific Rim region. This agreement is for a period of one year expiring on the first anniversary with an option by both parties to extend for an additional period of two years.






This prospectus is part of a registration statement we filed with the SEC. You should rely only on the information or representations provided in this prospectus. We have authorized no one to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus is accurate as of any date other than the date on the front of the document.


No one (including any salesman or broker) is authorized to provide oral or written information about this offering that is not included in this prospectus.


The information contained in this prospectus is correct only as of the date set forth on the cover page, regardless of the time of the delivery of this prospectus.


Until ________, 2012 (90 days after the commencement of the offering), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.


2,500,000 Shares

B-Maven, Inc.

Common Stock


PROSPECTUS

___________, __, 2012









TABLE OF CONTENTS



SUMMARY FINANCIAL DATA

34

6

RISK FACTORS

6

USE OF PROCEEDS

17

THE OFFERING

18

DETERMINATION OF OFFERING PRICE

19

DILUTION

19

DIVIDEND POLICY

21

MARKET FOR SECURITIES

21

NOTE REGARDING FORWARD-LOOKING STATEMENTS

23

MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

23

BUSINESS

28

DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

33

PRINCIPAL SHAREHOLDERS

35

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

36

DESCRIPTION OF CAPITAL STOCK

37

PLAN OF DISTRIBUTION

40

LEGAL MATTERS

44

EXPERTS

44

UNAUDITED INTERIM STATEMENTS

44

WHERE YOU CAN FIND MORE INFORMATION

45

Table of Contents









PartPART II


INFORMATION NOT REQUIRED IN PROSPECTUS


ITEM 13Item 13. Other Expenses of Issuance and Distribution.

OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION


The Registrant is bearing allfollowing table sets forth the estimated costs and expenses in connection with this registration statement other than sales commissions, underwriting discounts and underwriter's expense allowances designated as such. Estimated expenses payable by the Registrantto be incurred in connection with the registrationissuance and distribution of the Common Stocksecurities of IQSTEL Inc. (the “Registrant”) which are registered herebyunder this Registration Statement on Form S-1 (this “Registration Statement”). All amounts are as follows:estimates except the Securities and Exchange Commission registration fee.


SEC Registration fee

$

2.91

NASD filing fee

 

100.00

*Accounting fees and expenses

 

5,000.00

*Legal fees and expenses

 

50,000.00

*Transfer agent fees

 

2,500.00

*Blue Sky fees and expenses

 

5,000.00

*Miscellaneous expenses

 

2,397.09

 

 

 

Total

$

65,000.00

*IndicatesThe following expenses that have been estimated for filing purposes.will be borne solely by the Registrant.

  Amount to
  be Paid
SEC Registration fee $ 1,260.34
Legal fees and expenses  5,000
Accounting fees and expenses  5,000
Total $11,260.34


ITEM 14

INDEMNIFICATION OF DIRECTORS AND OFFICERSItem 14. Indemnification of Directors and Officers.


The Company hasUnder our bylaws, every person who was or is a provisionparty to, or is threatened to be made a party to, or is involved in its Certificateany action, suit, or proceeding, whether civil, criminal, administrative, or investigative, by reason of Incorporation at Article XI thereof providing for indemnification of its officers and directors as follows.


Our Articles of Incorporation at Article XI provide for indemnification as follows: "Nothe fact that he is or was our director or officer, of the Corporation shall be personally liable to the Corporation or any of its stockholders for damages for breach of fiduciary dutyis or was serving at our request as a director or officer; provided, however, that the foregoing provision shall not eliminate or limit the liability of a director or officer: (i) for acts or omissions which involve intentional misconduct, fraud or knowing violation of law; or (ii) the payment of dividends in violation of Section 78.300 of the Nevada Revised Statutes. Any repeal or modification of an Article by the stockholders of the Corporation shall be prospective only, and shall not adversely affect any limitation of the personal liability of a director or officer of another corporation, or as its representative in a partnership, joint venture, trust, or other enterprise, shall be indemnified and held harmless to the Corporation for actsfullest extent legally permissible under the laws of the State of Nevada from time to time against all expenses, liability, and loss (including attorneys’ fees judgments, fines, and amounts paid or omissions prior to be paid in settlement) reasonably incurred or suffered by him or her in connection therewith. Such right of indemnification shall be a contract right, which may be enforced in any manner desired by such repealperson. The expenses of officers and directors incurred in defending a civil or modification."


criminal action, suit, or proceeding must be paid by us as they are incurred and in advance of the final disposition of the action, suit, or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he is not entitled to be indemnified by us. Such right of indemnification shall not be exclusive of any other right which such directors, officers, or representatives may have or hereafter acquire, and, without limiting the generality of such statement, they shall be entitled to their respective rights of indemnification under any bylaw, agreement, vote of shareholders, provision of law, or otherwise.

 

Without limiting the application of the foregoing, our board of directors may adopt bylaws from time to time with respect to indemnification, to provide at all times the fullest indemnification permitted by the laws of the State of Nevada, and may cause us to purchase and maintain insurance on behalf of any person who is or was our director or officer, or is or was serving at our request as a director or officer of another corporation, or as its representative in a partnership, joint venture, trust, or other enterprise against any liability asserted against such person and incurred in any such capacity or arising out of such status, whether or not we would have the power to indemnify such person. The indemnification provided shall continue as to a person who has ceased to be a director, officer, employee, or agent, and shall inure to the benefit of the heirs, executors and administrators of such person.

Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to directors, officers andor persons controlling persons of the Companyus pursuant to the foregoing provisions, or otherwise, the registrant haswe have been advisedinformed that in the opinion of the Securities and Exchange CommissionSEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event

We have not entered into any agreements with our directors and executive officers that require us to indemnify these persons against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred (including expenses of a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any such action, suit or proceeding) is asserted by such director, officer or controlling personderivative action) in connection with any proceeding, whether actual or threatened, to which any such person may be made a party by reason of the securities being registered,fact that the Registrant will, unless inperson is or was our director or officer or any of our affiliated enterprises. We have an insurance policy covering our officers and directors with respect to certain liabilities, including liabilities arising under the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in theSecurities Act, and will be governed by the final adjudication of such issue.or otherwise.

35
Table of Contents


ITEM 15

RECENT SALES OF UNREGISTERED SECURITIESItem 15. Recent Sales of Unregistered Securities.


During the nine months ended September 30, 2023, the Company issued 8,635,884 shares of common stock, valued at fair market value on issuance as follows:

180,000 shares for compensation to our directors valued at $30,945; and
8,455,884 shares for exercise of warrants for $1,150,000. 

During the year ended December 31, 2022, the Company issued 14,118,153 shares of common stock, valued at fair market value on issuance as follows:

2,000,000 shares issued for cash of $1,000,000
5,066,667 shares for acquisitions of Whisl and Smartbiz valued at $1,550,000
550,000 shares for asset acquisition valued at $357,500
240,000 shares for compensation to our directors valued at $107,600
161,367 shares for settlement of debt valued at $80,674
6,100,119 shares for exercise of warrants for $400,000

During the three years precedingyear ended December 31, 2021, the filingCompany issued 51,638,526 shares of this Form S-1, Registrant hascommon stock, valued at fair market value on issuance as follows:

41,562,500 shares issued for cash of $6,536,250, of which $100,000 was recorded as subscription receivable as of December 31, 2021. The Company received the $100,000 on January 3, 2022.
2,230,394 shares, valued at $2,056,530, issued for settlement of debt of $1,516,667
195,000 shares for services valued at $284,700
1,320,000 shares issued to our management for compensation valued at $1,037,568
250,000 shares for forbearance of debt valued at $49,925
6,080,632 shares issued for conversion of debt of $422,295

The offers, sales, and issuances of the securities withoutdescribed above were deemed to be exempt from registration under the Securities Act on the terms and circumstances described in the following paragraphs.


Of the 7,500,000 outstanding shares, 5,000,000 were issued to Ms. Jones, the Company’s president upon our incorporation in Nevada in June 2011 in exchange for organizational services incurred upon incorporation. Following its formation, the Company issued 2,500,000 shares of its common stock to Ms. Jones, as consideration for her product formulas and sample materials.


The foregoing issuances of securities were affected in reliance upon the exemption from registration provided by section 4(2) underon Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder as transactions by an issuer not involving a public offering. The recipients of 1933, (the “Act”) as amended.


Notwithstanding being accredited all security holders were providedsecurities in each of these transactions acquired the securities for investment only and not with a final pre-filing copyview to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the Company’s Registrationrecipients of securities in these transactions was an accredited or sophisticated person and had adequate access, through employment, business or other relationships, to information about us.

Item 16. Exhibits and Financial Statement Schedules.

See Exhibit Index attached hereto and acknowledged having read and reviewed same and having no further questions with respect to their respective investments.incorporated herein by this reference.



II-1Item 17. Undertakings





ITEM 16

EXHIBITS


*3.1

Articles of Incorporation

*3.2

By-Laws

5.1b

Opinion of Quick Law Group, P.C.

*10.1

Agreement between B-Maven, Inc., and Gary B. Wolff, P.C.

*10.2

Agreement regarding Conflict of Interest

**10.3

Termination Agreement between B-Maven, Inc., and Gary B. Wolff, P.C.

**10.4

International Distribution Agreement between B-Maven, Inc. and ELVIE Corporation

*14.1

Code of Ethics

23.1e

Consent of PLS CPA, a professional corporation

23.2e

Consent of Quick Law Group, P.C. (included in Exhibit 5.1b)

*99.1

Copy of Subscription Agreement

99.1b

Copy of Subscription Agreement, as amended

99.2

Fund Retention Agreement with the Quick Law Group, P.C.


*Filed with initial filing.

** Filed with Pre-Effective Amendment No. 4.


Exhibits are not part of the prospectus and will not be distributed with the prospectus.


ITEM 17

UNDERTAKINGS


a.

(A) The undersigned registrant hereby undertakes:


1.

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:


i.

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;


36
Table of Contents

ii.

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increaseincreases or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation“Calculation of Registration Fee"Fee” table in the effective registration statement.statement;


iii.

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;statement.


2.

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.


3.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.



II-2






4.

(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:


(i) If the registrant is relying on Rule 430B:

(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or

(ii) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.


37
Table of Contents

5.

(5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: Thesecurities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:


i.

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;


ii.

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;


iii.

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and


iv.

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.


(b)(6) To provide to the underwriter at the closing specified in the underwriting agreements certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.

Request for Acceleration of Effective Date or Filing of Registration Statement Becoming Effective Upon Filing.


(B) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.




II-3(C) The undersigned registrant hereby undertakes that:





(1) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.


(2) For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

38
Table of Contents

SIGNATURES


Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the cityCity of San Diego,New York, State of CaliforniaNew York, on the 11th day of May, 2012.February 13, 2024.


IQSTEL Inc.

B-MAVEN, INC.

By:
/s/ Leandro Iglesias

/s/ Anna C. Jones

By: Anna C. Jones, President, CEO,Leandro Iglesias

Chief Executive Officer, Principal Executive Officer Treasurer, Chairman,and Director

By:/s/ Alvaro Quintana Cardona 
Alvaro Quintana Cardona    
Title:Chief Operating Officer, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer

and Director



POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints Leandro Iglesias and Alvaro Quintana Cardona with full power to act alone and without the others, his true and lawful attorney-in-fact, with full power of substitution, and with the authority to execute in the name of each such person, any and all amendments (including without limitation, post-effective amendments) to this registration statement, to sign any and all additional registration statements relating to the same offering of securities as this registration statement that are filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file such registration statements with the Securities and Exchange Commission, together with any exhibits thereto and other documents therewith, necessary or advisable to enable the registrant to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, which amendments may make such other changes in the registration statement as the aforesaid attorney-in-fact executing the same deems appropriate.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statementregistration statement has been signed below by the following persons in the capacities and on the datedates indicated.



By:/s/ Leandro Iglesias

Signature(s)

Title(s)

Date


/s/ Anna C. Jones


President, CEO, Principal Executive


May 11, 2012

By: Anna C. JonesLeandro Iglesias

Chief Executive Officer, Principal Executive Officer and Director

February 13, 2024

By:/s/ Alvaro Quintana Cardona 
Alvaro Quintana Cardona    
Title:Chief Operating Officer, Treasurer, Chairman,Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer and Director
Date:February 13, 2024

By:/s/ Raul Perez 
Raul Perez    
Title:Director
Date:February 13, 2024

By:/s/ Jose Antonio Barreto 
Jose Antonio Barreto
Title:Director
Date:February 13, 2024

By:/s/ Italo Segnini 
Italo Segnini
Title:Director
Date:February 13, 2024

39
Table of Contents

EXHIBIT INDEX

(a) Exhibits:

Exhibit No.Description of Exhibit
Exhibit 2.1Membership Interest Purchase Agreement(1)
Exhibit 2.2Memorandum of Understanding and Shareholders Agreement dated February 21, 2020(5)
Exhibit 2.3Memorandum of Understanding and Shareholders Agreement dated February 12, 2020(6)
Exhibit 2.4Company Purchase Agreement, dated April 1, 2019(11)
Exhibit 2.5Share Purchase Agreement, dated January 19, 2024(23)
Exhibit 3.1Articles of Incorporation of the Registrant(2)
Exhibit 3.2Certificate of Amendment(3)
Exhibit 3.3Certificate of Amendment(18)
Exhibit 3.4Certificate of Designation(20)
Exhibit 3.5

Certificate of Designation(21)

Exhibit 3.6

Certificate of Designation(22)

Exhibit 3.7

Amended and Restated Bylaws of the Registrant(19)

Exhibit 4.1

Amendment #2 to the Crown Capital Note dated March 2, 2020(4)
Exhibit 4.2Amendment #2 to the Auctus Fund Note dated March 2, 2020(4)
Exhibit 4.2Amendment #1 to the Labrys Fund Note dated February 11, 2020(7)
Exhibit 4.3Amendment #1 to the ADI Funding Note dated December 23, 2019(8)
Exhibit 4.4Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.5Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.6Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.7Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.8Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.9Amendment #1 to the ADI Funding Note dated December 24, 2019(8)
Exhibit 4.10Amendment #1 to the Crown Capital Note dated December 23, 2019(8)
Exhibit 4.11Amendment #1 to the Auctus Fund Note dated January 1, 2020(8)
Exhibit 4.12Senior Secured Convertible Promissory Note to Labrys Fund dated December 3, 2019(9)
Exhibit 4.13Purchase Company Agreement, dated April 21, 2022(12)
Exhibit 4.14Purchase Company Agreement, dated May 6, 2022(13)
Exhibit 4.15Common Stock Purchase Option with ADI Funding dated April 5, 2022(14)
Exhibit 4.16Amended Common Stock Purchase Option with ADI Funding dated September 29, 2022(15)
Exhibit 4.17Secured Convertible Promissory Note, dated January 24, 2024(23)
Exhibit 4.18Common Stock Purchase Option, dated February 12, 2024(24)
Exhibit 5.1Opinion of The Doney Law Firm, with consent to use**
Exhibit 10.1Conversion Agreement with Carmen Cabell(1)
Exhibit 10.2Conversion Agreement with Patrick Gosselin(1)
Exhibit 10.3Conversion Agreement with Mark Engler(1)
Exhibit 10.4Employment Agreement with Leandro Iglesias(1)
Exhibit 10.5Employment Agreement with Alvaro Quintana Cardona(1)
Exhibit 10.6Employment Agreement with Juan Carlos Lopez Silva(1)
Exhibit 10.7Forbearance Agreement dated December 12, 2019(8)
Exhibit 10.8Temporary Forbearance Agreement dated December 18, 2019(8)
Exhibit 10.9Securities Purchase Agreement, dated December 3, 2019(9)
Exhibit 10.10Employment and Indemnification Agreements with Leandro Iglesias, dated May 2, 2019(10)
Exhibit 10.11Employment and Indemnification Agreements with Alvaro Quintana, dated May 2, 2019(10)
Exhibit 10.12Employment and Indemnification Agreements with Juan Carlos Lopez Silva, dated May 2, 2019(10)
Exhibit 10.13Registration Rights Agreement with ADI Funding dated April 5, 2022(16)
Exhibit 10.14  Securities Purchase Agreement, dated January 24, 2024(23)
Exhibit 10.15  Registration Rights Agreement with M2B Funding Corp., dated January 24, 2024(23)
Exhibit 10.16  Security Agreement, dated January 24, 2024(23)
Exhibit 14.1Code of Business Conduct and Ethics(17)
Exhibit 23.1Consent of Independent Registered Public Accounting Firm**
Exhibit 23.2Consent of Independent Registered Public Accounting Firm**
Exhibit 23.3Consent of The Doney Law Firm (included in Exhibit 5.1)**
Exhibit 24.1Power of Attorney (included on signature page)
Exhibit 107Filing fee table**



Filed herewith**



41
Table of Contents

II-4

1.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on June 28, 2018.
2.Incorporated by reference to the Company’s Registration Statement on Form S-1 filed with the US Securities and Exchange Commission on August 18, 2011.
3.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on August 31, 2018.
4.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on March 30, 2020.
5.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on February 25, 2020.
6.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on February 19, 2020.
7.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on February 13, 2020.
8.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on January 6, 2020.
9.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on December 11, 2019.
10.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on May 6, 2019.
11.Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on April 4, 2019.
12Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on April 26, 2022.
13Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on May 10, 2022.
14Incorporated by reference to the Company’s Form S-1/A filed with the US Securities and Exchange Commission on September 22, 2022.
15Incorporated by reference to the Company’s Form 8-K/A filed with the US Securities and Exchange Commission on October 6, 2022.
16Incorporated by reference to the Company’s Form S-1/A filed with the US Securities and Exchange Commission on October 11, 2022.
17Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on November 2, 2022.
18Incorporated by reference to the Company’s DEF 14C filed with the US Securities and Exchange Commission on May 12, 2020.
19Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on December 14, 2022.
20Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on January 8, 2021.
21Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on November 13, 2020.
22Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on November 6, 2020.
23Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on January 25, 2024. 
24Incorporated by reference to the Company’s Form 8-K filed with the US Securities and Exchange Commission on February 13, 2024. 


42